Certain portions of the registrant\u2019s definitive proxy statement, in connection with its 2025 annual meeting of stockholders, to be filed within 120\u00a0days of December\u00a031, 2025, are incorporated by reference into Part\u00a0III of this Annual Report on Form\u00a010-K.
"}]},{"name":"rpt:f-61","factDimensions":{"xbrl:concept":"cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Risk Management and Strategy
The Company recognizes the importance of developing, implementing, and maintaining cybersecurity measures to assess, identify, and manage material risks from cybersecurity (including cybersecurity threats associated with the use of third-party service providers), to safeguard our information systems, and to protect the confidentiality, integrity, and availability of the data on our information systems.
Managing Material Risks & Integrated Overall Risk Management
The Company has strategically integrated cybersecurity risk management into our broader risk management framework. Management has formed cross-functional risk and information security committees (the \u201cSecurity Committees\u201d) to initiate, develop, review and implement cybersecurity policies, procedures and training to mitigate cybersecurity risks. Our information technology (\u201cIT\u201d) cybersecurity leadership team works closely with our Security Committees and internal audit team to evaluate and address cybersecurity risks in alignment with our business objectives and operational needs.
Using a risk-based prioritization approach, the IT cybersecurity leadership team and the Security Committees focus on securing our high value assets, updating our cybersecurity detection and prevention capabilities to identify new threats, and improving compliance processes to protect the Company\u2019s operations and data. During this process, the following factors, among others, are considered: likelihood and severity of risk, impact on the Company and others if a risk materializes, feasibility and cost of controls, and impact of controls on operations.
The Company has also implemented technical safeguards that are designed to protect our information systems from cybersecurity threats, including firewalls, intrusion prevention and detection systems, anti-malware functionality, access controls, and vulnerability and patch management. The Company also makes ongoing strategic investments to address cybersecurity risks, including maintaining insurance coverage to mitigate the potential financial consequences of cybersecurity incidents.
Risk Management Personnel
The Company\u2019s senior IT leadership, comprised of the Chief Information Officers of both AMC and Odeon, and IT cybersecurity teams have the primary responsibility for assessing, monitoring, and managing, our cybersecurity programs. The Company\u2019s senior IT leadership bring over fifty years of combined IT experience to their roles. Each member of the Company\u2019s IT cybersecurity leadership team, comprised of the AMC Director Cybersecurity, the Odeon Group Head of Cyber, Risk and Operations and the AMC SVP & Chief Information Officer, brings 20+ years of IT experience. The Company regularly invests in training for these teams, and key leadership positions hold Certified Information Systems Security Professional certifications. Our senior IT leadership and IT cybersecurity team, with input as appropriate from the Security Committees, oversee our governance programs, tests our compliance with standards, remediate known risks, and direct employee training.
Monitoring Cybersecurity Incidents
The Security Committees are continually informed about the latest developments in cybersecurity, including potential threats and risk management techniques. The Security Committees, and in particular senior IT leadership, IT cybersecurity and internal audit members serving on the Security Committees, implement and oversee processes for the regular monitoring of our information systems. The Company follows the National Institute of Standards and Technology framework to design and implement security processes, tools and procedures, and regular system audits identify and lead to prompt remediation of potential vulnerabilities. In the event of a cybersecurity incident, senior IT leadership and the Security Committees are equipped with a well-defined incident response plan. This plan includes immediate actions to mitigate the impact, internal and external communication plans, and notification requirements.
Engagement of Consultants for Risk Management Services
Recognizing the complexity and evolving nature of cybersecurity threats, the Company engages with a range of external experts to perform a variety of functions for the Company. These include, but are not limited to, cybermaturity audits, targeted ransomware assessment and table-top exercises, red and purple team attack simulations, internal penetration tests and other internal and external audits. These partnerships enable us to leverage specialized knowledge and insights into our cybersecurity strategies and processes.
Overseeing Third-Party Risk
Because we are aware of the risks associated with third-party service providers, the Company implements processes to oversee and manage these risks. The Company utilizes software products and services to monitor and protect the Company\u2019s environment from possible third-party breaches impacting the Company\u2019s environment. This approach is designed to mitigate risks related to data breaches or other security incidents originating from third-parties. Third-parties who have access to highly sensitive information due to services performed and data retained are subject to increased scrutiny.
Risks from Cybersecurity Threats
We have not experienced any cybersecurity incidents that we believe have materially affected, or are likely to materially affect, the Company.
"}]},{"name":"rpt:f-62","factDimensions":{"xbrl:concept":"cyd:CybersecurityRiskManagementProcessesIntegratedFlag","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"true"}]},{"name":"rpt:f-63","factDimensions":{"xbrl:concept":"cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Managing Material Risks & Integrated Overall Risk Management
The Company has strategically integrated cybersecurity risk management into our broader risk management framework. Management has formed cross-functional risk and information security committees (the \u201cSecurity Committees\u201d) to initiate, develop, review and implement cybersecurity policies, procedures and training to mitigate cybersecurity risks. Our information technology (\u201cIT\u201d) cybersecurity leadership team works closely with our Security Committees and internal audit team to evaluate and address cybersecurity risks in alignment with our business objectives and operational needs.
Using a risk-based prioritization approach, the IT cybersecurity leadership team and the Security Committees focus on securing our high value assets, updating our cybersecurity detection and prevention capabilities to identify new threats, and improving compliance processes to protect the Company\u2019s operations and data. During this process, the following factors, among others, are considered: likelihood and severity of risk, impact on the Company and others if a risk materializes, feasibility and cost of controls, and impact of controls on operations.
The Company has also implemented technical safeguards that are designed to protect our information systems from cybersecurity threats, including firewalls, intrusion prevention and detection systems, anti-malware functionality, access controls, and vulnerability and patch management. The Company also makes ongoing strategic investments to address cybersecurity risks, including maintaining insurance coverage to mitigate the potential financial consequences of cybersecurity incidents.
"}]},{"name":"rpt:f-64","factDimensions":{"xbrl:concept":"cyd:CybersecurityRiskManagementThirdPartyEngagedFlag","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"true"}]},{"name":"rpt:f-65","factDimensions":{"xbrl:concept":"cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"true"}]},{"name":"rpt:f-66","factDimensions":{"xbrl:concept":"cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"false"}]},{"name":"rpt:f-67","factDimensions":{"xbrl:concept":"cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Governance
Board of Directors and Audit Committee Oversight
Our board of directors (the \u201cBoard\u201d) understands the critical nature of managing risks associated with cybersecurity threats. The Board has established robust oversight mechanisms to ensure effective governance in managing risks associated with cybersecurity threats.
The audit committee of the Board (the \u201cAudit Committee\u201d) is central to the Board\u2019s oversight of cybersecurity risks and bears the primary responsibility for overseeing these risks. Senior IT leadership regularly informs the Audit Committee, the Chief Financial Officer and other members of the Company\u2019s senior leadership of cybersecurity risks and incidents. This ensures that the highest levels of management are kept abreast of the cybersecurity posture and potential risks facing the Company.
Management\u2019s Role Managing Risk
Senior IT leadership play a pivotal role in managing cybersecurity risk and keeping the Audit Committee apprised of cybersecurity developments. Senior IT leadership provide comprehensive briefings to the Audit Committee on a periodic basis. These briefings encompass a broad range of topics, including:
| \u25cf | current cybersecurity landscape and emerging threats; |
| \u25cf | status of ongoing cybersecurity initiatives and strategies; |
| \u25cf | learnings from any cybersecurity events; and |
| \u25cf | compliance with regulatory requirements and industry standards. |
In addition to our scheduled meetings, the Audit Committee and senior IT leadership maintain an ongoing dialogue regarding emerging or potential cybersecurity risks. The Company, at the direction of the Audit Committee, conducts periodic reviews of the Company\u2019s cybersecurity posture and the effectiveness of its risk management strategies. These reviews help in identifying areas for improvement and ensuring the alignment of cybersecurity efforts with the overall risk management framework.
"}]},{"name":"rpt:f-68","factDimensions":{"xbrl:concept":"cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Board of Directors and Audit Committee Oversight
Our board of directors (the \u201cBoard\u201d) understands the critical nature of managing risks associated with cybersecurity threats. The Board has established robust oversight mechanisms to ensure effective governance in managing risks associated with cybersecurity threats.
The audit committee of the Board (the \u201cAudit Committee\u201d) is central to the Board\u2019s oversight of cybersecurity risks and bears the primary responsibility for overseeing these risks. Senior IT leadership regularly informs the Audit Committee, the Chief Financial Officer and other members of the Company\u2019s senior leadership of cybersecurity risks and incidents. This ensures that the highest levels of management are kept abreast of the cybersecurity posture and potential risks facing the Company.
"}]},{"name":"rpt:f-69","factDimensions":{"xbrl:concept":"cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Audit Committee"}]},{"name":"rpt:f-70","factDimensions":{"xbrl:concept":"cyd:CybersecurityRiskRoleOfManagementTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Management\u2019s Role Managing Risk
Senior IT leadership play a pivotal role in managing cybersecurity risk and keeping the Audit Committee apprised of cybersecurity developments. Senior IT leadership provide comprehensive briefings to the Audit Committee on a periodic basis. These briefings encompass a broad range of topics, including:
| \u25cf | current cybersecurity landscape and emerging threats; |
| \u25cf | status of ongoing cybersecurity initiatives and strategies; |
| \u25cf | learnings from any cybersecurity events; and |
| \u25cf | compliance with regulatory requirements and industry standards. |
In addition to our scheduled meetings, the Audit Committee and senior IT leadership maintain an ongoing dialogue regarding emerging or potential cybersecurity risks. The Company, at the direction of the Audit Committee, conducts periodic reviews of the Company\u2019s cybersecurity posture and the effectiveness of its risk management strategies. These reviews help in identifying areas for improvement and ensuring the alignment of cybersecurity efforts with the overall risk management framework.
"}]},{"name":"rpt:f-71","factDimensions":{"xbrl:concept":"cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Senior IT leadership play a pivotal role in managing cybersecurity risk and keeping the Audit Committee apprised of cybersecurity developments. Senior IT leadership provide comprehensive briefings to the Audit Committee on a periodic basis. These briefings encompass a broad range of topics, including:
| \u25cf | current cybersecurity landscape and emerging threats; |
| \u25cf | status of ongoing cybersecurity initiatives and strategies; |
| \u25cf | learnings from any cybersecurity events; and |
| \u25cf | compliance with regulatory requirements and industry standards. |
| \u25cf | current cybersecurity landscape and emerging threats; |
| \u25cf | status of ongoing cybersecurity initiatives and strategies; |
| \u25cf | learnings from any cybersecurity events; and |
| \u25cf | compliance with regulatory requirements and industry standards. |
NOTE 1\u2014THE COMPANY AND SIGNIFICANT ACCOUNTING POLICIES
\u200b
AMC Entertainment Holdings, Inc. (\u201cHoldings\u201d), through its direct and indirect subsidiaries, including American Multi-Cinema, Inc. (\u201cMulti-Cinema\u201d) and its subsidiaries, (collectively with Holdings, unless the context otherwise requires, the \u201cCompany\u201d or \u201cAMC\u201d), is principally involved in the theatrical exhibition business and owns, operates or has interests in theatres located in the United States and Europe.
Reverse Stock Split. On August 24, 2023, the Company effectuated a reverse stock split at a ratio of one share of Common Stock for every ten shares of Common Stock. As a result of the reverse stock split, each share of Series A Convertible Participating Preferred Stock became convertible into ten shares of Common Stock, and by extension each AMC Preferred Equity Unit became equivalent to one-tenth (1/10th) of a share of Common Stock. The reverse stock split did not impact the number of AMC Preferred Equity Units outstanding. The Company concluded that this change in conversion ratio is analogous to a reverse stock split of the AMC Preferred Equity Units even though the reverse stock split did not have an effect on the number of AMC Preferred Equity Units outstanding.
Accordingly, all references made to share, per share, unit, per unit, or common share amounts in the accompanying consolidated financial statements and applicable disclosures have been retroactively adjusted to reflect the effects of the subsequent reverse stock split. References made to AMC Preferred Equity Units have been retroactively adjusted to reflect the effect of the reverse stock split on their equivalent Common Stock shares.
Liquidity. The Company believes its existing cash and cash equivalents, together with cash generated from operations, will be sufficient to fund its operations and satisfy its obligations currently and through the next twelve months. The Company\u2019s cash burn rates are not sustainable long-term. In order to achieve sustainable net positive cash flows from operating activities and long-term profitability, the Company believes that revenues will need to increase to levels at least in line with pre-COVID-19 revenues. North America box office grosses were down approximately 22% for the year ended December 31, 2025, compared to the year ended December 31, 2019. Until such time as the Company is able to achieve sustainable net positive cash flows from operating activities, it is difficult to estimate the Company\u2019s future cash burn rates and liquidity requirements. Depending on the Company\u2019s assumptions regarding the timing and ability to achieve increased levels of revenue, the estimates of amounts of required liquidity vary significantly.
There can be no assurance that the revenues, attendance levels, and other assumptions used to estimate the Company\u2019s liquidity requirements and future cash burn rates will be correct, and the ability to be predictive is uncertain due to limited ability to predict studio film release dates, the overall production and theatrical release levels, and success of individual titles. Further, there can be no assurances that the Company will be successful in generating the additional liquidity necessary to meet the Company\u2019s obligations beyond twelve months from the issuance of these financial statements on terms acceptable to the Company or at all.
The Company expects, from time to time, to continue to seek to retire or purchase its outstanding debt through cash purchases and/or exchanges for equity or debt, in open-market purchases, privately negotiated transactions or otherwise. Such repurchases or exchanges, if any, will be upon such terms and at such prices as it may determine, and will depend on prevailing market conditions, its liquidity requirements, the availability of authorized share capital, contractual restrictions and other factors. The amounts involved may be material and to the extent equity is used, dilutive. See Note 7\u2014Corporate Borrowings and Finance Lease Liabilities for a summary of debt transactions that occurred during the years ended December 31, 2025, December 31, 2024, and December 31, 2023. Additionally, the Company has bolstered its liquidity through sales of its Common Stock, see Note 8\u2014Stockholders\u2019 Deficit and Note 14\u2014Subsequent Events for further information on these sales.
Use of Estimates. The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Principles of Consolidation. The consolidated financial statements include the accounts of Holdings and all subsidiaries, as discussed above. All significant intercompany balances and transactions have been eliminated in consolidation. The Company manages its business under two reportable segments for its theatrical exhibition operations: U.S. markets and International markets.
Revenues. The Company recognizes revenue, net of sales tax, when it satisfies a performance obligation by transferring control over a product or service to a customer. Admissions and food and beverage revenues are recorded at a point in time when a film is exhibited to a customer and when a customer takes possession of food and beverage offerings.
The Company defers 100% of the revenue associated with the sales of gift cards and exchange tickets until such time as the items are redeemed or estimated income from non-redemption is recorded. The Company recognizes revenue from non-redeemed or partially redeemed gift cards in proportion to the pattern of rights exercised by the customer (the \u201cProportional Method\u201d). The Company estimates the non-redemption rate for its gift card sales and then applies the rates to the current month sales. The non-redemption rates range from 13% to 30%. The Company recognizes the total amount of expected revenue for non-redemption for that current month\u2019s sales as income over the next to 36 months in proportion to the pattern of actual redemptions. The non-redemption revenue is recorded in other theatre revenues. The Company has used significant amounts of historical data to estimate its non-redemption rates and redemption patterns. The Company also recognizes revenue from non-redeemed or partially redeemed exchange tickets using the Proportional Method. In the International markets, certain exchange tickets are subject to expiration dates, which triggers recognition of non-redemption in other revenues.
The Company recognizes ticket fee revenues based on a gross transaction price. The Company is a principal (as opposed to agent) in the arrangement with third-party internet ticketing companies in regard to the sale of online tickets because the Company controls the online tickets before they are transferred to the customer. The online ticket fee revenues and the third-party commission or service fees are recorded in the line items other theatre revenues and operating expense, respectively, in the consolidated statements of operations.
Film Exhibition Costs. Film exhibition costs are accrued based on the applicable box office receipts and estimates of the final settlement to the film licensors. Film exhibition costs include certain advertising costs. As of December\u00a031, 2025 and December\u00a031, 2024, the Company recorded film payables of $144.4\u00a0million and $143.9\u00a0million, respectively, which are included in accounts payable in the accompanying consolidated balance sheets. During the year ended December 31, 2025, films licensed from the Company\u2019s seven largest movie studio distributors based on revenues accounted for approximately 83% of our U.S. admissions revenues, which consisted of Disney, Warner Bros., Universal, Sony, Paramount, 20th Century Studios, and Lionsgate Films. In Europe, approximately 76% of the Company\u2019s box office revenue came from films attributed to our five largest movie distributor groups, which consisted of Disney, Universal, Warner Bros., Paramount, and Sony. The Company\u2019s revenues attributable to individual distributors may vary significantly from year to year depending upon the commercial success of each distributor\u2019s films in any given year.
Food and Beverage Costs. The Company records rebate payments from vendors as a reduction of food and beverage costs when earned.
Exhibitor Services Agreement. The Company recognizes advertising revenues, which are included in other theatre revenues in the consolidated statements of operations, when it satisfies a performance obligation by transferring a promised good or service to the customers. The advertising contracts with customers generally consist of a series of distinct periods of service, satisfied over time, to provide rights to advertising services. The Company\u2019s exhibitor services agreement with National CineMedia, LLC (\u201cNCM\u201d) includes a significant financing component due to the significant length of time between receiving the non-cash consideration and fulfilling the performance obligation. On April 17, 2025, NCM and the Company entered into the Second Amended and Restated Exhibitor Services Agreement (the \u201cAmended ESA\u201d). The term of the Amended ESA has been extended by five years through February 13, 2042. The Company treated the Amended ESA as a contract modification pursuant to ASC 606 \u2013 Revenue from Contracts with Customers. Accordingly, the Company has allocated the additional consideration received from the contract modification to the exhibitor services agreement contract liability and updated the discount rate used for the significant financing component to 16.12%. Prior to the contract modification, the weighted average discount rate used to account for the significant financing component was approximately 7.5%. The contract liability will be reclassified to other theatre revenue over the new term of the Amended ESA as the remaining performance obligations are satisfied. See Note 2\u2014Revenue Recognition for further information regarding the Amended ESA.
Customer Loyalty Programs. The Company offers a range of customer loyalty programs worldwide. Depending on the specific program, members can earn rewards, receive discounts, and access exclusive offers and services available only to members. Certain loyalty programs we offer, such as A-List, operate on a subscription model and enable members to watch multiple movies for a recurring fee. Rewards earned by members are redeemable on future purchases at our locations.
The portion of the admissions and food and beverage revenues attributed to the rewards is deferred. Upon redemption or expiration, deferred revenues associated with the rewards are recognized as revenues. The Company estimates reward non-redemption rates using historical information when assigning value to the rewards at the time of sale. Membership fees, net of estimated refunds, for our paid loyalty programs are initially deferred and allocated to the material rights for discounted or free products and services. Revenue is recognized as the rights are redeemed based on estimated utilization, over the membership period in admissions, food and beverage, and other revenues.
Membership fees for our subscription programs are recognized ratably over the subscription period in admissions revenue.
Advertising Costs. The Company expenses advertising costs as incurred and does not have any direct-response advertising recorded as assets. Advertising costs were $21.5 million, $22.2 million, and $43.6 million for the years ended December\u00a031, 2025, December\u00a031, 2024, and December\u00a031, 2023, respectively. Advertising costs are recorded in operating expense in the accompanying consolidated statements of operations.
Cash and Cash Equivalents. All investments purchased with an original maturity of three months or less are classified as cash equivalents. As of December 31, 2025, cash and cash equivalents for the U.S. markets and International markets were $302.6 million and $125.9 million, respectively. As of December 31, 2024, cash and cash equivalents were $513.0 million and $119.3 million, respectively.
Restricted Cash. Restricted cash includes cash held in the Company's bank accounts as a guarantee for certain landlords, legal settlements, and cash collateralized letters of credit relating to the Company\u2019s insurance and utilities programs. The following table provides a reconciliation of cash and cash equivalents and restricted cash reported in the consolidated balance sheet to the total of the amounts in the consolidated statements of cash flows.
Year Ended | |||||||||
(In millions) | December\u00a031, 2025 | December\u00a031, 2024 | December\u00a031, 2023 | ||||||
Cash and cash equivalents | $ | 428.5 | $ | 632.3 | $ | 884.3 | |||
Restricted cash | 48.8 | 48.5 | 27.1 | ||||||
Total cash and cash equivalents and restricted cash in the statement of cash flows | $ | 477.3 | $ | 680.8 | $ | 911.4 |
As of December 31, 2025, restricted cash for the U.S. markets and International markets was $20.5 million and $28.3 million, respectively. As of December 31, 2024, restricted cash for the U.S. markets and International markets was $20.7 million and $27.8 million, respectively.
Intangible Assets. Amortizable intangible assets are being amortized on a straight-line basis over the estimated remaining useful lives of the assets. The Company evaluates definite-lived intangible assets whenever events or changes in circumstances indicate that the carrying amount of the intangible asset may not be fully recoverable. Indefinite-lived intangible assets are not amortized but rather evaluated for impairment annually as of the beginning of the fourth quarter or more frequently if events or circumstances indicate that it is more likely than not that the asset is impaired.
The Company first assesses the qualitative factors to determine whether the existence of events and circumstances indicate that it is more likely than not the fair value of an indefinite-lived intangible asset is less than its carrying amount as a basis for determining whether it is necessary to perform the quantitative impairment test. There were no intangible asset impairment charges incurred during the years ended December\u00a031, 2025, December\u00a031, 2024, and December\u00a031, 2023.
Investments. The Company accounts for its investments in non-consolidated entities using the equity method when Company\u2019s ownership interest provides the Company with significant influence. The Company follows the guidance in ASC\u00a0323-30-35-3, investment in a limited liability company, which prescribes the use of the equity method for investments where the Company has significant influence. Under the equity method, the Company shall recognize its
share of the earnings or losses of an investee. In 2024, the Company reclassified equity earnings and losses to other expense (income), all comparative periods have also been reclassified. Equity investments without readily determinable fair values are recorded at cost less impairment. The Company classifies gains and losses on sales of investments or impairments of investments without a readily determinable fair value in investment expense (income). Investments in non-consolidated entities are presented within other long-term assets in the consolidated balance sheets.
The Company holds common shares and warrants to purchase common shares of Hycroft. The common shares and warrants are recorded at fair value at each reporting period and unrealized gains and losses are reported in investment expense (income). In December 2025, the Company sold 2.3 million shares of Hycroft common stock and warrants for 1.3 million shares for $24.1 million. The Company retained warrants to purchase approximately 1 million Hycroft common shares and approximately 64,000 Hycroft common shares.
During the years ended December 31, 2025, December 31, 2024, and December 31, 2023, the Company recorded realized and unrealized losses (gains) related to the investments in Hycroft of $(34.4) million, $2.9 million, and $12.6 million, respectively in investment income.
On December 30, 2022, the Company entered into an agreement to sell its 10.0% investment in Saudi Cinema Company LLC for SAR 112.5 million ($30.0 million), and on January 24, 2023, the Saudi Ministry of Commerce recorded the sale of equity and the Company received the proceeds on January 25, 2023. The Company recorded a gain on the sale of $(15.5) million in investment income during the year ended December 31, 2023.
Related Party Transactions. The Company conducts business with certain of its equity method investees in the ordinary course of business. Transactions primarily relate to advertising revenue and film exhibition costs for film rent. The Company recorded related party advertising revenue of $26.9 million, $26.7 million, and $28.6 million during the years ended December 31, 2025, December 31, 2024, and December 31, 2023, respectively. The Company recorded related party film exhibition costs of $17.5 million, $29.6 million, and $17.5 million during the years ended December 31, 2025, December 31, 2024, and December 31, 2023, respectively.
Derivatives. The Company remeasures the derivative liabilities related to the conversion features in its Existing Exchangeable Notes and New Exchangeable Notes at fair value each reporting period, with changes in fair value recorded in the consolidated statement of operations in other expense (income). The Company has obtained independent third-party valuation studies to assist in determining fair value. The valuation studies use binomial lattice models and are based on significant inputs not observable in the market and thus represent Level 3 measurements within the fair value measurement hierarchy. The binomial lattice models consist of simulated Common Stock prices from the valuation date to the maturity of the Existing Exchangeable Notes and New Exchangeable Notes. The inputs used to value the derivative include the share price of the Common Stock, the volatility of the share price, time to maturity, risk-free interest rate, credit spread, and the discount yield. The volatility of the Company\u2019s Common Stock, the Common Stock price at the end of each reporting period, and the remaining amount of time until maturity of the Existing Exchangeable Notes and New Exchangeable Notes are key inputs for the estimation of fair value that are expected to change each reporting period.
The Company recorded other income related to the change in fair value of the derivatives of $(37.4) million and $(75.8) million as of December 31, 2025 and December 31, 2024, respectively. See Note 7\u2014Corporate Borrowings and Finance Lease Obligations and Note 10\u2014Fair Value Measurements for further discussions regarding the Company\u2019s derivatives.
Goodwill. The Company\u2019s recorded goodwill was $2,416.1\u00a0million and $2,301.1\u00a0million as of December\u00a031, 2025 and December\u00a031, 2024, respectively. Goodwill represents the excess of purchase price over fair value of net tangible and identifiable intangible assets resulting from the acquisition of Holdings on August 30, 2012 and subsequent business combinations. The Company has assigned goodwill to two reporting units (Domestic Theatres and International Theatres). The Company performs a qualitative assessment of goodwill at least annually as of the beginning of the fourth quarter or more frequently if events or circumstances indicate that it is more likely than not that the fair value for a reporting unit is less than its carrying amount, including goodwill.
The Company will perform a quantitative impairment test of goodwill if the qualitative assessment concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. The quantitative impairment test of goodwill involves estimating the fair value of the reporting unit and comparing that value to its
carrying value. If the estimated fair value of the reporting unit is less than its carrying value, the difference is recorded as goodwill impairment charge, not to exceed the total amount of goodwill allocated to that reporting unit.
The Company performed qualitative assessments as of October 1, 2025 and October 1, 2024 and concluded that it was not more likely than not that the fair value of either of the Company\u2019s two reporting units was less than their respective carrying amounts. The Company also concluded that there were no triggering events requiring additional assessments that had occurred between October 1, 2025 and December 31, 2025 and October 1, 2024 and December 31, 2024, respectively.
Leases. The Company leases theatres and equipment under operating and finance leases. Many of the leases contain options to extend the leases for additional periods. The Company typically does not believe that the exercise of the renewal options is reasonably assured at the inception of the lease agreements and, therefore, considers the initial base term as the lease term. Lease terms vary but generally, the leases provide for fixed and escalating rentals, contingent escalating rentals based on the Consumer Price Index or other indexes not to exceed certain specified amounts, and variable rentals based on a percentage of revenues. The Company often receives incentives from lessors to assist with renovations at existing locations. The Company records the incentives received from the lessors as an adjustment to the right-of-use asset which results in a reduction to lease costs over the lease term. Operating lease cost for theatre properties are recorded as rent expense in the consolidated statements of operations, except when the lease costs pertain to periods before a theatre opens or after it closes; in those cases, the costs are recorded to operating expense. Operating lease cost for equipment leases is recorded in operating expense in the consolidated statements of operations. The operating lease cost relating to the fixed lease payments is recorded on a straight-line basis over the lease term. Finance lease cost for both theatre properties and equipment are recorded as finance lease interest and depreciation and amortization in the consolidated statements of operations.
Lease right-of-use assets and lease liabilities are recorded at the lease commencement date based on the present value of minimum lease payments over the remaining lease term. The minimum lease payments include base rent and other fixed payments, including fixed maintenance costs. The present value of the lease payments is calculated using the incremental borrowing rate, which was determined using a portfolio approach based on the rate of interest that the Company would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term.
The Company elected the practical expedient to not separate lease and non-lease components and also elected the short-term practical expedient for all leases that qualify. As a result, the Company will not recognize right-of-use assets or liabilities for short-term leases that qualify for the short-term practical expedient, but instead will recognize the lease payments as lease cost on a straight-line basis over the lease term. The Company\u2019s lease agreements do not contain residual value guarantees. Short-term leases and sublease arrangements are immaterial. Equipment leases primarily consist of food and beverage and digital equipment.
Impairment of Long-lived Assets. The Company reviews long-lived assets, including definite-lived intangibles, theatre assets (including operating lease right-of-use assets), and internal-use software whenever events or changes in circumstances indicate that the carrying amount of the asset or asset group may not be fully recoverable. The Company evaluates events or circumstances, including competition in the markets where it operates, that would indicate the carrying value of the asset groups may not be fully recoverable. If an event or circumstance is identified that indicates the carrying value may not be recoverable, the sum of future undiscounted cash flows is compared to the carrying value. If the carrying value exceeds the future undiscounted cash flows, the asset group may be impaired. If the asset group is determined to be impaired, the carrying value of the asset group is reduced to fair value as estimated primarily by using a discounted cash flow model, with the difference recorded as an impairment charge. Management believes that individual theatres are the lowest level for which there are identifiable cash flows and therefore each individual theatre represents an asset group. The Company evaluates theatre asset groups for recoverability using projected data of theatre level cash flow as its primary indicator of potential impairment, giving consideration to the seasonality of its business when making these evaluations. The fair value of assets is determined as either the expected selling price less selling costs (where appropriate) or the present value of the estimated future cash flows, adjusted as necessary for market participant factors.
There is considerable management judgment necessary to determine the estimated future cash flows and fair values of the Company\u2019s theatres and other long-lived assets. Actual future cash flows could vary significantly from such
estimates. The estimated future cash flows are considered Level\u00a03 inputs within the fair value measurement hierarchy, see Note\u00a010\u2014Fair Value Measurements for further information.
The following table summarizes the Company\u2019s impairments, including impairments of equity investments, for the years ended December 31, 2025, December 31, 2024, and December 31, 2023:
Year Ended | |||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2023 | |||
Impairment of long-lived assets | $ | 43.5 | $ | 72.3 | $ | 106.9 | |||
Impairment of equity investments recorded in investment income | 10.3 | \u2014 | 1.0 | ||||||
Total impairment loss | $ | 53.8 | $ | 72.3 | $ | 107.9 |
During the year ended December 31, 2025, the Company recorded non-cash impairment of long-lived assets of $28.0 million on 47 theatres in the U.S. markets with 560 screens (in Alabama, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Iowa, Kansas, Louisiana, Massachusetts, Michigan, Minnesota, New Jersey, New York, North Carolina, Pennsylvania, Tennessee, Texas, Utah, Virginia, Washington, and Wisconsin) and $15.5 million on 20 theatres in the International markets with 159 screens (in Germany, Italy, Spain, Sweden, and the United Kingdom), which were related to property, net and operating lease right-of-use assets, net. In addition, during the year ended December 31, 2025, the Company recorded impairment losses of $10.3 million within investment income related to an equity investment without a readily determinable fair value in the U.S. markets.
During the year ended December 31, 2024, the Company recorded non-cash impairment of long-lived assets of $51.9 million on 39 theatres in the U.S. markets with 469 screens and $20.4 million on 23 theatres in the International markets with 188 screens, which were related to property, net and operating lease right-of-use assets, net.
During the year ended December 31,\u00a02023, the Company recorded non-cash impairment of long-lived assets of $49.2\u00a0million on 68 theatres in the U.S. markets with 738\u00a0screens and $57.7 million on 57\u00a0theatres in the International markets with 488\u00a0screens, which were related to property, net and operating lease right-of-use assets, net. In addition, during the year ended December 31, 2023, the Company recorded impairment losses of $1.0 million within investment income, related to an equity investment without a readily determinable fair value in the U.S. markets.
Foreign Currency Translation. Operations outside the United States are generally measured using the local currency as the functional currency. Assets and liabilities are translated to U.S. dollars using exchange rates as of the balance sheet date. Income and expense items are translated using average exchange rates. The foreign currency translation adjustments are a separate component of accumulated other comprehensive income (loss). Gains and losses from foreign currency transactions are included in net earnings (loss), except intercompany transactions of a long-term investment nature, which are included in comprehensive income (loss). Upon substantial liquidation of an investment in a foreign entity, the related foreign currency translation adjustment in accumulated other comprehensive income (loss) is reclassified into earnings as part of the gain or loss on disposition.
Contingencies. The Company, in the normal course of business, is a party to various ordinary course claims from vendors (including food and beverage suppliers and film distributors), landlords, competitors, and other legal proceedings. If management believes that a loss arising from these actions is probable and can reasonably be estimated, the Company records the amount of the loss, or the minimum estimated liability when the loss is estimated using a range and no point is more probable than another. As additional information becomes available, any potential liability related to these actions is assessed and the estimates are revised, if necessary. Management believes that the ultimate outcome of such matters discussed below, individually and in the aggregate, will not have a material adverse effect on the Company\u2019s financial position or overall trends in results of operations. However, litigation and claims are subject to inherent uncertainties and unfavorable outcomes can occur. An unfavorable outcome might include monetary damages. If an unfavorable outcome were to occur, there exists the possibility of a material adverse impact on the results of operations in the period in which the outcome occurs or in future periods. An unfavorable outcome could also have a material adverse effect on the Company\u2019s financial position or the market prices of the Company\u2019s securities, including the Company\u2019s Common Stock.
Employee Benefit Plans. The Company sponsors frozen non-contributory qualified and non-qualified defined benefit pension plans in the U.S. and frozen defined benefit pension plans in the United Kingdom and Sweden. The Company also sponsors various defined contribution plans.
The following table sets forth the plans\u2019 benefit obligations and plan assets included in the consolidated balance sheets:
U.S. Pension Benefits | International Pension Benefits | |||||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | ||||
Aggregated projected benefit obligation at end of period | $ | (73.9) | $ | (73.8) | $ | (71.4) | $ | (63.7) | ||||
Aggregated fair value of plan assets at end of period | \u00a0 | 61.5 | \u00a0 | 59.5 | \u00a0 | 67.2 | \u00a0 | 66.6 | ||||
Net asset (liability) for benefit cost - funded status | $ | (12.4) | $ | (14.3) | $ | (4.2) | $ | 2.9 |
All pension plans are frozen; therefore, aggregated accumulated benefit obligations are equal to aggregated projected benefit obligations as of December 31, 2025 and December 31, 2024, respectively.
The Company expects to contribute $3.0 million to the U.S. pension plans during the year ended December 31, 2026. The Company intends to make future cash contributions to the plans in an amount necessary to meet minimum funding requirements according to applicable benefit plan regulations.
The weighted-average assumptions used to determine benefit obligations are as follows:
U.S. Pension Benefits | International Pension Benefits | |||||||
December\u00a031, 2025 | December\u00a031, 2024 | December\u00a031, 2025 | December\u00a031, 2024 | |||||
Discount rate | \u00a0 | 5.28% | 5.43% | 4.78% | 5.18% | |||
Rate of compensation increase | \u00a0 | N/A | N/A | 2.13% | 2.22% |
The weighted-average assumptions used to determine net periodic benefit cost are as follows:
U.S. Pension Benefits | International Pension Benefits | ||||||||||||
Year Ended | Year Ended | ||||||||||||
December 31, | December 31, | December 31, | December 31, | December 31, | December 31, | ||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | 2023 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | 2023 | ||
Discount rate | \u00a0 | 5.43% | 4.76% | 4.97% | 5.18% | 4.53% | 4.82% | ||||||
Weighted average expected long-term return on plan assets | \u00a0 | 6.56% | 6.56% | 6.56% | 5.41% | 4.34% | 4.32% | ||||||
Rate of compensation increase | \u00a0 | N/A | N/A | N/A | 2.22% | 2.07% | 2.19% |
Pension actuarial gains and losses are recorded in stockholders\u2019 deficit as a component of accumulated other comprehensive loss. For further information, see Note 12\u2014Accumulated Other Comprehensive Loss for pension amounts and activity recorded in accumulated other comprehensive loss.
For the years ended December 31, 2025, December 31, 2024, and December 31, 2023, net periodic benefit costs were $1.2 million, $1.8 million, and $1.4 million, respectively. The non-operating component of net periodic benefit costs is recorded in other expense (income) in the consolidated statements of operations.
The following table provides the benefits expected to be paid in each of the next five years, and in the aggregate for the five years thereafter:
(In millions) | U.S. Pension Benefits | International Pension Benefits | ||||
2026 | $ | 6.3 | $ | 4.2 | ||
2027 | \u00a0 | 5.9 | 4.3 | |||
2028 | \u00a0 | 6.4 | 4.5 | |||
2029 | \u00a0 | 6.7 | 4.3 | |||
2030 | \u00a0 | 6.2 | 4.8 | |||
Years 2031 - 2035 | \u00a0 | 27.1 | 25.9 |
The Company\u2019s investment objectives for its U.S. defined benefit pension plan investments are: (1)\u00a0to preserve the value of its principal; (2)\u00a0to maximize a real long-term return with respect to the plan assets consistent with
minimizing risk; (3)\u00a0to achieve and maintain adequate asset coverage for accrued benefits under the plan; and (4)\u00a0to maintain sufficient liquidity for payment of the plan obligations and expenses. The Company uses a diversified allocation of equity, debt, commodity and real estate exposures that are customized to the plan\u2019s cash flow benefit needs. A weighted average targeted allocation percentage is assigned to each asset class as follows: equity securities of 30%, debt securities of 67%, and private real estate of 3%. The International pension benefit plans do not have an established asset target allocation.
Investments in the pension plan assets are measured at fair value on a recurring basis. As of December 31, 2025, for the U.S. investment portfolio, 95% were valued using the net asset value per share (or its equivalent) as a practical expedient and 5% of the investment included pooled separate accounts valued using market prices for the underlying instruments that were observable in the market or could be derived by observable market data from independent external valuation information (Level 2 of the fair value hierarchy). As of December 31, 2025, for the International investment portfolio, 8% consisting of cash and equivalents was valued using quoted market prices from actively traded markets (Level 1 of the fair value hierarchy), 38% was an insurance contract whose value has been set equal to the present value of the related benefit obligation (Level 3 of the fair value hierarchy), and 54% were valued using the net asset value per share (or its equivalent) as a practical expedient.
In June 2023, the High Court in the UK issued a ruling in respect of Virgin Media Limited v NTL Pension Trustees II Limited, that decided certain amendments were invalid when amending contracted-out salary-related defined benefit pension plans in the period from April 6, 1997 until April 6, 2016, if these amendments were not accompanied by actuarial confirmations (section 37 certificates). An appeal on this decision was heard in June 2024 and The Court of Appeal ruled in July 2024 that the appeal was unsuccessful, i.e., it upheld the original High Court judgment, removing uncertainty around its application. In light of the ruling, the Company initiated an investigation with its pension trustees, of all known amendments to its two UK defined benefit pension plans during the affected period, with a view to determining whether section 37 certificates have been obtained where deemed required. The initial review concluded that across the two plans there are three documents where a section 37 certificate may have been required but the amendment document is silent. In June 2025, the UK government announced it will introduce legislation to give pension plans the ability to retrospectively obtain written actuarial confirmations that historic benefit changes met the necessary standards. This therefore provides clarity around plan liabilities and member benefit levels. On September 1, 2025, the UK government published the bill with these amendments. This legislation will not be in place until it has received royal assent, which is expected to occur in 2026. The Company will continue to monitor this change in legislation and assess any further reviews and potential retrospective confirmation with the trustees in due course.
The Company sponsors various defined contribution plans worldwide which include company match features. The expense related to defined contribution plans for the years ended December 31, 2025, December 31, 2024, and December 31, 2023, was $11.7 million, $10.5 million, and $9.8 million, respectively.
Income and Operating Taxes. The Company accounts for income taxes in accordance with ASC\u00a0740-10. Under ASC\u00a0740-10, deferred income tax effects of transactions reported in different periods for financial reporting and income tax return purposes are recorded by the asset and liability method. This method gives consideration to the future tax consequences of deferred income or expense items and recognizes changes in income tax laws in the period of enactment.
Holdings and its U.S. subsidiaries file a consolidated U.S. federal income tax return and combined income tax returns in certain state jurisdictions. Foreign subsidiaries file income tax returns in foreign jurisdictions. Income taxes are determined based on separate company computations of income or loss. Tax sharing arrangements are in place and utilized when tax benefits from affiliates in the consolidated group are used to offset what would otherwise be taxable income generated by Holdings or another affiliate.
Casualty Insurance. The Company is self-insured for general liability up to $1.0\u00a0million per occurrence and carries a $0.5\u00a0million deductible limit per occurrence for workers\u2019 compensation claims. The Company utilizes actuarial projections of its ultimate losses to calculate its reserves and expense. The actuarial method includes an allowance for adverse developments on known claims and an allowance for claims which have been incurred but which have not yet been reported. As of December\u00a031, 2025 and December\u00a031, 2024, the Company recorded casualty insurance reserves of $33.7 million and $25.7\u00a0million, respectively. The Company recorded expenses related to general liability and workers\u2019 compensation claims of $64.2\u00a0million, $65.5\u00a0million, and $53.1\u00a0million for the years ended December\u00a031, 2025, December\u00a031, 2024, and December\u00a031, 2023, respectively. Casualty insurance expense is recorded in operating expense.
Government Assistance. The Company recognizes government assistance when the conditions of the grant have been met and there is reasonable assurance that the assistance will be received. Grants relating to specific costs are treated as a reduction of that cost in the consolidated statement of operations. General grants are recorded within other expense (income). Grants related to the construction of long-lived assets are treated as reductions to the cost of the associated assets.
During the year ended December 31, 2025, the Company recognized government assistance in other expense (income) of $10.8 million related to cash grants received in the International markets to support businesses impacted by the COVID-19 pandemic. The Company concluded all grant criteria had been met and that the likelihood of recapture was remote, therefore the entire award has been recognized. During the year ended December 31, 2024, the Company recognized government assistance in other income of $0.1 million related to government assistance for theatres impacted by flooding in Spain. During the year ended December 31, 2023, the Company recognized government assistance in other income of $4.8 million, primarily related to grants in the International markets. The general requirements of the grants were that the grantees must have lost income due to the COVID-19 pandemic. The Company concluded all grant criteria had been met and therefore have recognized the entire award.
Additionally, the Company recognized $1.1 million, $4.5 million and $3.2 million of government assistance as reduction to property, net during the years ended December 31, 2025, December 31, 2024, and December 31, 2023, respectively. The assistance relates to the construction of capital assets related to the innovation, modernization, and digitalization of the theatrical exhibition industry in certain countries in the International markets.
During the years ended December 31, 2025, December 31, 2024, and December 31, 2023, the Company was awarded $0.0 million, $9.7 million and $10.0 million, respectively, of tax credits in our International markets that have been or will be utilized to offset employer payroll tax or value-added tax liabilities. The tax credits are granted by the government to support entities in the film exhibition industry. The Company recorded these credits as reductions to operating expense in 2024 and as reductions to rent and operating expense during 2023 as those expenses were the basis for the tax credits awarded.
Other Expense (Income): The following table sets forth the components of other expense (income):
Year Ended | |||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2023 | |||
Governmental assistance - International markets | $ | (10.8) | $ | (0.1) | $ | (3.8) | |||
Governmental assistance - U.S. markets | \u2014 | \u2014 | (1.0) | ||||||
Foreign currency transaction (gains) losses | (28.1) | 7.0 | (17.8) | ||||||
Non-operating components of net periodic benefit cost | 1.2 | 1.8 | 1.4 | ||||||
Gain on extinguishment - Second Lien Notes due 2026 | (6.6) | (40.3) | (140.5) | ||||||
Loss on extinguishment - Senior Subordinated Notes due 2025 | \u2014 | 2.7 | \u2014 | ||||||
Loss (gain) on extinguishment - Senior Subordinated Notes due 2026 | 0.3 | (1.3) | (2.3) | ||||||
Loss on extinguishment - 6.00%/8.00% Cash/PIK Toggle Senior Secured Exchangeable Notes due 2030 | 103.3 | \u2014 | \u2014 | ||||||
Loss on extinguishment - 7.5% First Lien Notes due 2029 | 99.0 | \u2014 | \u2014 | ||||||
Term Loan modifications - third party fees | 3.1 | 42.3 | \u2014 | ||||||
Increase in fair value of bifurcated embedded derivative liability - Senior Secured Exchangeable Notes due 2030 | 19.3 | \u2014 | \u2014 | ||||||
Decrease in fair value of bifurcated embedded derivative liability - 6.00%/8.00% Cash/PIK Toggle Senior Secured Exchangeable Notes due 2030 | (56.7) | (75.8) | \u2014 | ||||||
Equity in earnings of non-consolidated entities | (6.8) | (12.4) | (7.7) | ||||||
Derivative stockholder settlement (1) | \u2014 | \u2014 | (14.0) | ||||||
Shareholder litigation expense and (recoveries) (2) | (3.8) | (40.2) | 110.2 | ||||||
Vendor dispute settlement (3) | \u2014 | (36.2) | \u2014 | ||||||
Other settlement proceeds | \u2014 | (3.6) | \u2014 | ||||||
Business interruption insurance recoveries | (1.0) | (0.1) | (1.3) | ||||||
Total other expense (income) | $ | 112.4 | $ | (156.2) | $ | (76.8) |
| (1) | The Company received $14.0 million as a result of a derivative stockholder settlement which was recorded as other income during the year ended December 31, 2023. |
| (2) | The Company recorded a $110.2 million charge for the settlement of shareholder litigation during the year ended December 31, 2023. The Company recorded other income related to recoveries of insurance claims associated with the shareholder litigation of $3.8 million and $40.2 million during the years ended December 31, 2025 and December 31, 2024, respectively. |
| (3) | The Company executed an agreement to collect $37.5 million as a resolution of a dispute with a vendor. The proceeds, net of legal costs, were recorded to other income during the year ended December 31, 2024. |
Accounting Pronouncements Recently Adopted
Income Tax Disclosures. In December 2023, the Financial Accounting Standards Bord (\u201cFASB\u201d) issued ASU 2023-09, Income Taxes (Topic 740) Improvements to Income Tax Disclosures (\u201cASU 2023-09\u201d). The amendments in ASU 2023-09 require entities to disclose on an annual basis (1) specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. The amendments also require that entities disclose various information about income taxes paid and (1) income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and (2) foreign and income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. The Company adopted the new standard during the fourth quarter of 2025 on a full retrospective basis and recast certain prior period amounts and disclosures to conform to current year presentation. See Note 9\u2014Income Taxes for the required disclosure information resulting from ASU 2023-09.
Accounting Pronouncements Issued Not Yet Adopted
Disaggregation of Income Statement Expenses. In November 2024, the FASB issued ASU 2024-03, Income Statement (Subtopic 220-40)\u2014Reporting Comprehensive Income-Expense Disaggregation Disclosures (\u201cASU 2024-03\u201d). The amendments in ASU 2024-03 require that public business entities disclose additional information about specific expense categories in the notes to financial statements for interim and annual reporting periods. ASU 2024-03 is effective for the Company for the year ended December 31, 2027. The Company is currently evaluating the effect that ASU 2024-03 will have on its consolidated financial statements.
Induced Conversions of Convertible Debt Instruments. In November 2024, the FASB issued ASU 2024-04, Debt\u2014Debt with Conversion and Other Options (Subtopic 470-20) Induced Conversions of Convertible Debt Instruments (\u201cASU 2024-04\u201d). The amendments in ASU 2024-04 clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. The amendments are effective for annual reporting periods beginning after December 15, 2025. The Company is currently evaluating the effect that ASU 2024-04 will have on its consolidated financial statements.
Internal-Use Software. In September 2025, the FASB issued ASU 2025-06, Intangibles\u2013Goodwill and Other (Subtopic 350-40) Targeted Improvements to the Accounting for Internal-Use Software (\u201cASU 2025-06\u201d), which is intended to modernize the accounting for software costs that are accounted for under Subtopic 350-40. ASU 2025-06 removes references to prescriptive and sequential software development stages and replaces them with a probable-to-complete recognition threshold. ASU 2025-06 also clarifies which disclosures apply to capitalized internal-use software costs. ASU 2025-06 is effective for annual reporting periods beginning after December 15, 2027, and interim reporting periods within those reporting periods. Early adoption at the beginning of a fiscal year is permitted. The Company is currently evaluating the effect that ASU 2025-06 will have on its consolidated financial statements.
Derivatives Scope Refinements and Share-Based Noncash Consideration. In September 2025, the FASB issued ASU 2025-07, Derivatives and Hedging (Topic 815) and Revenue from Contracts with Customers (Topic 606) (\u201cASU 2025-07\u201d), which (1) refines the scope of the guidance on derivatives in Topic 815 and (2) clarifies the guidance on share-based payments from a customer in ASC 606. ASU 2025-07 is intended to address concerns about the application of derivative accounting to contracts that have features based on the operations or activities of one of the parties to the contract and to reduce diversity in the accounting for share-based payments in revenue contracts. ASU 2025-07 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within those reporting periods. Early adoption is permitted. The Company is currently evaluating the effect that ASU 2025-07 will have on its consolidated financial statements.
Accounting for Government Grants. In December 2025, the FASB issued ASU 2025-10, Accounting for Government Grants Received by Business Entities (Topic 832) (\u201cASU 2025-10\u201d), which establishes the accounting for a government grant received by a business entity, including guidance for a grant related to an asset and a grant related to income. ASU 2025-10 adds guidance on Topic 832 on the recognition, measurement, and presentation of government grants. ASU 2025-10 is effective for annual reporting periods beginning after December 15, 2028, and interim reporting periods within those annual reporting periods. Early adoption is permitted in both interim and annual reporting periods in which financial statements have not yet been issued or made available for issuance. The Company is currently evaluating the impact of ASU 2025-10 on its consolidated financial statements.
Interim Reporting Narrow-Scope Improvements. In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270) Narrow-Scope Improvements (\u201cASU 2025-11\u201d). The amendments in ASU 2025-11 clarify interim disclosure requirements and the applicability of Topic 270. The amendments in ASU 2025-11 also include a disclosure principle that requires entities to disclose events since the end of the last annual reporting period that have a material impact on the entity. ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2025-11 on its consolidated financial statements.
"}]},{"name":"rpt:f-511","factDimensions":{"xbrl:concept":"us-gaap:StockholdersEquityPolicyTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Reverse Stock Split. On August 24, 2023, the Company effectuated a reverse stock split at a ratio of one share of Common Stock for every ten shares of Common Stock. As a result of the reverse stock split, each share of Series A Convertible Participating Preferred Stock became convertible into ten shares of Common Stock, and by extension each AMC Preferred Equity Unit became equivalent to one-tenth (1/10th) of a share of Common Stock. The reverse stock split did not impact the number of AMC Preferred Equity Units outstanding. The Company concluded that this change in conversion ratio is analogous to a reverse stock split of the AMC Preferred Equity Units even though the reverse stock split did not have an effect on the number of AMC Preferred Equity Units outstanding.
Accordingly, all references made to share, per share, unit, per unit, or common share amounts in the accompanying consolidated financial statements and applicable disclosures have been retroactively adjusted to reflect the effects of the subsequent reverse stock split. References made to AMC Preferred Equity Units have been retroactively adjusted to reflect the effect of the reverse stock split on their equivalent Common Stock shares.
"}]},{"name":"rpt:f-512","factDimensions":{"xbrl:concept":"us-gaap:StockholdersEquityNoteStockSplitConversionRatio1","xbrl:period":"2023-08-24T00:00:00/2023-08-25T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"0.1","decimals":1}]},{"name":"rpt:f-513","factDimensions":{"xbrl:concept":"us-gaap:PreferredStockConvertibleConversionRatio","xbrl:period":"2023-08-25T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"0.1","decimals":1}]},{"name":"rpt:f-514","factDimensions":{"xbrl:concept":"amch:LiquidityPolicyPolicyTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Liquidity. The Company believes its existing cash and cash equivalents, together with cash generated from operations, will be sufficient to fund its operations and satisfy its obligations currently and through the next twelve months. The Company\u2019s cash burn rates are not sustainable long-term. In order to achieve sustainable net positive cash flows from operating activities and long-term profitability, the Company believes that revenues will need to increase to levels at least in line with pre-COVID-19 revenues. North America box office grosses were down approximately 22% for the year ended December 31, 2025, compared to the year ended December 31, 2019. Until such time as the Company is able to achieve sustainable net positive cash flows from operating activities, it is difficult to estimate the Company\u2019s future cash burn rates and liquidity requirements. Depending on the Company\u2019s assumptions regarding the timing and ability to achieve increased levels of revenue, the estimates of amounts of required liquidity vary significantly.
There can be no assurance that the revenues, attendance levels, and other assumptions used to estimate the Company\u2019s liquidity requirements and future cash burn rates will be correct, and the ability to be predictive is uncertain due to limited ability to predict studio film release dates, the overall production and theatrical release levels, and success of individual titles. Further, there can be no assurances that the Company will be successful in generating the additional liquidity necessary to meet the Company\u2019s obligations beyond twelve months from the issuance of these financial statements on terms acceptable to the Company or at all.
The Company expects, from time to time, to continue to seek to retire or purchase its outstanding debt through cash purchases and/or exchanges for equity or debt, in open-market purchases, privately negotiated transactions or otherwise. Such repurchases or exchanges, if any, will be upon such terms and at such prices as it may determine, and will depend on prevailing market conditions, its liquidity requirements, the availability of authorized share capital, contractual restrictions and other factors. The amounts involved may be material and to the extent equity is used, dilutive. See Note 7\u2014Corporate Borrowings and Finance Lease Liabilities for a summary of debt transactions that occurred during the years ended December 31, 2025, December 31, 2024, and December 31, 2023. Additionally, the Company has bolstered its liquidity through sales of its Common Stock, see Note 8\u2014Stockholders\u2019 Deficit and Note 14\u2014Subsequent Events for further information on these sales.
"}]},{"name":"rpt:f-515","factDimensions":{"xbrl:concept":"amch:PercentageOfGrossesNorthAmericanBoxOffice","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"0.22","decimals":2}]},{"name":"rpt:f-516","factDimensions":{"xbrl:concept":"us-gaap:UseOfEstimates","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Use of Estimates. The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
"}]},{"name":"rpt:f-517","factDimensions":{"xbrl:concept":"us-gaap:ConsolidationPolicyTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Principles of Consolidation. The consolidated financial statements include the accounts of Holdings and all subsidiaries, as discussed above. All significant intercompany balances and transactions have been eliminated in consolidation. The Company manages its business under two reportable segments for its theatrical exhibition operations: U.S. markets and International markets.
"}]},{"name":"rpt:f-518","factDimensions":{"xbrl:concept":"us-gaap:NumberOfReportableSegments","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"amch:segment"},"factValues":[{"value":"2"}]},{"name":"rpt:f-519","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerPolicyTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Revenues. The Company recognizes revenue, net of sales tax, when it satisfies a performance obligation by transferring control over a product or service to a customer. Admissions and food and beverage revenues are recorded at a point in time when a film is exhibited to a customer and when a customer takes possession of food and beverage offerings.
The Company defers 100% of the revenue associated with the sales of gift cards and exchange tickets until such time as the items are redeemed or estimated income from non-redemption is recorded. The Company recognizes revenue from non-redeemed or partially redeemed gift cards in proportion to the pattern of rights exercised by the customer (the \u201cProportional Method\u201d). The Company estimates the non-redemption rate for its gift card sales and then applies the rates to the current month sales. The non-redemption rates range from 13% to 30%. The Company recognizes the total amount of expected revenue for non-redemption for that current month\u2019s sales as income over the next to 36 months in proportion to the pattern of actual redemptions. The non-redemption revenue is recorded in other theatre revenues. The Company has used significant amounts of historical data to estimate its non-redemption rates and redemption patterns. The Company also recognizes revenue from non-redeemed or partially redeemed exchange tickets using the Proportional Method. In the International markets, certain exchange tickets are subject to expiration dates, which triggers recognition of non-redemption in other revenues.
The Company recognizes ticket fee revenues based on a gross transaction price. The Company is a principal (as opposed to agent) in the arrangement with third-party internet ticketing companies in regard to the sale of online tickets because the Company controls the online tickets before they are transferred to the customer. The online ticket fee revenues and the third-party commission or service fees are recorded in the line items other theatre revenues and operating expense, respectively, in the consolidated statements of operations.
"}]},{"name":"rpt:f-520","factDimensions":{"xbrl:concept":"amch:RevenueRecognitionDeferredPercentage","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"1","decimals":2}]},{"name":"rpt:f-521","factDimensions":{"xbrl:concept":"amch:NonRedemptionRateOnGiftCards","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","srt:RangeAxis":"srt:MinimumMember"},"factValues":[{"value":"0.13","decimals":2}]},{"name":"rpt:f-522","factDimensions":{"xbrl:concept":"amch:NonRedemptionRateOnGiftCards","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"0.30","decimals":2}]},{"name":"rpt:f-523","factDimensions":{"xbrl:concept":"amch:PeriodOverWhichTotalAmountOfBreakageForCurrentMonthSalesInProportionToPatternOfActualRedemptionsIsRecognized","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","srt:RangeAxis":"srt:MaximumMember"},"factValues":[{"value":"P36M"}]},{"name":"rpt:f-524","factDimensions":{"xbrl:concept":"us-gaap:FilmCostsPolicyPolicyTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Film Exhibition Costs. Film exhibition costs are accrued based on the applicable box office receipts and estimates of the final settlement to the film licensors. Film exhibition costs include certain advertising costs. As of December\u00a031, 2025 and December\u00a031, 2024, the Company recorded film payables of $144.4\u00a0million and $143.9\u00a0million, respectively, which are included in accounts payable in the accompanying consolidated balance sheets. During the year ended December 31, 2025, films licensed from the Company\u2019s seven largest movie studio distributors based on revenues accounted for approximately 83% of our U.S. admissions revenues, which consisted of Disney, Warner Bros., Universal, Sony, Paramount, 20th Century Studios, and Lionsgate Films. In Europe, approximately 76% of the Company\u2019s box office revenue came from films attributed to our five largest movie distributor groups, which consisted of Disney, Universal, Warner Bros., Paramount, and Sony. The Company\u2019s revenues attributable to individual distributors may vary significantly from year to year depending upon the commercial success of each distributor\u2019s films in any given year.
"}]},{"name":"rpt:f-525","factDimensions":{"xbrl:concept":"amch:FilmExhibitionCostPayable","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"144400000","decimals":-5}]},{"name":"rpt:f-526","factDimensions":{"xbrl:concept":"amch:FilmExhibitionCostPayable","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"143900000","decimals":-5}]},{"name":"rpt:f-527","factDimensions":{"xbrl:concept":"amch:NumberOfMovieStudioDistributors","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"amch:item","srt:StatementGeographicalAxis":"country:US","us-gaap:ConcentrationRiskByBenchmarkAxis":"us-gaap:RevenueFromContractWithCustomerMember","us-gaap:ConcentrationRiskByTypeAxis":"us-gaap:CustomerConcentrationRiskMember"},"factValues":[{"value":"7"}]},{"name":"rpt:f-528","factDimensions":{"xbrl:concept":"us-gaap:ConcentrationRiskPercentage1","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","srt:StatementGeographicalAxis":"country:US","us-gaap:ConcentrationRiskByBenchmarkAxis":"us-gaap:RevenueFromContractWithCustomerMember","us-gaap:ConcentrationRiskByTypeAxis":"us-gaap:CustomerConcentrationRiskMember"},"factValues":[{"value":"0.83","decimals":2}]},{"name":"rpt:f-529","factDimensions":{"xbrl:concept":"us-gaap:ConcentrationRiskPercentage1","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","srt:StatementGeographicalAxis":"srt:EuropeMember","us-gaap:ConcentrationRiskByBenchmarkAxis":"us-gaap:RevenueFromContractWithCustomerMember","us-gaap:ConcentrationRiskByTypeAxis":"us-gaap:CustomerConcentrationRiskMember"},"factValues":[{"value":"0.76","decimals":2}]},{"name":"rpt:f-530","factDimensions":{"xbrl:concept":"amch:NumberOfMovieStudioDistributors","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"amch:item","srt:StatementGeographicalAxis":"srt:EuropeMember","us-gaap:ConcentrationRiskByBenchmarkAxis":"us-gaap:RevenueFromContractWithCustomerMember","us-gaap:ConcentrationRiskByTypeAxis":"us-gaap:CustomerConcentrationRiskMember"},"factValues":[{"value":"5"}]},{"name":"rpt:f-531","factDimensions":{"xbrl:concept":"amch:FoodAndBeverageCostsPolicyTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Food and Beverage Costs. The Company records rebate payments from vendors as a reduction of food and beverage costs when earned.
"}]},{"name":"rpt:f-532","factDimensions":{"xbrl:concept":"amch:ScreenAdvertisingPolicyTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Exhibitor Services Agreement. The Company recognizes advertising revenues, which are included in other theatre revenues in the consolidated statements of operations, when it satisfies a performance obligation by transferring a promised good or service to the customers. The advertising contracts with customers generally consist of a series of distinct periods of service, satisfied over time, to provide rights to advertising services. The Company\u2019s exhibitor services agreement with National CineMedia, LLC (\u201cNCM\u201d) includes a significant financing component due to the significant length of time between receiving the non-cash consideration and fulfilling the performance obligation. On April 17, 2025, NCM and the Company entered into the Second Amended and Restated Exhibitor Services Agreement (the \u201cAmended ESA\u201d). The term of the Amended ESA has been extended by five years through February 13, 2042. The Company treated the Amended ESA as a contract modification pursuant to ASC 606 \u2013 Revenue from Contracts with Customers. Accordingly, the Company has allocated the additional consideration received from the contract modification to the exhibitor services agreement contract liability and updated the discount rate used for the significant financing component to 16.12%. Prior to the contract modification, the weighted average discount rate used to account for the significant financing component was approximately 7.5%. The contract liability will be reclassified to other theatre revenue over the new term of the Amended ESA as the remaining performance obligations are satisfied. See Note 2\u2014Revenue Recognition for further information regarding the Amended ESA.
"}]},{"name":"rpt:f-533","factDimensions":{"xbrl:concept":"amch:ExhibitorServicesAgreementExtensionTerm","xbrl:period":"2025-04-17T00:00:00/2025-04-18T00:00:00","xbrl:entity":"cik:0001411579","amch:EquityMethodInvestmentActivityByClassificationAxis":"amch:AmendedExhibitorServicesAgreementMember"},"factValues":[{"value":"P5Y"}]},{"name":"rpt:f-534","factDimensions":{"xbrl:concept":"amch:ContractModificationWeightedAverageDiscountRate","xbrl:period":"2025-04-18T00:00:00","xbrl:entity":"cik:0001411579","amch:EquityMethodInvestmentActivityByClassificationAxis":"amch:AmendedExhibitorServicesAgreementMember"},"factValues":[{"value":"0.1612","decimals":4}]},{"name":"rpt:f-535","factDimensions":{"xbrl:concept":"amch:ContractModificationWeightedAverageDiscountRate","xbrl:period":"2025-04-17T00:00:00","xbrl:entity":"cik:0001411579","amch:EquityMethodInvestmentActivityByClassificationAxis":"amch:ExhibitorServicesAgreementMember"},"factValues":[{"value":"0.075","decimals":3}]},{"name":"rpt:f-536","factDimensions":{"xbrl:concept":"amch:CustomerFrequencyProgramPolicyTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Customer Loyalty Programs. The Company offers a range of customer loyalty programs worldwide. Depending on the specific program, members can earn rewards, receive discounts, and access exclusive offers and services available only to members. Certain loyalty programs we offer, such as A-List, operate on a subscription model and enable members to watch multiple movies for a recurring fee. Rewards earned by members are redeemable on future purchases at our locations.
The portion of the admissions and food and beverage revenues attributed to the rewards is deferred. Upon redemption or expiration, deferred revenues associated with the rewards are recognized as revenues. The Company estimates reward non-redemption rates using historical information when assigning value to the rewards at the time of sale. Membership fees, net of estimated refunds, for our paid loyalty programs are initially deferred and allocated to the material rights for discounted or free products and services. Revenue is recognized as the rights are redeemed based on estimated utilization, over the membership period in admissions, food and beverage, and other revenues.
Membership fees for our subscription programs are recognized ratably over the subscription period in admissions revenue.
"}]},{"name":"rpt:f-537","factDimensions":{"xbrl:concept":"us-gaap:AdvertisingCostsPolicyTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Advertising Costs. The Company expenses advertising costs as incurred and does not have any direct-response advertising recorded as assets. Advertising costs were $21.5 million, $22.2 million, and $43.6 million for the years ended December\u00a031, 2025, December\u00a031, 2024, and December\u00a031, 2023, respectively. Advertising costs are recorded in operating expense in the accompanying consolidated statements of operations.
"}]},{"name":"rpt:f-538","factDimensions":{"xbrl:concept":"us-gaap:AdvertisingExpense","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"21500000","decimals":-5}]},{"name":"rpt:f-539","factDimensions":{"xbrl:concept":"us-gaap:AdvertisingExpense","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"22200000","decimals":-5}]},{"name":"rpt:f-540","factDimensions":{"xbrl:concept":"us-gaap:AdvertisingExpense","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"43600000","decimals":-5}]},{"name":"rpt:f-541","factDimensions":{"xbrl:concept":"us-gaap:CashAndCashEquivalentsPolicyTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Cash and Cash Equivalents. All investments purchased with an original maturity of three months or less are classified as cash equivalents. As of December 31, 2025, cash and cash equivalents for the U.S. markets and International markets were $302.6 million and $125.9 million, respectively. As of December 31, 2024, cash and cash equivalents were $513.0 million and $119.3 million, respectively.
"}]},{"name":"rpt:f-542","factDimensions":{"xbrl:concept":"us-gaap:CashAndCashEquivalentsAtCarryingValue","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"country:US"},"factValues":[{"value":"302600000","decimals":-5}]},{"name":"rpt:f-543","factDimensions":{"xbrl:concept":"us-gaap:CashAndCashEquivalentsAtCarryingValue","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"us-gaap:NonUsMember"},"factValues":[{"value":"125900000","decimals":-5}]},{"name":"rpt:f-544","factDimensions":{"xbrl:concept":"us-gaap:CashAndCashEquivalentsAtCarryingValue","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"country:US"},"factValues":[{"value":"513000000","decimals":-5}]},{"name":"rpt:f-545","factDimensions":{"xbrl:concept":"us-gaap:CashAndCashEquivalentsAtCarryingValue","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"us-gaap:NonUsMember"},"factValues":[{"value":"119300000","decimals":-5}]},{"name":"rpt:f-546","factDimensions":{"xbrl:concept":"us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Restricted Cash. Restricted cash includes cash held in the Company's bank accounts as a guarantee for certain landlords, legal settlements, and cash collateralized letters of credit relating to the Company\u2019s insurance and utilities programs. The following table provides a reconciliation of cash and cash equivalents and restricted cash reported in the consolidated balance sheet to the total of the amounts in the consolidated statements of cash flows.
Year Ended | |||||||||
(In millions) | December\u00a031, 2025 | December\u00a031, 2024 | December\u00a031, 2023 | ||||||
Cash and cash equivalents | $ | 428.5 | $ | 632.3 | $ | 884.3 | |||
Restricted cash | 48.8 | 48.5 | 27.1 | ||||||
Total cash and cash equivalents and restricted cash in the statement of cash flows | $ | 477.3 | $ | 680.8 | $ | 911.4 |
As of December 31, 2025, restricted cash for the U.S. markets and International markets was $20.5 million and $28.3 million, respectively. As of December 31, 2024, restricted cash for the U.S. markets and International markets was $20.7 million and $27.8 million, respectively.
"}]},{"name":"rpt:f-547","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Year Ended | |||||||||
(In millions) | December\u00a031, 2025 | December\u00a031, 2024 | December\u00a031, 2023 | ||||||
Cash and cash equivalents | $ | 428.5 | $ | 632.3 | $ | 884.3 | |||
Restricted cash | 48.8 | 48.5 | 27.1 | ||||||
Total cash and cash equivalents and restricted cash in the statement of cash flows | $ | 477.3 | $ | 680.8 | $ | 911.4 |
Intangible Assets. Amortizable intangible assets are being amortized on a straight-line basis over the estimated remaining useful lives of the assets. The Company evaluates definite-lived intangible assets whenever events or changes in circumstances indicate that the carrying amount of the intangible asset may not be fully recoverable. Indefinite-lived intangible assets are not amortized but rather evaluated for impairment annually as of the beginning of the fourth quarter or more frequently if events or circumstances indicate that it is more likely than not that the asset is impaired.
The Company first assesses the qualitative factors to determine whether the existence of events and circumstances indicate that it is more likely than not the fair value of an indefinite-lived intangible asset is less than its carrying amount as a basis for determining whether it is necessary to perform the quantitative impairment test. There were no intangible asset impairment charges incurred during the years ended December\u00a031, 2025, December\u00a031, 2024, and December\u00a031, 2023.
"}]},{"name":"rpt:f-562","factDimensions":{"xbrl:concept":"us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"0","decimals":-6}]},{"name":"rpt:f-563","factDimensions":{"xbrl:concept":"us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"0","decimals":-6}]},{"name":"rpt:f-564","factDimensions":{"xbrl:concept":"us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"0","decimals":-6}]},{"name":"rpt:f-565","factDimensions":{"xbrl:concept":"us-gaap:InvestmentPolicyTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Investments. The Company accounts for its investments in non-consolidated entities using the equity method when Company\u2019s ownership interest provides the Company with significant influence. The Company follows the guidance in ASC\u00a0323-30-35-3, investment in a limited liability company, which prescribes the use of the equity method for investments where the Company has significant influence. Under the equity method, the Company shall recognize its
share of the earnings or losses of an investee. In 2024, the Company reclassified equity earnings and losses to other expense (income), all comparative periods have also been reclassified. Equity investments without readily determinable fair values are recorded at cost less impairment. The Company classifies gains and losses on sales of investments or impairments of investments without a readily determinable fair value in investment expense (income). Investments in non-consolidated entities are presented within other long-term assets in the consolidated balance sheets.
The Company holds common shares and warrants to purchase common shares of Hycroft. The common shares and warrants are recorded at fair value at each reporting period and unrealized gains and losses are reported in investment expense (income). In December 2025, the Company sold 2.3 million shares of Hycroft common stock and warrants for 1.3 million shares for $24.1 million. The Company retained warrants to purchase approximately 1 million Hycroft common shares and approximately 64,000 Hycroft common shares.
During the years ended December 31, 2025, December 31, 2024, and December 31, 2023, the Company recorded realized and unrealized losses (gains) related to the investments in Hycroft of $(34.4) million, $2.9 million, and $12.6 million, respectively in investment income.
On December 30, 2022, the Company entered into an agreement to sell its 10.0% investment in Saudi Cinema Company LLC for SAR 112.5 million ($30.0 million), and on January 24, 2023, the Saudi Ministry of Commerce recorded the sale of equity and the Company received the proceeds on January 25, 2023. The Company recorded a gain on the sale of $(15.5) million in investment income during the year ended December 31, 2023.
"}]},{"name":"rpt:f-566","factDimensions":{"xbrl:concept":"amch:EquityMethodInvestmentNumberOfSharesSold","xbrl:period":"2025-12-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"xbrla:shares","srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis":"amch:HycroftMiningHoldingCorporationMember"},"factValues":[{"value":"2300000","decimals":-5}]},{"name":"rpt:f-567","factDimensions":{"xbrl:concept":"amch:EquityMethodInvestmentNumberOfWarrantsSold","xbrl:period":"2025-12-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"xbrla:shares","srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis":"amch:HycroftMiningHoldingCorporationMember"},"factValues":[{"value":"1300000","decimals":-5}]},{"name":"rpt:f-568","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromSaleOfEquityMethodInvestments","xbrl:period":"2025-12-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis":"amch:HycroftMiningHoldingCorporationMember"},"factValues":[{"value":"24100000","decimals":-5}]},{"name":"rpt:f-569","factDimensions":{"xbrl:concept":"amch:EquityMethodInvestmentNumberOfWarrantsHeld","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"xbrla:shares","srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis":"amch:HycroftMiningHoldingCorporationMember"},"factValues":[{"value":"1000000","decimals":-6}]},{"name":"rpt:f-570","factDimensions":{"xbrl:concept":"amch:EquityMethodInvestmentCommonSharesRetained","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"xbrla:shares","srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis":"amch:HycroftMiningHoldingCorporationMember"},"factValues":[{"value":"64000"}]},{"name":"rpt:f-571","factDimensions":{"xbrl:concept":"us-gaap:GainLossOnInvestments","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis":"amch:HycroftMiningHoldingCorporationMember","us-gaap:IncomeStatementLocationAxis":"us-gaap:InvestmentIncomeExpenseMember"},"factValues":[{"value":"34400000","decimals":-5}]},{"name":"rpt:f-572","factDimensions":{"xbrl:concept":"us-gaap:GainLossOnInvestments","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis":"amch:HycroftMiningHoldingCorporationMember","us-gaap:IncomeStatementLocationAxis":"us-gaap:InvestmentIncomeExpenseMember"},"factValues":[{"value":"-2900000","decimals":-5}]},{"name":"rpt:f-573","factDimensions":{"xbrl:concept":"us-gaap:GainLossOnInvestments","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis":"amch:HycroftMiningHoldingCorporationMember","us-gaap:IncomeStatementLocationAxis":"us-gaap:InvestmentIncomeExpenseMember"},"factValues":[{"value":"-12600000","decimals":-5}]},{"name":"rpt:f-574","factDimensions":{"xbrl:concept":"amch:PercentageOfEquityMethodInvestmentSold","xbrl:period":"2022-12-30T00:00:00/2022-12-31T00:00:00","xbrl:entity":"cik:0001411579","srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis":"amch:SaudiCinemaCompanyLlcMember"},"factValues":[{"value":"0.10","decimals":3}]},{"name":"rpt:f-575","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestmentSoldCarryingAmount","xbrl:period":"2022-12-30T00:00:00/2022-12-31T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:SAR","srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis":"amch:SaudiCinemaCompanyLlcMember"},"factValues":[{"value":"112500000","decimals":-5}]},{"name":"rpt:f-576","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestmentSoldCarryingAmount","xbrl:period":"2022-12-30T00:00:00/2022-12-31T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis":"amch:SaudiCinemaCompanyLlcMember"},"factValues":[{"value":"30000000","decimals":-5}]},{"name":"rpt:f-577","factDimensions":{"xbrl:concept":"us-gaap:GainOnSaleOfInvestments","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis":"amch:SaudiCinemaCompanyLlcMember"},"factValues":[{"value":"15500000","decimals":-5}]},{"name":"rpt:f-578","factDimensions":{"xbrl:concept":"amch:RelatedPartyTransactionsPolicyTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Related Party Transactions. The Company conducts business with certain of its equity method investees in the ordinary course of business. Transactions primarily relate to advertising revenue and film exhibition costs for film rent. The Company recorded related party advertising revenue of $26.9 million, $26.7 million, and $28.6 million during the years ended December 31, 2025, December 31, 2024, and December 31, 2023, respectively. The Company recorded related party film exhibition costs of $17.5 million, $29.6 million, and $17.5 million during the years ended December 31, 2025, December 31, 2024, and December 31, 2023, respectively.
"}]},{"name":"rpt:f-579","factDimensions":{"xbrl:concept":"us-gaap:RelatedPartyTransactionAmountsOfTransaction","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:RelatedPartyTransactionAxis":"amch:ScreenAdvertisingRevenuesMember"},"factValues":[{"value":"26900000","decimals":-5}]},{"name":"rpt:f-580","factDimensions":{"xbrl:concept":"us-gaap:RelatedPartyTransactionAmountsOfTransaction","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:RelatedPartyTransactionAxis":"amch:ScreenAdvertisingRevenuesMember"},"factValues":[{"value":"26700000","decimals":-5}]},{"name":"rpt:f-581","factDimensions":{"xbrl:concept":"us-gaap:RelatedPartyTransactionAmountsOfTransaction","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:RelatedPartyTransactionAxis":"amch:ScreenAdvertisingRevenuesMember"},"factValues":[{"value":"28600000","decimals":-5}]},{"name":"rpt:f-582","factDimensions":{"xbrl:concept":"us-gaap:RelatedPartyTransactionAmountsOfTransaction","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:RelatedPartyTransactionAxis":"amch:FilmExhibitionCostsMember"},"factValues":[{"value":"17500000","decimals":-5}]},{"name":"rpt:f-583","factDimensions":{"xbrl:concept":"us-gaap:RelatedPartyTransactionAmountsOfTransaction","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:RelatedPartyTransactionAxis":"amch:FilmExhibitionCostsMember"},"factValues":[{"value":"29600000","decimals":-5}]},{"name":"rpt:f-584","factDimensions":{"xbrl:concept":"us-gaap:RelatedPartyTransactionAmountsOfTransaction","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:RelatedPartyTransactionAxis":"amch:FilmExhibitionCostsMember"},"factValues":[{"value":"17500000","decimals":-5}]},{"name":"rpt:f-585","factDimensions":{"xbrl:concept":"us-gaap:DerivativesPolicyTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Derivatives. The Company remeasures the derivative liabilities related to the conversion features in its Existing Exchangeable Notes and New Exchangeable Notes at fair value each reporting period, with changes in fair value recorded in the consolidated statement of operations in other expense (income). The Company has obtained independent third-party valuation studies to assist in determining fair value. The valuation studies use binomial lattice models and are based on significant inputs not observable in the market and thus represent Level 3 measurements within the fair value measurement hierarchy. The binomial lattice models consist of simulated Common Stock prices from the valuation date to the maturity of the Existing Exchangeable Notes and New Exchangeable Notes. The inputs used to value the derivative include the share price of the Common Stock, the volatility of the share price, time to maturity, risk-free interest rate, credit spread, and the discount yield. The volatility of the Company\u2019s Common Stock, the Common Stock price at the end of each reporting period, and the remaining amount of time until maturity of the Existing Exchangeable Notes and New Exchangeable Notes are key inputs for the estimation of fair value that are expected to change each reporting period.
The Company recorded other income related to the change in fair value of the derivatives of $(37.4) million and $(75.8) million as of December 31, 2025 and December 31, 2024, respectively. See Note 7\u2014Corporate Borrowings and Finance Lease Obligations and Note 10\u2014Fair Value Measurements for further discussions regarding the Company\u2019s derivatives.
"}]},{"name":"rpt:f-586","factDimensions":{"xbrl:concept":"us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"37400000","decimals":-5}]},{"name":"rpt:f-587","factDimensions":{"xbrl:concept":"us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"75800000","decimals":-5}]},{"name":"rpt:f-588","factDimensions":{"xbrl:concept":"us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Goodwill. The Company\u2019s recorded goodwill was $2,416.1\u00a0million and $2,301.1\u00a0million as of December\u00a031, 2025 and December\u00a031, 2024, respectively. Goodwill represents the excess of purchase price over fair value of net tangible and identifiable intangible assets resulting from the acquisition of Holdings on August 30, 2012 and subsequent business combinations. The Company has assigned goodwill to two reporting units (Domestic Theatres and International Theatres). The Company performs a qualitative assessment of goodwill at least annually as of the beginning of the fourth quarter or more frequently if events or circumstances indicate that it is more likely than not that the fair value for a reporting unit is less than its carrying amount, including goodwill.
The Company will perform a quantitative impairment test of goodwill if the qualitative assessment concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. The quantitative impairment test of goodwill involves estimating the fair value of the reporting unit and comparing that value to its
carrying value. If the estimated fair value of the reporting unit is less than its carrying value, the difference is recorded as goodwill impairment charge, not to exceed the total amount of goodwill allocated to that reporting unit.
The Company performed qualitative assessments as of October 1, 2025 and October 1, 2024 and concluded that it was not more likely than not that the fair value of either of the Company\u2019s two reporting units was less than their respective carrying amounts. The Company also concluded that there were no triggering events requiring additional assessments that had occurred between October 1, 2025 and December 31, 2025 and October 1, 2024 and December 31, 2024, respectively.
"}]},{"name":"rpt:f-589","factDimensions":{"xbrl:concept":"us-gaap:Goodwill","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2416100000","decimals":-5}]},{"name":"rpt:f-590","factDimensions":{"xbrl:concept":"us-gaap:Goodwill","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2301100000","decimals":-5}]},{"name":"rpt:f-591","factDimensions":{"xbrl:concept":"us-gaap:NumberOfReportingUnits","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"amch:item"},"factValues":[{"value":"2"}]},{"name":"rpt:f-592","factDimensions":{"xbrl:concept":"us-gaap:LesseeLeasesPolicyTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Leases. The Company leases theatres and equipment under operating and finance leases. Many of the leases contain options to extend the leases for additional periods. The Company typically does not believe that the exercise of the renewal options is reasonably assured at the inception of the lease agreements and, therefore, considers the initial base term as the lease term. Lease terms vary but generally, the leases provide for fixed and escalating rentals, contingent escalating rentals based on the Consumer Price Index or other indexes not to exceed certain specified amounts, and variable rentals based on a percentage of revenues. The Company often receives incentives from lessors to assist with renovations at existing locations. The Company records the incentives received from the lessors as an adjustment to the right-of-use asset which results in a reduction to lease costs over the lease term. Operating lease cost for theatre properties are recorded as rent expense in the consolidated statements of operations, except when the lease costs pertain to periods before a theatre opens or after it closes; in those cases, the costs are recorded to operating expense. Operating lease cost for equipment leases is recorded in operating expense in the consolidated statements of operations. The operating lease cost relating to the fixed lease payments is recorded on a straight-line basis over the lease term. Finance lease cost for both theatre properties and equipment are recorded as finance lease interest and depreciation and amortization in the consolidated statements of operations.
Lease right-of-use assets and lease liabilities are recorded at the lease commencement date based on the present value of minimum lease payments over the remaining lease term. The minimum lease payments include base rent and other fixed payments, including fixed maintenance costs. The present value of the lease payments is calculated using the incremental borrowing rate, which was determined using a portfolio approach based on the rate of interest that the Company would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term.
The Company elected the practical expedient to not separate lease and non-lease components and also elected the short-term practical expedient for all leases that qualify. As a result, the Company will not recognize right-of-use assets or liabilities for short-term leases that qualify for the short-term practical expedient, but instead will recognize the lease payments as lease cost on a straight-line basis over the lease term. The Company\u2019s lease agreements do not contain residual value guarantees. Short-term leases and sublease arrangements are immaterial. Equipment leases primarily consist of food and beverage and digital equipment.
"}]},{"name":"rpt:f-593","factDimensions":{"xbrl:concept":"us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Impairment of Long-lived Assets. The Company reviews long-lived assets, including definite-lived intangibles, theatre assets (including operating lease right-of-use assets), and internal-use software whenever events or changes in circumstances indicate that the carrying amount of the asset or asset group may not be fully recoverable. The Company evaluates events or circumstances, including competition in the markets where it operates, that would indicate the carrying value of the asset groups may not be fully recoverable. If an event or circumstance is identified that indicates the carrying value may not be recoverable, the sum of future undiscounted cash flows is compared to the carrying value. If the carrying value exceeds the future undiscounted cash flows, the asset group may be impaired. If the asset group is determined to be impaired, the carrying value of the asset group is reduced to fair value as estimated primarily by using a discounted cash flow model, with the difference recorded as an impairment charge. Management believes that individual theatres are the lowest level for which there are identifiable cash flows and therefore each individual theatre represents an asset group. The Company evaluates theatre asset groups for recoverability using projected data of theatre level cash flow as its primary indicator of potential impairment, giving consideration to the seasonality of its business when making these evaluations. The fair value of assets is determined as either the expected selling price less selling costs (where appropriate) or the present value of the estimated future cash flows, adjusted as necessary for market participant factors.
There is considerable management judgment necessary to determine the estimated future cash flows and fair values of the Company\u2019s theatres and other long-lived assets. Actual future cash flows could vary significantly from such
estimates. The estimated future cash flows are considered Level\u00a03 inputs within the fair value measurement hierarchy, see Note\u00a010\u2014Fair Value Measurements for further information.
The following table summarizes the Company\u2019s impairments, including impairments of equity investments, for the years ended December 31, 2025, December 31, 2024, and December 31, 2023:
Year Ended | |||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2023 | |||
Impairment of long-lived assets | $ | 43.5 | $ | 72.3 | $ | 106.9 | |||
Impairment of equity investments recorded in investment income | 10.3 | \u2014 | 1.0 | ||||||
Total impairment loss | $ | 53.8 | $ | 72.3 | $ | 107.9 |
During the year ended December 31, 2025, the Company recorded non-cash impairment of long-lived assets of $28.0 million on 47 theatres in the U.S. markets with 560 screens (in Alabama, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Iowa, Kansas, Louisiana, Massachusetts, Michigan, Minnesota, New Jersey, New York, North Carolina, Pennsylvania, Tennessee, Texas, Utah, Virginia, Washington, and Wisconsin) and $15.5 million on 20 theatres in the International markets with 159 screens (in Germany, Italy, Spain, Sweden, and the United Kingdom), which were related to property, net and operating lease right-of-use assets, net. In addition, during the year ended December 31, 2025, the Company recorded impairment losses of $10.3 million within investment income related to an equity investment without a readily determinable fair value in the U.S. markets.
During the year ended December 31, 2024, the Company recorded non-cash impairment of long-lived assets of $51.9 million on 39 theatres in the U.S. markets with 469 screens and $20.4 million on 23 theatres in the International markets with 188 screens, which were related to property, net and operating lease right-of-use assets, net.
During the year ended December 31,\u00a02023, the Company recorded non-cash impairment of long-lived assets of $49.2\u00a0million on 68 theatres in the U.S. markets with 738\u00a0screens and $57.7 million on 57\u00a0theatres in the International markets with 488\u00a0screens, which were related to property, net and operating lease right-of-use assets, net. In addition, during the year ended December 31, 2023, the Company recorded impairment losses of $1.0 million within investment income, related to an equity investment without a readily determinable fair value in the U.S. markets.
"}]},{"name":"rpt:f-594","factDimensions":{"xbrl:concept":"us-gaap:DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Year Ended | |||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2023 | |||
Impairment of long-lived assets | $ | 43.5 | $ | 72.3 | $ | 106.9 | |||
Impairment of equity investments recorded in investment income | 10.3 | \u2014 | 1.0 | ||||||
Total impairment loss | $ | 53.8 | $ | 72.3 | $ | 107.9 |
Foreign Currency Translation. Operations outside the United States are generally measured using the local currency as the functional currency. Assets and liabilities are translated to U.S. dollars using exchange rates as of the balance sheet date. Income and expense items are translated using average exchange rates. The foreign currency translation adjustments are a separate component of accumulated other comprehensive income (loss). Gains and losses from foreign currency transactions are included in net earnings (loss), except intercompany transactions of a long-term investment nature, which are included in comprehensive income (loss). Upon substantial liquidation of an investment in a foreign entity, the related foreign currency translation adjustment in accumulated other comprehensive income (loss) is reclassified into earnings as part of the gain or loss on disposition.
"}]},{"name":"rpt:f-624","factDimensions":{"xbrl:concept":"us-gaap:CommitmentsAndContingenciesPolicyTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Contingencies. The Company, in the normal course of business, is a party to various ordinary course claims from vendors (including food and beverage suppliers and film distributors), landlords, competitors, and other legal proceedings. If management believes that a loss arising from these actions is probable and can reasonably be estimated, the Company records the amount of the loss, or the minimum estimated liability when the loss is estimated using a range and no point is more probable than another. As additional information becomes available, any potential liability related to these actions is assessed and the estimates are revised, if necessary. Management believes that the ultimate outcome of such matters discussed below, individually and in the aggregate, will not have a material adverse effect on the Company\u2019s financial position or overall trends in results of operations. However, litigation and claims are subject to inherent uncertainties and unfavorable outcomes can occur. An unfavorable outcome might include monetary damages. If an unfavorable outcome were to occur, there exists the possibility of a material adverse impact on the results of operations in the period in which the outcome occurs or in future periods. An unfavorable outcome could also have a material adverse effect on the Company\u2019s financial position or the market prices of the Company\u2019s securities, including the Company\u2019s Common Stock.
"}]},{"name":"rpt:f-625","factDimensions":{"xbrl:concept":"amch:EmployeeBenefitPlansPolicyTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Employee Benefit Plans. The Company sponsors frozen non-contributory qualified and non-qualified defined benefit pension plans in the U.S. and frozen defined benefit pension plans in the United Kingdom and Sweden. The Company also sponsors various defined contribution plans.
The following table sets forth the plans\u2019 benefit obligations and plan assets included in the consolidated balance sheets:
U.S. Pension Benefits | International Pension Benefits | |||||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | ||||
Aggregated projected benefit obligation at end of period | $ | (73.9) | $ | (73.8) | $ | (71.4) | $ | (63.7) | ||||
Aggregated fair value of plan assets at end of period | \u00a0 | 61.5 | \u00a0 | 59.5 | \u00a0 | 67.2 | \u00a0 | 66.6 | ||||
Net asset (liability) for benefit cost - funded status | $ | (12.4) | $ | (14.3) | $ | (4.2) | $ | 2.9 |
All pension plans are frozen; therefore, aggregated accumulated benefit obligations are equal to aggregated projected benefit obligations as of December 31, 2025 and December 31, 2024, respectively.
The Company expects to contribute $3.0 million to the U.S. pension plans during the year ended December 31, 2026. The Company intends to make future cash contributions to the plans in an amount necessary to meet minimum funding requirements according to applicable benefit plan regulations.
The weighted-average assumptions used to determine benefit obligations are as follows:
U.S. Pension Benefits | International Pension Benefits | |||||||
December\u00a031, 2025 | December\u00a031, 2024 | December\u00a031, 2025 | December\u00a031, 2024 | |||||
Discount rate | \u00a0 | 5.28% | 5.43% | 4.78% | 5.18% | |||
Rate of compensation increase | \u00a0 | N/A | N/A | 2.13% | 2.22% |
The weighted-average assumptions used to determine net periodic benefit cost are as follows:
U.S. Pension Benefits | International Pension Benefits | ||||||||||||
Year Ended | Year Ended | ||||||||||||
December 31, | December 31, | December 31, | December 31, | December 31, | December 31, | ||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | 2023 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | 2023 | ||
Discount rate | \u00a0 | 5.43% | 4.76% | 4.97% | 5.18% | 4.53% | 4.82% | ||||||
Weighted average expected long-term return on plan assets | \u00a0 | 6.56% | 6.56% | 6.56% | 5.41% | 4.34% | 4.32% | ||||||
Rate of compensation increase | \u00a0 | N/A | N/A | N/A | 2.22% | 2.07% | 2.19% |
Pension actuarial gains and losses are recorded in stockholders\u2019 deficit as a component of accumulated other comprehensive loss. For further information, see Note 12\u2014Accumulated Other Comprehensive Loss for pension amounts and activity recorded in accumulated other comprehensive loss.
For the years ended December 31, 2025, December 31, 2024, and December 31, 2023, net periodic benefit costs were $1.2 million, $1.8 million, and $1.4 million, respectively. The non-operating component of net periodic benefit costs is recorded in other expense (income) in the consolidated statements of operations.
The following table provides the benefits expected to be paid in each of the next five years, and in the aggregate for the five years thereafter:
(In millions) | U.S. Pension Benefits | International Pension Benefits | ||||
2026 | $ | 6.3 | $ | 4.2 | ||
2027 | \u00a0 | 5.9 | 4.3 | |||
2028 | \u00a0 | 6.4 | 4.5 | |||
2029 | \u00a0 | 6.7 | 4.3 | |||
2030 | \u00a0 | 6.2 | 4.8 | |||
Years 2031 - 2035 | \u00a0 | 27.1 | 25.9 |
The Company\u2019s investment objectives for its U.S. defined benefit pension plan investments are: (1)\u00a0to preserve the value of its principal; (2)\u00a0to maximize a real long-term return with respect to the plan assets consistent with
minimizing risk; (3)\u00a0to achieve and maintain adequate asset coverage for accrued benefits under the plan; and (4)\u00a0to maintain sufficient liquidity for payment of the plan obligations and expenses. The Company uses a diversified allocation of equity, debt, commodity and real estate exposures that are customized to the plan\u2019s cash flow benefit needs. A weighted average targeted allocation percentage is assigned to each asset class as follows: equity securities of 30%, debt securities of 67%, and private real estate of 3%. The International pension benefit plans do not have an established asset target allocation.
Investments in the pension plan assets are measured at fair value on a recurring basis. As of December 31, 2025, for the U.S. investment portfolio, 95% were valued using the net asset value per share (or its equivalent) as a practical expedient and 5% of the investment included pooled separate accounts valued using market prices for the underlying instruments that were observable in the market or could be derived by observable market data from independent external valuation information (Level 2 of the fair value hierarchy). As of December 31, 2025, for the International investment portfolio, 8% consisting of cash and equivalents was valued using quoted market prices from actively traded markets (Level 1 of the fair value hierarchy), 38% was an insurance contract whose value has been set equal to the present value of the related benefit obligation (Level 3 of the fair value hierarchy), and 54% were valued using the net asset value per share (or its equivalent) as a practical expedient.
In June 2023, the High Court in the UK issued a ruling in respect of Virgin Media Limited v NTL Pension Trustees II Limited, that decided certain amendments were invalid when amending contracted-out salary-related defined benefit pension plans in the period from April 6, 1997 until April 6, 2016, if these amendments were not accompanied by actuarial confirmations (section 37 certificates). An appeal on this decision was heard in June 2024 and The Court of Appeal ruled in July 2024 that the appeal was unsuccessful, i.e., it upheld the original High Court judgment, removing uncertainty around its application. In light of the ruling, the Company initiated an investigation with its pension trustees, of all known amendments to its two UK defined benefit pension plans during the affected period, with a view to determining whether section 37 certificates have been obtained where deemed required. The initial review concluded that across the two plans there are three documents where a section 37 certificate may have been required but the amendment document is silent. In June 2025, the UK government announced it will introduce legislation to give pension plans the ability to retrospectively obtain written actuarial confirmations that historic benefit changes met the necessary standards. This therefore provides clarity around plan liabilities and member benefit levels. On September 1, 2025, the UK government published the bill with these amendments. This legislation will not be in place until it has received royal assent, which is expected to occur in 2026. The Company will continue to monitor this change in legislation and assess any further reviews and potential retrospective confirmation with the trustees in due course.
The Company sponsors various defined contribution plans worldwide which include company match features. The expense related to defined contribution plans for the years ended December 31, 2025, December 31, 2024, and December 31, 2023, was $11.7 million, $10.5 million, and $9.8 million, respectively.
"}]},{"name":"rpt:f-626","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfBenefitObligationsInExcessOfFairValueOfPlanAssetsTableTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"U.S. Pension Benefits | International Pension Benefits | |||||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | ||||
Aggregated projected benefit obligation at end of period | $ | (73.9) | $ | (73.8) | $ | (71.4) | $ | (63.7) | ||||
Aggregated fair value of plan assets at end of period | \u00a0 | 61.5 | \u00a0 | 59.5 | \u00a0 | 67.2 | \u00a0 | 66.6 | ||||
Net asset (liability) for benefit cost - funded status | $ | (12.4) | $ | (14.3) | $ | (4.2) | $ | 2.9 |
"}]},{"name":"rpt:f-627","factDimensions":{"xbrl:concept":"us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:RetirementPlanNameAxis":"amch:UsPensionBenefitsMember"},"factValues":[{"value":"73900000","decimals":-5}]},{"name":"rpt:f-628","factDimensions":{"xbrl:concept":"us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:RetirementPlanNameAxis":"amch:UsPensionBenefitsMember"},"factValues":[{"value":"73800000","decimals":-5}]},{"name":"rpt:f-629","factDimensions":{"xbrl:concept":"us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:RetirementPlanNameAxis":"amch:InternationalPensionBenefitsMember"},"factValues":[{"value":"71400000","decimals":-5}]},{"name":"rpt:f-630","factDimensions":{"xbrl:concept":"us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:RetirementPlanNameAxis":"amch:InternationalPensionBenefitsMember"},"factValues":[{"value":"63700000","decimals":-5}]},{"name":"rpt:f-631","factDimensions":{"xbrl:concept":"us-gaap:DefinedBenefitPlanFairValueOfPlanAssets","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:RetirementPlanNameAxis":"amch:UsPensionBenefitsMember"},"factValues":[{"value":"61500000","decimals":-5}]},{"name":"rpt:f-632","factDimensions":{"xbrl:concept":"us-gaap:DefinedBenefitPlanFairValueOfPlanAssets","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:RetirementPlanNameAxis":"amch:UsPensionBenefitsMember"},"factValues":[{"value":"59500000","decimals":-5}]},{"name":"rpt:f-633","factDimensions":{"xbrl:concept":"us-gaap:DefinedBenefitPlanFairValueOfPlanAssets","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:RetirementPlanNameAxis":"amch:InternationalPensionBenefitsMember"},"factValues":[{"value":"67200000","decimals":-5}]},{"name":"rpt:f-634","factDimensions":{"xbrl:concept":"us-gaap:DefinedBenefitPlanFairValueOfPlanAssets","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:RetirementPlanNameAxis":"amch:InternationalPensionBenefitsMember"},"factValues":[{"value":"66600000","decimals":-5}]},{"name":"rpt:f-635","factDimensions":{"xbrl:concept":"us-gaap:DefinedBenefitPlanFundedStatusOfPlan","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:RetirementPlanNameAxis":"amch:UsPensionBenefitsMember"},"factValues":[{"value":"-12400000","decimals":-5}]},{"name":"rpt:f-636","factDimensions":{"xbrl:concept":"us-gaap:DefinedBenefitPlanFundedStatusOfPlan","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:RetirementPlanNameAxis":"amch:UsPensionBenefitsMember"},"factValues":[{"value":"-14300000","decimals":-5}]},{"name":"rpt:f-637","factDimensions":{"xbrl:concept":"us-gaap:DefinedBenefitPlanFundedStatusOfPlan","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:RetirementPlanNameAxis":"amch:InternationalPensionBenefitsMember"},"factValues":[{"value":"-4200000","decimals":-5}]},{"name":"rpt:f-638","factDimensions":{"xbrl:concept":"us-gaap:DefinedBenefitPlanFundedStatusOfPlan","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:RetirementPlanNameAxis":"amch:InternationalPensionBenefitsMember"},"factValues":[{"value":"2900000","decimals":-5}]},{"name":"rpt:f-639","factDimensions":{"xbrl:concept":"us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:RetirementPlanNameAxis":"amch:UsPensionBenefitsMember"},"factValues":[{"value":"3000000","decimals":-5}]},{"name":"rpt:f-640","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfAssumptionsUsedTableTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"
The weighted-average assumptions used to determine benefit obligations are as follows:
U.S. Pension Benefits | International Pension Benefits | |||||||
December\u00a031, 2025 | December\u00a031, 2024 | December\u00a031, 2025 | December\u00a031, 2024 | |||||
Discount rate | \u00a0 | 5.28% | 5.43% | 4.78% | 5.18% | |||
Rate of compensation increase | \u00a0 | N/A | N/A | 2.13% | 2.22% |
The weighted-average assumptions used to determine net periodic benefit cost are as follows:
U.S. Pension Benefits | International Pension Benefits | ||||||||||||
Year Ended | Year Ended | ||||||||||||
December 31, | December 31, | December 31, | December 31, | December 31, | December 31, | ||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | 2023 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | 2023 | ||
Discount rate | \u00a0 | 5.43% | 4.76% | 4.97% | 5.18% | 4.53% | 4.82% | ||||||
Weighted average expected long-term return on plan assets | \u00a0 | 6.56% | 6.56% | 6.56% | 5.41% | 4.34% | 4.32% | ||||||
Rate of compensation increase | \u00a0 | N/A | N/A | N/A | 2.22% | 2.07% | 2.19% |
(In millions) | U.S. Pension Benefits | International Pension Benefits | ||||
2026 | $ | 6.3 | $ | 4.2 | ||
2027 | \u00a0 | 5.9 | 4.3 | |||
2028 | \u00a0 | 6.4 | 4.5 | |||
2029 | \u00a0 | 6.7 | 4.3 | |||
2030 | \u00a0 | 6.2 | 4.8 | |||
Years 2031 - 2035 | \u00a0 | 27.1 | 25.9 |
Income and Operating Taxes. The Company accounts for income taxes in accordance with ASC\u00a0740-10. Under ASC\u00a0740-10, deferred income tax effects of transactions reported in different periods for financial reporting and income tax return purposes are recorded by the asset and liability method. This method gives consideration to the future tax consequences of deferred income or expense items and recognizes changes in income tax laws in the period of enactment.
Holdings and its U.S. subsidiaries file a consolidated U.S. federal income tax return and combined income tax returns in certain state jurisdictions. Foreign subsidiaries file income tax returns in foreign jurisdictions. Income taxes are determined based on separate company computations of income or loss. Tax sharing arrangements are in place and utilized when tax benefits from affiliates in the consolidated group are used to offset what would otherwise be taxable income generated by Holdings or another affiliate.
"}]},{"name":"rpt:f-690","factDimensions":{"xbrl:concept":"amch:CasualtyInsurancePolicyTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Casualty Insurance. The Company is self-insured for general liability up to $1.0\u00a0million per occurrence and carries a $0.5\u00a0million deductible limit per occurrence for workers\u2019 compensation claims. The Company utilizes actuarial projections of its ultimate losses to calculate its reserves and expense. The actuarial method includes an allowance for adverse developments on known claims and an allowance for claims which have been incurred but which have not yet been reported. As of December\u00a031, 2025 and December\u00a031, 2024, the Company recorded casualty insurance reserves of $33.7 million and $25.7\u00a0million, respectively. The Company recorded expenses related to general liability and workers\u2019 compensation claims of $64.2\u00a0million, $65.5\u00a0million, and $53.1\u00a0million for the years ended December\u00a031, 2025, December\u00a031, 2024, and December\u00a031, 2023, respectively. Casualty insurance expense is recorded in operating expense.
"}]},{"name":"rpt:f-691","factDimensions":{"xbrl:concept":"amch:GeneralLiabilitySelfInsuredAmountPerOccurrence","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1000000","decimals":-5}]},{"name":"rpt:f-692","factDimensions":{"xbrl:concept":"amch:GeneralLiabilitySelfInsuredDeductibleLimitPerOccurrence","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"500000","decimals":-5}]},{"name":"rpt:f-693","factDimensions":{"xbrl:concept":"us-gaap:SelfInsuranceReserve","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"33700000","decimals":-5}]},{"name":"rpt:f-694","factDimensions":{"xbrl:concept":"us-gaap:SelfInsuranceReserve","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"25700000","decimals":-5}]},{"name":"rpt:f-695","factDimensions":{"xbrl:concept":"amch:GeneralLiabilityAndWorkersCompensationExpense","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"64200000","decimals":-5}]},{"name":"rpt:f-696","factDimensions":{"xbrl:concept":"amch:GeneralLiabilityAndWorkersCompensationExpense","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"65500000","decimals":-5}]},{"name":"rpt:f-697","factDimensions":{"xbrl:concept":"amch:GeneralLiabilityAndWorkersCompensationExpense","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"53100000","decimals":-5}]},{"name":"rpt:f-698","factDimensions":{"xbrl:concept":"us-gaap:GovernmentAssistancePolicyTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Government Assistance. The Company recognizes government assistance when the conditions of the grant have been met and there is reasonable assurance that the assistance will be received. Grants relating to specific costs are treated as a reduction of that cost in the consolidated statement of operations. General grants are recorded within other expense (income). Grants related to the construction of long-lived assets are treated as reductions to the cost of the associated assets.
During the year ended December 31, 2025, the Company recognized government assistance in other expense (income) of $10.8 million related to cash grants received in the International markets to support businesses impacted by the COVID-19 pandemic. The Company concluded all grant criteria had been met and that the likelihood of recapture was remote, therefore the entire award has been recognized. During the year ended December 31, 2024, the Company recognized government assistance in other income of $0.1 million related to government assistance for theatres impacted by flooding in Spain. During the year ended December 31, 2023, the Company recognized government assistance in other income of $4.8 million, primarily related to grants in the International markets. The general requirements of the grants were that the grantees must have lost income due to the COVID-19 pandemic. The Company concluded all grant criteria had been met and therefore have recognized the entire award.
Additionally, the Company recognized $1.1 million, $4.5 million and $3.2 million of government assistance as reduction to property, net during the years ended December 31, 2025, December 31, 2024, and December 31, 2023, respectively. The assistance relates to the construction of capital assets related to the innovation, modernization, and digitalization of the theatrical exhibition industry in certain countries in the International markets.
During the years ended December 31, 2025, December 31, 2024, and December 31, 2023, the Company was awarded $0.0 million, $9.7 million and $10.0 million, respectively, of tax credits in our International markets that have been or will be utilized to offset employer payroll tax or value-added tax liabilities. The tax credits are granted by the government to support entities in the film exhibition industry. The Company recorded these credits as reductions to operating expense in 2024 and as reductions to rent and operating expense during 2023 as those expenses were the basis for the tax credits awarded.
"}]},{"name":"rpt:f-699","factDimensions":{"xbrl:concept":"us-gaap:GovernmentAssistanceNonoperatingIncome","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"10800000","decimals":-5}]},{"name":"rpt:f-700","factDimensions":{"xbrl:concept":"us-gaap:GovernmentAssistanceNonoperatingIncome","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"100000","decimals":-5}]},{"name":"rpt:f-701","factDimensions":{"xbrl:concept":"us-gaap:GovernmentAssistanceNonoperatingIncome","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"4800000","decimals":-5}]},{"name":"rpt:f-702","factDimensions":{"xbrl:concept":"amch:GovernmentAssistanceRecognizedAsReductionToPropertyPlantAndEquipmentNet","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1100000","decimals":-5}]},{"name":"rpt:f-703","factDimensions":{"xbrl:concept":"amch:GovernmentAssistanceRecognizedAsReductionToPropertyPlantAndEquipmentNet","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"4500000","decimals":-5}]},{"name":"rpt:f-704","factDimensions":{"xbrl:concept":"amch:GovernmentAssistanceRecognizedAsReductionToPropertyPlantAndEquipmentNet","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"3200000","decimals":-5}]},{"name":"rpt:f-705","factDimensions":{"xbrl:concept":"us-gaap:IncomeTaxCreditsAndAdjustments","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"0","decimals":-5}]},{"name":"rpt:f-706","factDimensions":{"xbrl:concept":"us-gaap:IncomeTaxCreditsAndAdjustments","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"9700000","decimals":-5}]},{"name":"rpt:f-707","factDimensions":{"xbrl:concept":"us-gaap:IncomeTaxCreditsAndAdjustments","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"10000000","decimals":-5}]},{"name":"rpt:f-708","factDimensions":{"xbrl:concept":"amch:OtherExpenseIncomePolicyTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Other Expense (Income): The following table sets forth the components of other expense (income):
Year Ended | |||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2023 | |||
Governmental assistance - International markets | $ | (10.8) | $ | (0.1) | $ | (3.8) | |||
Governmental assistance - U.S. markets | \u2014 | \u2014 | (1.0) | ||||||
Foreign currency transaction (gains) losses | (28.1) | 7.0 | (17.8) | ||||||
Non-operating components of net periodic benefit cost | 1.2 | 1.8 | 1.4 | ||||||
Gain on extinguishment - Second Lien Notes due 2026 | (6.6) | (40.3) | (140.5) | ||||||
Loss on extinguishment - Senior Subordinated Notes due 2025 | \u2014 | 2.7 | \u2014 | ||||||
Loss (gain) on extinguishment - Senior Subordinated Notes due 2026 | 0.3 | (1.3) | (2.3) | ||||||
Loss on extinguishment - 6.00%/8.00% Cash/PIK Toggle Senior Secured Exchangeable Notes due 2030 | 103.3 | \u2014 | \u2014 | ||||||
Loss on extinguishment - 7.5% First Lien Notes due 2029 | 99.0 | \u2014 | \u2014 | ||||||
Term Loan modifications - third party fees | 3.1 | 42.3 | \u2014 | ||||||
Increase in fair value of bifurcated embedded derivative liability - Senior Secured Exchangeable Notes due 2030 | 19.3 | \u2014 | \u2014 | ||||||
Decrease in fair value of bifurcated embedded derivative liability - 6.00%/8.00% Cash/PIK Toggle Senior Secured Exchangeable Notes due 2030 | (56.7) | (75.8) | \u2014 | ||||||
Equity in earnings of non-consolidated entities | (6.8) | (12.4) | (7.7) | ||||||
Derivative stockholder settlement (1) | \u2014 | \u2014 | (14.0) | ||||||
Shareholder litigation expense and (recoveries) (2) | (3.8) | (40.2) | 110.2 | ||||||
Vendor dispute settlement (3) | \u2014 | (36.2) | \u2014 | ||||||
Other settlement proceeds | \u2014 | (3.6) | \u2014 | ||||||
Business interruption insurance recoveries | (1.0) | (0.1) | (1.3) | ||||||
Total other expense (income) | $ | 112.4 | $ | (156.2) | $ | (76.8) |
| (1) | The Company received $14.0 million as a result of a derivative stockholder settlement which was recorded as other income during the year ended December 31, 2023. |
| (2) | The Company recorded a $110.2 million charge for the settlement of shareholder litigation during the year ended December 31, 2023. The Company recorded other income related to recoveries of insurance claims associated with the shareholder litigation of $3.8 million and $40.2 million during the years ended December 31, 2025 and December 31, 2024, respectively. |
| (3) | The Company executed an agreement to collect $37.5 million as a resolution of a dispute with a vendor. The proceeds, net of legal costs, were recorded to other income during the year ended December 31, 2024. |
Year Ended | |||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2023 | |||
Governmental assistance - International markets | $ | (10.8) | $ | (0.1) | $ | (3.8) | |||
Governmental assistance - U.S. markets | \u2014 | \u2014 | (1.0) | ||||||
Foreign currency transaction (gains) losses | (28.1) | 7.0 | (17.8) | ||||||
Non-operating components of net periodic benefit cost | 1.2 | 1.8 | 1.4 | ||||||
Gain on extinguishment - Second Lien Notes due 2026 | (6.6) | (40.3) | (140.5) | ||||||
Loss on extinguishment - Senior Subordinated Notes due 2025 | \u2014 | 2.7 | \u2014 | ||||||
Loss (gain) on extinguishment - Senior Subordinated Notes due 2026 | 0.3 | (1.3) | (2.3) | ||||||
Loss on extinguishment - 6.00%/8.00% Cash/PIK Toggle Senior Secured Exchangeable Notes due 2030 | 103.3 | \u2014 | \u2014 | ||||||
Loss on extinguishment - 7.5% First Lien Notes due 2029 | 99.0 | \u2014 | \u2014 | ||||||
Term Loan modifications - third party fees | 3.1 | 42.3 | \u2014 | ||||||
Increase in fair value of bifurcated embedded derivative liability - Senior Secured Exchangeable Notes due 2030 | 19.3 | \u2014 | \u2014 | ||||||
Decrease in fair value of bifurcated embedded derivative liability - 6.00%/8.00% Cash/PIK Toggle Senior Secured Exchangeable Notes due 2030 | (56.7) | (75.8) | \u2014 | ||||||
Equity in earnings of non-consolidated entities | (6.8) | (12.4) | (7.7) | ||||||
Derivative stockholder settlement (1) | \u2014 | \u2014 | (14.0) | ||||||
Shareholder litigation expense and (recoveries) (2) | (3.8) | (40.2) | 110.2 | ||||||
Vendor dispute settlement (3) | \u2014 | (36.2) | \u2014 | ||||||
Other settlement proceeds | \u2014 | (3.6) | \u2014 | ||||||
Business interruption insurance recoveries | (1.0) | (0.1) | (1.3) | ||||||
Total other expense (income) | $ | 112.4 | $ | (156.2) | $ | (76.8) |
| (1) | The Company received $14.0 million as a result of a derivative stockholder settlement which was recorded as other income during the year ended December 31, 2023. |
| (2) | The Company recorded a $110.2 million charge for the settlement of shareholder litigation during the year ended December 31, 2023. The Company recorded other income related to recoveries of insurance claims associated with the shareholder litigation of $3.8 million and $40.2 million during the years ended December 31, 2025 and December 31, 2024, respectively. |
| (3) | The Company executed an agreement to collect $37.5 million as a resolution of a dispute with a vendor. The proceeds, net of legal costs, were recorded to other income during the year ended December 31, 2024. |
Accounting Pronouncements Recently Adopted
Income Tax Disclosures. In December 2023, the Financial Accounting Standards Bord (\u201cFASB\u201d) issued ASU 2023-09, Income Taxes (Topic 740) Improvements to Income Tax Disclosures (\u201cASU 2023-09\u201d). The amendments in ASU 2023-09 require entities to disclose on an annual basis (1) specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. The amendments also require that entities disclose various information about income taxes paid and (1) income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and (2) foreign and income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. The Company adopted the new standard during the fourth quarter of 2025 on a full retrospective basis and recast certain prior period amounts and disclosures to conform to current year presentation. See Note 9\u2014Income Taxes for the required disclosure information resulting from ASU 2023-09.
Accounting Pronouncements Issued Not Yet Adopted
Disaggregation of Income Statement Expenses. In November 2024, the FASB issued ASU 2024-03, Income Statement (Subtopic 220-40)\u2014Reporting Comprehensive Income-Expense Disaggregation Disclosures (\u201cASU 2024-03\u201d). The amendments in ASU 2024-03 require that public business entities disclose additional information about specific expense categories in the notes to financial statements for interim and annual reporting periods. ASU 2024-03 is effective for the Company for the year ended December 31, 2027. The Company is currently evaluating the effect that ASU 2024-03 will have on its consolidated financial statements.
Induced Conversions of Convertible Debt Instruments. In November 2024, the FASB issued ASU 2024-04, Debt\u2014Debt with Conversion and Other Options (Subtopic 470-20) Induced Conversions of Convertible Debt Instruments (\u201cASU 2024-04\u201d). The amendments in ASU 2024-04 clarify the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. The amendments are effective for annual reporting periods beginning after December 15, 2025. The Company is currently evaluating the effect that ASU 2024-04 will have on its consolidated financial statements.
Internal-Use Software. In September 2025, the FASB issued ASU 2025-06, Intangibles\u2013Goodwill and Other (Subtopic 350-40) Targeted Improvements to the Accounting for Internal-Use Software (\u201cASU 2025-06\u201d), which is intended to modernize the accounting for software costs that are accounted for under Subtopic 350-40. ASU 2025-06 removes references to prescriptive and sequential software development stages and replaces them with a probable-to-complete recognition threshold. ASU 2025-06 also clarifies which disclosures apply to capitalized internal-use software costs. ASU 2025-06 is effective for annual reporting periods beginning after December 15, 2027, and interim reporting periods within those reporting periods. Early adoption at the beginning of a fiscal year is permitted. The Company is currently evaluating the effect that ASU 2025-06 will have on its consolidated financial statements.
Derivatives Scope Refinements and Share-Based Noncash Consideration. In September 2025, the FASB issued ASU 2025-07, Derivatives and Hedging (Topic 815) and Revenue from Contracts with Customers (Topic 606) (\u201cASU 2025-07\u201d), which (1) refines the scope of the guidance on derivatives in Topic 815 and (2) clarifies the guidance on share-based payments from a customer in ASC 606. ASU 2025-07 is intended to address concerns about the application of derivative accounting to contracts that have features based on the operations or activities of one of the parties to the contract and to reduce diversity in the accounting for share-based payments in revenue contracts. ASU 2025-07 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within those reporting periods. Early adoption is permitted. The Company is currently evaluating the effect that ASU 2025-07 will have on its consolidated financial statements.
Accounting for Government Grants. In December 2025, the FASB issued ASU 2025-10, Accounting for Government Grants Received by Business Entities (Topic 832) (\u201cASU 2025-10\u201d), which establishes the accounting for a government grant received by a business entity, including guidance for a grant related to an asset and a grant related to income. ASU 2025-10 adds guidance on Topic 832 on the recognition, measurement, and presentation of government grants. ASU 2025-10 is effective for annual reporting periods beginning after December 15, 2028, and interim reporting periods within those annual reporting periods. Early adoption is permitted in both interim and annual reporting periods in which financial statements have not yet been issued or made available for issuance. The Company is currently evaluating the impact of ASU 2025-10 on its consolidated financial statements.
Interim Reporting Narrow-Scope Improvements. In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270) Narrow-Scope Improvements (\u201cASU 2025-11\u201d). The amendments in ASU 2025-11 clarify interim disclosure requirements and the applicability of Topic 270. The amendments in ASU 2025-11 also include a disclosure principle that requires entities to disclose events since the end of the last annual reporting period that have a material impact on the entity. ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2025-11 on its consolidated financial statements.
"}]},{"name":"rpt:f-760","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"NOTE 2\u2014REVENUE RECOGNITION
Disaggregation of Revenue. Revenue is disaggregated in the following tables by major revenue types and by timing of revenue recognition:
Year Ended | |||||||||
(In millions) | December\u00a031,\u00a02025 | December\u00a031,\u00a02024 | December\u00a031,\u00a02023 | ||||||
Major revenue types | |||||||||
Admissions | $ | 2,652.8 | $ | 2,560.5 | $ | 2,690.5 | |||
Food and beverage | 1,671.3 | 1,624.9 | 1,669.8 | ||||||
Other theatre: | |||||||||
Advertising | 152.1 | 132.9 | 129.5 | ||||||
Other theatre | 372.7 | 318.9 | 322.8 | ||||||
Other theatre | 524.8 | 451.8 | 452.3 | ||||||
Total revenues | $ | 4,848.9 | $ | 4,637.2 | $ | 4,812.6 |
Year Ended | |||||||||
(In millions) | December\u00a031,\u00a02025 | December\u00a031,\u00a02024 | December\u00a031,\u00a02023 | ||||||
Timing of revenue recognition | |||||||||
Products and services transferred at a point in time | $ | 4,362.5 | $ | 4,224.7 | $ | 4,424.1 | |||
Products and services transferred over time (1) | 486.4 | 412.5 | 388.5 | ||||||
Total revenues | $ | 4,848.9 | $ | 4,637.2 | $ | 4,812.6 |
| (1) | Amounts primarily include subscription and advertising revenues. |
The following tables provide the balances of receivables, net and deferred revenues and income:
(In millions) | December\u00a031,\u00a02025 | December 31, 2024 | ||||
Current assets | ||||||
Receivables related to contracts with customers | $ | 95.1 | $ | 86.0 | ||
Miscellaneous receivables | 60.9 | 82.1 | ||||
Receivables, net | $ | 156.0 | $ | 168.1 |
(In millions) | December\u00a031,\u00a02025 | December 31, 2024 | ||||
Current liabilities | ||||||
Deferred revenues related to contracts with customers | $ | 462.4 | $ | 425.6 | ||
Miscellaneous deferred income | 3.1 | 6.8 | ||||
Deferred revenues and income | $ | 465.5 | $ | 432.4 |
The significant changes in contract liabilities with customers included in deferred revenues and income are as follows:
Deferred Revenues | |||
Related to Contracts | |||
(In millions) | with Customers | ||
Balance December 31, 2023 | $ | 415.3 | |
Cash received in advance (1) | 354.1 | ||
Customer loyalty rewards accumulated, net of expirations: | |||
Admission revenues (2) | 22.6 | ||
Food and beverage revenues (2) | 39.5 | ||
Other theatre revenues (2) | (2.6) | ||
Reclassification to revenue as the result of performance obligations satisfied: | |||
Admission revenues (3) | (254.1) | ||
Food and beverage revenues (3) | (75.8) | ||
Other theatre revenues (4) | (73.2) | ||
Foreign currency translation adjustment | (0.2) | ||
Balance December 31, 2024 | $ | 425.6 | |
Cash received in advance (1) | 393.8 | ||
Customer loyalty rewards accumulated, net of expirations: | |||
Admission revenues (2) | 19.7 | ||
Food and beverage revenues (2) | 55.1 | ||
Reclassification to revenue as the result of performance obligations satisfied: | |||
Admission revenues (3) | (256.9) | ||
Food and beverage revenues (3) | (91.0) | ||
Other theatre revenues (4) | (88.6) | ||
Foreign currency translation adjustment | 4.7 | ||
Balance December 31, 2025 | $ | 462.4 |
| (1) | Includes movie tickets, food and beverage, gift cards, exchange tickets, subscription membership fees, and other loyalty membership fees. |
| (2) | Amount of rewards accumulated, net of expirations, that are attributed to loyalty programs. |
| (3) | Amount of revenue recognized from redemption of gift cards, exchange tickets, movie tickets, and rewards related to loyalty programs. |
| (4) | Amounts relate to income from non-redeemed or partially redeemed gift cards, non-redeemed exchange tickets, subscription membership fees, and loyalty programs membership fees. |
The significant changes to contract liabilities included in the exhibitor services agreement in the consolidated balance sheets are as follows:
Exhibitor Services | |||
(In millions) | Agreement (1) | ||
Balance December 31, 2023 | $ | 486.6 | |
Other theatre revenue recognized, net of adjustments, as performance obligations are satisfied | (22.6) | ||
Balance December 31, 2024 | $ | 464.0 | |
Contract modification consideration (1) | 5.3 | ||
Other theatre revenue recognized as performance obligations are satisfied | (10.2) | ||
Balance December 31, 2025 | $ | 459.1 |
| (1) | The exhibitor services agreement contract liability relates to NCM common units that were previously received under the exhibitor services agreement dated February 13, 2007 and amended and restated as of December 13, 2013. On April 17, 2025, NCM entered into the Amended ESA with the Company. The term of the Amended ESA has been extended by five years through February 13, 2042. The Company treated the Amended ESA as a contract modification pursuant to ASC 606 \u2013 Revenue from Contracts with Customers. Accordingly, the Company has allocated the additional consideration received from the contract modification to the exhibitor services agreement contract liability and updated the discount rate used to account for the significant financing component to 16.12%. Prior to the contract modification, the weighted average discount rate used to account for the significant financing component was approximately 7.5%. The contract liability will be reclassified to other theatre revenue over the new term of the Amended ESA as the remaining performance obligations are satisfied. |
NCM Bankruptcy. On April 11, 2023, NCM filed a petition under Chapter 11 of the U.S. Bankruptcy Code in the Southern District of Texas. The Chapter 11 plan of reorganization became effective on August 7, 2023 (the \u201cPlan\u201d). The Company appealed certain terms of the Plan and rulings of the bankruptcy court with the United States District Court for the Southern District of Texas, which affirmed the rulings of the bankruptcy court, and subsequently with the United States Court of Appeals for the Fifth Circuit. On April 17, 2025, concurrently with entering into the Amended ESA, NCM and the Company reached an agreement to, among other things, dismiss with prejudice the ongoing litigation between the parties.
Transaction Price Allocated to the Remaining Performance Obligations. The following table includes the amount of the exhibitor services agreement contract liability that is expected to be recognized as revenues in the future related to performance obligations that are unsatisfied as of December\u00a031, 2025:
(In millions) | Exhibitor Services Agreement | ||
Year ended 2026 | $ | 6.5 | |
Year ended 2027 | 7.6 | ||
Year ended 2028 | 8.9 | ||
Year ended 2029 | 10.5 | ||
Year ended 2030 | 12.3 | ||
Years ended 2031 through February 2042 | 413.3 | ||
Total | $ | 459.1 |
Gift Cards and Exchange Tickets. The total amount of non-redeemed gift cards and exchange tickets included in deferred revenues and income as of December\u00a031, 2025 was $341.8\u00a0million. This will be recognized as revenues as the gift cards and exchange tickets are redeemed, as the estimated non-redeemed gift card and exchange ticket revenues are recognized in proportion to the pattern of actual redemptions which is estimated to occur over the next to 36 months, or as the gift cards or exchange tickets expire.
Loyalty Programs. As of December\u00a031, 2025, the amount of deferred revenues related to loyalty programs included in deferred revenues and income was $94.4\u00a0million. The earned points will be recognized as revenue as the points are redeemed or expire. Subscription membership fees and loyalty membership fees are recognized ratably over their respective membership periods.
The Company applies the practical expedient in ASC 606-10-50-14 and does not disclose information about remaining performance obligations that have original expected durations of one year or less.
"}]},{"name":"rpt:f-761","factDimensions":{"xbrl:concept":"us-gaap:DisaggregationOfRevenueTableTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Year Ended | |||||||||
(In millions) | December\u00a031,\u00a02025 | December\u00a031,\u00a02024 | December\u00a031,\u00a02023 | ||||||
Major revenue types | |||||||||
Admissions | $ | 2,652.8 | $ | 2,560.5 | $ | 2,690.5 | |||
Food and beverage | 1,671.3 | 1,624.9 | 1,669.8 | ||||||
Other theatre: | |||||||||
Advertising | 152.1 | 132.9 | 129.5 | ||||||
Other theatre | 372.7 | 318.9 | 322.8 | ||||||
Other theatre | 524.8 | 451.8 | 452.3 | ||||||
Total revenues | $ | 4,848.9 | $ | 4,637.2 | $ | 4,812.6 |
Year Ended | |||||||||
(In millions) | December\u00a031,\u00a02025 | December\u00a031,\u00a02024 | December\u00a031,\u00a02023 | ||||||
Timing of revenue recognition | |||||||||
Products and services transferred at a point in time | $ | 4,362.5 | $ | 4,224.7 | $ | 4,424.1 | |||
Products and services transferred over time (1) | 486.4 | 412.5 | 388.5 | ||||||
Total revenues | $ | 4,848.9 | $ | 4,637.2 | $ | 4,812.6 |
| (1) | Amounts primarily include subscription and advertising revenues. |
"}]},{"name":"rpt:f-762","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"us-gaap:AdmissionMember"},"factValues":[{"value":"2652800000","decimals":-5}]},{"name":"rpt:f-763","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"us-gaap:AdmissionMember"},"factValues":[{"value":"2560500000","decimals":-5}]},{"name":"rpt:f-764","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"us-gaap:AdmissionMember"},"factValues":[{"value":"2690500000","decimals":-5}]},{"name":"rpt:f-765","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"us-gaap:FoodAndBeverageMember"},"factValues":[{"value":"1671300000","decimals":-5}]},{"name":"rpt:f-766","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"us-gaap:FoodAndBeverageMember"},"factValues":[{"value":"1624900000","decimals":-5}]},{"name":"rpt:f-767","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"us-gaap:FoodAndBeverageMember"},"factValues":[{"value":"1669800000","decimals":-5}]},{"name":"rpt:f-768","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"us-gaap:AdvertisingMember"},"factValues":[{"value":"152100000","decimals":-5}]},{"name":"rpt:f-769","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"us-gaap:AdvertisingMember"},"factValues":[{"value":"132900000","decimals":-5}]},{"name":"rpt:f-770","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"us-gaap:AdvertisingMember"},"factValues":[{"value":"129500000","decimals":-5}]},{"name":"rpt:f-771","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"us-gaap:ProductAndServiceOtherMember"},"factValues":[{"value":"372700000","decimals":-5}]},{"name":"rpt:f-772","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"us-gaap:ProductAndServiceOtherMember"},"factValues":[{"value":"318900000","decimals":-5}]},{"name":"rpt:f-773","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"us-gaap:ProductAndServiceOtherMember"},"factValues":[{"value":"322800000","decimals":-5}]},{"name":"rpt:f-774","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"amch:TotalOtherProductAndServiceMember"},"factValues":[{"value":"524800000","decimals":-5}]},{"name":"rpt:f-775","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"amch:TotalOtherProductAndServiceMember"},"factValues":[{"value":"451800000","decimals":-5}]},{"name":"rpt:f-776","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:ProductOrServiceAxis":"amch:TotalOtherProductAndServiceMember"},"factValues":[{"value":"452300000","decimals":-5}]},{"name":"rpt:f-777","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"4848900000","decimals":-5}]},{"name":"rpt:f-778","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"4637200000","decimals":-5}]},{"name":"rpt:f-779","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"4812600000","decimals":-5}]},{"name":"rpt:f-780","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:TimingOfTransferOfGoodOrServiceAxis":"us-gaap:TransferredAtPointInTimeMember"},"factValues":[{"value":"4362500000","decimals":-5}]},{"name":"rpt:f-781","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:TimingOfTransferOfGoodOrServiceAxis":"us-gaap:TransferredAtPointInTimeMember"},"factValues":[{"value":"4224700000","decimals":-5}]},{"name":"rpt:f-782","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:TimingOfTransferOfGoodOrServiceAxis":"us-gaap:TransferredAtPointInTimeMember"},"factValues":[{"value":"4424100000","decimals":-5}]},{"name":"rpt:f-783","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:TimingOfTransferOfGoodOrServiceAxis":"us-gaap:TransferredOverTimeMember"},"factValues":[{"value":"486400000","decimals":-5}]},{"name":"rpt:f-784","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:TimingOfTransferOfGoodOrServiceAxis":"us-gaap:TransferredOverTimeMember"},"factValues":[{"value":"412500000","decimals":-5}]},{"name":"rpt:f-785","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:TimingOfTransferOfGoodOrServiceAxis":"us-gaap:TransferredOverTimeMember"},"factValues":[{"value":"388500000","decimals":-5}]},{"name":"rpt:f-786","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"4848900000","decimals":-5}]},{"name":"rpt:f-787","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"4637200000","decimals":-5}]},{"name":"rpt:f-788","factDimensions":{"xbrl:concept":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"4812600000","decimals":-5}]},{"name":"rpt:f-789","factDimensions":{"xbrl:concept":"us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"
(In millions) | December\u00a031,\u00a02025 | December 31, 2024 | ||||
Current assets | ||||||
Receivables related to contracts with customers | $ | 95.1 | $ | 86.0 | ||
Miscellaneous receivables | 60.9 | 82.1 | ||||
Receivables, net | $ | 156.0 | $ | 168.1 |
(In millions) | December\u00a031,\u00a02025 | December 31, 2024 | ||||
Current liabilities | ||||||
Deferred revenues related to contracts with customers | $ | 462.4 | $ | 425.6 | ||
Miscellaneous deferred income | 3.1 | 6.8 | ||||
Deferred revenues and income | $ | 465.5 | $ | 432.4 |
"}]},{"name":"rpt:f-790","factDimensions":{"xbrl:concept":"us-gaap:ContractWithCustomerAssetNetCurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"95100000","decimals":-5}]},{"name":"rpt:f-791","factDimensions":{"xbrl:concept":"us-gaap:ContractWithCustomerAssetNetCurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"86000000","decimals":-5}]},{"name":"rpt:f-792","factDimensions":{"xbrl:concept":"amch:MiscellaneousCurrentReceivables","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"60900000","decimals":-5}]},{"name":"rpt:f-793","factDimensions":{"xbrl:concept":"amch:MiscellaneousCurrentReceivables","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"82100000","decimals":-5}]},{"name":"rpt:f-794","factDimensions":{"xbrl:concept":"us-gaap:ReceivablesNetCurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"156000000","decimals":-5}]},{"name":"rpt:f-795","factDimensions":{"xbrl:concept":"us-gaap:ReceivablesNetCurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"168100000","decimals":-5}]},{"name":"rpt:f-796","factDimensions":{"xbrl:concept":"amch:ContractsWithCustomersDeferredRevenue","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"462400000","decimals":-5}]},{"name":"rpt:f-797","factDimensions":{"xbrl:concept":"amch:ContractsWithCustomersDeferredRevenue","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"425600000","decimals":-5}]},{"name":"rpt:f-798","factDimensions":{"xbrl:concept":"amch:MiscellaneousDeferredIncome","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"3100000","decimals":-5}]},{"name":"rpt:f-799","factDimensions":{"xbrl:concept":"amch:MiscellaneousDeferredIncome","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"6800000","decimals":-5}]},{"name":"rpt:f-800","factDimensions":{"xbrl:concept":"us-gaap:ContractWithCustomerLiability","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"465500000","decimals":-5}]},{"name":"rpt:f-801","factDimensions":{"xbrl:concept":"us-gaap:ContractWithCustomerLiability","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"432400000","decimals":-5}]},{"name":"rpt:f-802","factDimensions":{"xbrl:concept":"amch:ChangesInContractsWithCustomersTableTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","us-gaap:ContractWithCustomerSalesChannelAxis":"us-gaap:SalesChannelDirectlyToConsumerMember"},"factValues":[{"value":"
Deferred Revenues | |||
Related to Contracts | |||
(In millions) | with Customers | ||
Balance December 31, 2023 | $ | 415.3 | |
Cash received in advance (1) | 354.1 | ||
Customer loyalty rewards accumulated, net of expirations: | |||
Admission revenues (2) | 22.6 | ||
Food and beverage revenues (2) | 39.5 | ||
Other theatre revenues (2) | (2.6) | ||
Reclassification to revenue as the result of performance obligations satisfied: | |||
Admission revenues (3) | (254.1) | ||
Food and beverage revenues (3) | (75.8) | ||
Other theatre revenues (4) | (73.2) | ||
Foreign currency translation adjustment | (0.2) | ||
Balance December 31, 2024 | $ | 425.6 | |
Cash received in advance (1) | 393.8 | ||
Customer loyalty rewards accumulated, net of expirations: | |||
Admission revenues (2) | 19.7 | ||
Food and beverage revenues (2) | 55.1 | ||
Reclassification to revenue as the result of performance obligations satisfied: | |||
Admission revenues (3) | (256.9) | ||
Food and beverage revenues (3) | (91.0) | ||
Other theatre revenues (4) | (88.6) | ||
Foreign currency translation adjustment | 4.7 | ||
Balance December 31, 2025 | $ | 462.4 |
| (1) | Includes movie tickets, food and beverage, gift cards, exchange tickets, subscription membership fees, and other loyalty membership fees. |
| (2) | Amount of rewards accumulated, net of expirations, that are attributed to loyalty programs. |
| (3) | Amount of revenue recognized from redemption of gift cards, exchange tickets, movie tickets, and rewards related to loyalty programs. |
| (4) | Amounts relate to income from non-redeemed or partially redeemed gift cards, non-redeemed exchange tickets, subscription membership fees, and loyalty programs membership fees. |
Exhibitor Services | |||
(In millions) | Agreement (1) | ||
Balance December 31, 2023 | $ | 486.6 | |
Other theatre revenue recognized, net of adjustments, as performance obligations are satisfied | (22.6) | ||
Balance December 31, 2024 | $ | 464.0 | |
Contract modification consideration (1) | 5.3 | ||
Other theatre revenue recognized as performance obligations are satisfied | (10.2) | ||
Balance December 31, 2025 | $ | 459.1 |
| (1) | The exhibitor services agreement contract liability relates to NCM common units that were previously received under the exhibitor services agreement dated February 13, 2007 and amended and restated as of December 13, 2013. On April 17, 2025, NCM entered into the Amended ESA with the Company. The term of the Amended ESA has been extended by five years through February 13, 2042. The Company treated the Amended ESA as a contract modification pursuant to ASC 606 \u2013 Revenue from Contracts with Customers. Accordingly, the Company has allocated the additional consideration received from the contract modification to the exhibitor services agreement contract liability and updated the discount rate used to account for the significant financing component to 16.12%. Prior to the contract modification, the weighted average discount rate used to account for the significant financing component was approximately 7.5%. The contract liability will be reclassified to other theatre revenue over the new term of the Amended ESA as the remaining performance obligations are satisfied. |
(In millions) | Exhibitor Services Agreement | ||
Year ended 2026 | $ | 6.5 | |
Year ended 2027 | 7.6 | ||
Year ended 2028 | 8.9 | ||
Year ended 2029 | 10.5 | ||
Year ended 2030 | 12.3 | ||
Years ended 2031 through February 2042 | 413.3 | ||
Total | $ | 459.1 |
NOTE 3\u2014LEASES
The following table reflects the lease costs for the years indicated below:
Year Ended | |||||||||||
December\u00a031, | December\u00a031, | December\u00a031, | |||||||||
(In millions) | Consolidated Statements of Operations | 2025 | 2024 | 2023 | |||||||
Operating lease cost | |||||||||||
Theatre properties | Rent | $ | 771.1 | $ | 775.3 | $ | 788.1 | ||||
Theatre properties | Operating expense | 7.2 | 5.6 | 2.0 | |||||||
Equipment | Operating expense | 43.7 | 31.1 | 17.5 | |||||||
Office and other | General and administrative: other | 5.2 | 5.4 | 5.4 | |||||||
Finance lease cost | |||||||||||
Amortization of finance lease assets | Depreciation and amortization | 2.9 | 2.7 | 2.0 | |||||||
Interest expense on lease liabilities | Interest expense | 3.3 | 3.4 | 3.7 | |||||||
Variable operating and finance lease cost | |||||||||||
Theatre properties | Rent | 116.2 | 98.3 | 85.4 | |||||||
Theatre properties | Interest expense | 2.7 | 2.0 | \u2014 | |||||||
Equipment | Operating expense | 75.6 | 65.4 | 63.3 | |||||||
Total lease cost | $ | 1,027.9 | $ | 989.2 | $ | 967.4 |
The following table represents the weighted-average remaining lease term and discount rate as of December\u00a031, 2025:
Weighted Average | Weighted Average | |||||
Remaining | Discount | |||||
Lease Term and Discount Rate | Lease Term (years) | Rate | ||||
Operating leases | 7.7 | 11.0% | ||||
Finance leases | 12.4 | 6.5% |
Cash flow and supplemental information is presented below:
Year Ended | |||||||||
December\u00a031, | December\u00a031, | December\u00a031, | |||||||
(In millions) | 2025 | 2024 | 2023 | ||||||
Cash paid for amounts included in the measurement of lease liabilities: | |||||||||
Operating cash flows used in finance leases | $ | (2.8) | $ | (3.4) | $ | (3.7) | |||
Operating cash flows used in operating leases | (925.0) | (925.1) | (986.4) | ||||||
Financing cash flows used in finance leases | (4.2) | (4.6) | (5.6) | ||||||
Lease incentives: | |||||||||
Operating cash flows provided by operating leases | 45.6 | 31.8 | 23.9 | ||||||
Supplemental disclosure of noncash leasing activities: | |||||||||
Right-of-use assets obtained in exchange for new operating lease liabilities (1) | 302.9 | 196.3 | 214.1 | ||||||
Right-of-use assets obtained in exchange for new finance lease liabilities | 2.9 | 2.6 | \u2014 |
| (1) | Includes lease extensions and option exercises. |
Minimum annual payments required under existing operating and finance leases and the net present value thereof as of December\u00a031, 2025 are as follows:
Operating Lease | Finance Lease | |||||
(In millions) | Payments | Payments | ||||
2026 | $ | 945.6 | $ | 9.0 | ||
2027 | 889.9 | 9.0 | ||||
2028 | 801.1 | 9.0 | ||||
2029 | 694.1 | 8.8 | ||||
2030 | 591.1 | 7.9 | ||||
Thereafter | 1,994.6 | 34.0 | ||||
Total lease payments | 5,916.4 | 77.7 | ||||
Less imputed interest | (1,871.4) | (25.2) | ||||
Total operating and finance lease liabilities, respectively | $ | 4,045.0 | $ | 52.5 |
As of December\u00a031, 2025, the Company had signed an operating lease agreement for one theatre that has not yet commenced. The lease has a 10 year term and total lease payments of approximately $7.1\u00a0million. The timing of lease commencement is dependent on the landlord providing the Company with control and access to the related facility.
During the year ended December 31, 2023, the Company received a $13.0 million buyout incentive from a landlord which provided the landlord the right to terminate the lease of one theatre. The incentive was treated as a reduction to rent expense in the Company\u2019s consolidated statement of operations.
"}]},{"name":"rpt:f-844","factDimensions":{"xbrl:concept":"us-gaap:LeaseCostTableTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Year Ended | |||||||||||
December\u00a031, | December\u00a031, | December\u00a031, | |||||||||
(In millions) | Consolidated Statements of Operations | 2025 | 2024 | 2023 | |||||||
Operating lease cost | |||||||||||
Theatre properties | Rent | $ | 771.1 | $ | 775.3 | $ | 788.1 | ||||
Theatre properties | Operating expense | 7.2 | 5.6 | 2.0 | |||||||
Equipment | Operating expense | 43.7 | 31.1 | 17.5 | |||||||
Office and other | General and administrative: other | 5.2 | 5.4 | 5.4 | |||||||
Finance lease cost | |||||||||||
Amortization of finance lease assets | Depreciation and amortization | 2.9 | 2.7 | 2.0 | |||||||
Interest expense on lease liabilities | Interest expense | 3.3 | 3.4 | 3.7 | |||||||
Variable operating and finance lease cost | |||||||||||
Theatre properties | Rent | 116.2 | 98.3 | 85.4 | |||||||
Theatre properties | Interest expense | 2.7 | 2.0 | \u2014 | |||||||
Equipment | Operating expense | 75.6 | 65.4 | 63.3 | |||||||
Total lease cost | $ | 1,027.9 | $ | 989.2 | $ | 967.4 |
Weighted Average | Weighted Average | |||||
Remaining | Discount | |||||
Lease Term and Discount Rate | Lease Term (years) | Rate | ||||
Operating leases | 7.7 | 11.0% | ||||
Finance leases | 12.4 | 6.5% |
Year Ended | |||||||||
December\u00a031, | December\u00a031, | December\u00a031, | |||||||
(In millions) | 2025 | 2024 | 2023 | ||||||
Cash paid for amounts included in the measurement of lease liabilities: | |||||||||
Operating cash flows used in finance leases | $ | (2.8) | $ | (3.4) | $ | (3.7) | |||
Operating cash flows used in operating leases | (925.0) | (925.1) | (986.4) | ||||||
Financing cash flows used in finance leases | (4.2) | (4.6) | (5.6) | ||||||
Lease incentives: | |||||||||
Operating cash flows provided by operating leases | 45.6 | 31.8 | 23.9 | ||||||
Supplemental disclosure of noncash leasing activities: | |||||||||
Right-of-use assets obtained in exchange for new operating lease liabilities (1) | 302.9 | 196.3 | 214.1 | ||||||
Right-of-use assets obtained in exchange for new finance lease liabilities | 2.9 | 2.6 | \u2014 |
| (1) | Includes lease extensions and option exercises. |
Operating Lease | Finance Lease | |||||
(In millions) | Payments | Payments | ||||
2026 | $ | 945.6 | $ | 9.0 | ||
2027 | 889.9 | 9.0 | ||||
2028 | 801.1 | 9.0 | ||||
2029 | 694.1 | 8.8 | ||||
2030 | 591.1 | 7.9 | ||||
Thereafter | 1,994.6 | 34.0 | ||||
Total lease payments | 5,916.4 | 77.7 | ||||
Less imputed interest | (1,871.4) | (25.2) | ||||
Total operating and finance lease liabilities, respectively | $ | 4,045.0 | $ | 52.5 |
"}]},{"name":"rpt:f-898","factDimensions":{"xbrl:concept":"us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"945600000","decimals":-5}]},{"name":"rpt:f-899","factDimensions":{"xbrl:concept":"us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"9000000","decimals":-5}]},{"name":"rpt:f-900","factDimensions":{"xbrl:concept":"us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"889900000","decimals":-5}]},{"name":"rpt:f-901","factDimensions":{"xbrl:concept":"us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"9000000","decimals":-5}]},{"name":"rpt:f-902","factDimensions":{"xbrl:concept":"us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"801100000","decimals":-5}]},{"name":"rpt:f-903","factDimensions":{"xbrl:concept":"us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"9000000","decimals":-5}]},{"name":"rpt:f-904","factDimensions":{"xbrl:concept":"us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"694100000","decimals":-5}]},{"name":"rpt:f-905","factDimensions":{"xbrl:concept":"us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"8800000","decimals":-5}]},{"name":"rpt:f-906","factDimensions":{"xbrl:concept":"us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"591100000","decimals":-5}]},{"name":"rpt:f-907","factDimensions":{"xbrl:concept":"us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"7900000","decimals":-5}]},{"name":"rpt:f-908","factDimensions":{"xbrl:concept":"us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1994600000","decimals":-5}]},{"name":"rpt:f-909","factDimensions":{"xbrl:concept":"us-gaap:FinanceLeaseLiabilityPaymentsDueInRollingAfterYearFive","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"34000000","decimals":-5}]},{"name":"rpt:f-910","factDimensions":{"xbrl:concept":"us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"5916400000","decimals":-5}]},{"name":"rpt:f-911","factDimensions":{"xbrl:concept":"us-gaap:FinanceLeaseLiabilityPaymentsDue","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"77700000","decimals":-5}]},{"name":"rpt:f-912","factDimensions":{"xbrl:concept":"us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1871400000","decimals":-5}]},{"name":"rpt:f-913","factDimensions":{"xbrl:concept":"us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"25200000","decimals":-5}]},{"name":"rpt:f-914","factDimensions":{"xbrl:concept":"us-gaap:OperatingLeaseLiability","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"4045000000","decimals":-5}]},{"name":"rpt:f-915","factDimensions":{"xbrl:concept":"us-gaap:FinanceLeaseLiability","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"52500000","decimals":-5}]},{"name":"rpt:f-916","factDimensions":{"xbrl:concept":"amch:NumberOfTheatres","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"amch:item","us-gaap:FairValueByLiabilityClassAxis":"us-gaap:CommitmentsMember"},"factValues":[{"value":"1"}]},{"name":"rpt:f-917","factDimensions":{"xbrl:concept":"us-gaap:LesseeOperatingLeaseTermOfContract","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","us-gaap:FairValueByLiabilityClassAxis":"us-gaap:CommitmentsMember"},"factValues":[{"value":"P10Y"}]},{"name":"rpt:f-918","factDimensions":{"xbrl:concept":"amch:OperatingLeaseCommitmentsNotYetCommenced","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:FairValueByLiabilityClassAxis":"us-gaap:CommitmentsMember"},"factValues":[{"value":"7100000","decimals":-5}]},{"name":"rpt:f-919","factDimensions":{"xbrl:concept":"amch:LeaseBuyoutIncentive","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:FairValueByLiabilityClassAxis":"us-gaap:CommitmentsMember"},"factValues":[{"value":"13000000","decimals":-5}]},{"name":"rpt:f-920","factDimensions":{"xbrl:concept":"amch:LeaseRightToTerminateByLandlordNumberOfTheatre","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"amch:item","us-gaap:FairValueByLiabilityClassAxis":"us-gaap:CommitmentsMember"},"factValues":[{"value":"1"}]},{"name":"rpt:f-921","factDimensions":{"xbrl:concept":"us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"
NOTE 4\u2014PROPERTY
A summary of property, net is as follows:
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | ||
Property owned: | ||||||
Land | $ | 56.8 | $ | 62.3 | ||
Buildings and improvements | \u00a0 | 191.0 | \u00a0 | 205.5 | ||
Leasehold improvements | \u00a0 | 2,149.5 | \u00a0 | 2,018.6 | ||
Furniture, fixtures and equipment | \u00a0 | 2,443.7 | \u00a0 | 2,386.6 | ||
\u00a0 | 4,841.0 | \u00a0 | 4,673.0 | |||
Less: accumulated depreciation | \u00a0 | 3,502.7 | \u00a0 | 3,265.1 | ||
1,338.3 | 1,407.9 | |||||
Finance lease right-of-use assets: | ||||||
Buildings, improvements, and equipment | 65.8 | 57.4 | ||||
Less: accumulated depreciation and amortization | 29.9 | 23.0 | ||||
35.9 | 34.4 | |||||
Property, net | $ | 1,374.2 | $ | 1,442.3 |
Property is recorded at cost or fair value, in the case of property resulting from acquisitions. The Company uses the straight-line method in computing depreciation and amortization for financial reporting purposes. The estimated useful lives for leasehold improvements and buildings subject to a ground lease reflect the shorter of the expected useful lives of the assets or the remaining lease terms of the corresponding lease agreements. The estimated useful lives of each major class of depreciable assets are as follows:
Buildings and improvements | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | 1 to 40 years |
Leasehold improvements | 1 to 20 years | |
Furniture, fixtures and equipment | 1 to 15 years |
Expenditures for additions (including interest during construction) and betterments are capitalized, and expenditures for maintenance and repairs are charged to expense as incurred. The cost of assets retired or otherwise
disposed of and the related accumulated depreciation and amortization are eliminated from the accounts in the year of disposal. Gains or losses resulting from property disposals are included in operating expense in the accompanying consolidated statements of operations.
Depreciation expense was $286.8 million, $295.4 million, and $337.5 million for the years ended December\u00a031, 2025, December\u00a031, 2024 and December\u00a031, 2023, respectively.
"}]},{"name":"rpt:f-922","factDimensions":{"xbrl:concept":"amch:ScheduleOfPropertyPlantAndEquipmentComponentsTableTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | ||
Property owned: | ||||||
Land | $ | 56.8 | $ | 62.3 | ||
Buildings and improvements | \u00a0 | 191.0 | \u00a0 | 205.5 | ||
Leasehold improvements | \u00a0 | 2,149.5 | \u00a0 | 2,018.6 | ||
Furniture, fixtures and equipment | \u00a0 | 2,443.7 | \u00a0 | 2,386.6 | ||
\u00a0 | 4,841.0 | \u00a0 | 4,673.0 | |||
Less: accumulated depreciation | \u00a0 | 3,502.7 | \u00a0 | 3,265.1 | ||
1,338.3 | 1,407.9 | |||||
Finance lease right-of-use assets: | ||||||
Buildings, improvements, and equipment | 65.8 | 57.4 | ||||
Less: accumulated depreciation and amortization | 29.9 | 23.0 | ||||
35.9 | 34.4 | |||||
Property, net | $ | 1,374.2 | $ | 1,442.3 |
Buildings and improvements | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | 1 to 40 years |
Leasehold improvements | 1 to 20 years | |
Furniture, fixtures and equipment | 1 to 15 years |
NOTE 5\u2014GOODWILL AND INTANGIBLE ASSETS
The following table summarizes the changes in goodwill by reporting unit:
U.S. | International | Consolidated Goodwill | |||||||||||||||||||||||||
(In\u00a0millions) | Gross Carrying Amount | Accumulated Impairment Losses | Net Carrying Amount | Gross Carrying Amount | Accumulated Impairment Losses | Net Carrying Amount | Gross Carrying Amount | Accumulated Impairment Losses | Net Carrying Amount | ||||||||||||||||||
Balance December 31, 2023 | $ | 3,072.6 | $ | (1,276.1) | $ | 1,796.5 | $ | 1,589.5 | $ | (1,027.3) | $ | 562.2 | $ | 4,662.1 | $ | (2,303.4) | $ | 2,358.7 | |||||||||
Currency translation adjustment | \u2014 | \u2014 | \u2014 | (72.5) | 14.9 | (57.6) | (72.5) | 14.9 | (57.6) | ||||||||||||||||||
Balance December 31, 2024 | $ | 3,072.6 | $ | (1,276.1) | $ | 1,796.5 | $ | 1,517.0 | $ | (1,012.4) | $ | 504.6 | $ | 4,589.6 | $ | (2,288.5) | $ | 2,301.1 | |||||||||
Currency translation adjustment | \u2014 | \u2014 | \u2014 | 188.2 | (73.2) | 115.0 | 188.2 | (73.2) | 115.0 | ||||||||||||||||||
Balance December 31, 2025 | $ | 3,072.6 | $ | (1,276.1) | $ | 1,796.5 | $ | 1,705.2 | $ | (1,085.6) | $ | 619.6 | $ | 4,777.8 | $ | (2,361.7) | $ | 2,416.1 |
Detail of non-amortizing intangible assets is presented below:
(In millions) | December\u00a031, 2025 | December\u00a031, 2024 | ||||
Non-amortizing intangible assets: | ||||||
AMC trademark | $ | 104.4 | $ | 104.4 | ||
Odeon trade names | 39.5 | 36.0 | ||||
Nordic trade names | 2.9 | 2.5 | ||||
Total non-amortizing intangible assets | $ | 146.8 | $ | 142.9 |
Amortizing intangible assets had carrying values of $0.6 million and $1.4 million as of December 31, 2025 and December 31, 2024, respectively.
"}]},{"name":"rpt:f-956","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfGoodwillTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"U.S. | International | Consolidated Goodwill | |||||||||||||||||||||||||
(In\u00a0millions) | Gross Carrying Amount | Accumulated Impairment Losses | Net Carrying Amount | Gross Carrying Amount | Accumulated Impairment Losses | Net Carrying Amount | Gross Carrying Amount | Accumulated Impairment Losses | Net Carrying Amount | ||||||||||||||||||
Balance December 31, 2023 | $ | 3,072.6 | $ | (1,276.1) | $ | 1,796.5 | $ | 1,589.5 | $ | (1,027.3) | $ | 562.2 | $ | 4,662.1 | $ | (2,303.4) | $ | 2,358.7 | |||||||||
Currency translation adjustment | \u2014 | \u2014 | \u2014 | (72.5) | 14.9 | (57.6) | (72.5) | 14.9 | (57.6) | ||||||||||||||||||
Balance December 31, 2024 | $ | 3,072.6 | $ | (1,276.1) | $ | 1,796.5 | $ | 1,517.0 | $ | (1,012.4) | $ | 504.6 | $ | 4,589.6 | $ | (2,288.5) | $ | 2,301.1 | |||||||||
Currency translation adjustment | \u2014 | \u2014 | \u2014 | 188.2 | (73.2) | 115.0 | 188.2 | (73.2) | 115.0 | ||||||||||||||||||
Balance December 31, 2025 | $ | 3,072.6 | $ | (1,276.1) | $ | 1,796.5 | $ | 1,705.2 | $ | (1,085.6) | $ | 619.6 | $ | 4,777.8 | $ | (2,361.7) | $ | 2,416.1 |
"}]},{"name":"rpt:f-957","factDimensions":{"xbrl:concept":"us-gaap:GoodwillGross","xbrl:period":"2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"country:US"},"factValues":[{"value":"3072600000","decimals":-5}]},{"name":"rpt:f-958","factDimensions":{"xbrl:concept":"us-gaap:GoodwillImpairedAccumulatedImpairmentLoss","xbrl:period":"2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"country:US"},"factValues":[{"value":"1276100000","decimals":-5}]},{"name":"rpt:f-959","factDimensions":{"xbrl:concept":"us-gaap:Goodwill","xbrl:period":"2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"country:US"},"factValues":[{"value":"1796500000","decimals":-5}]},{"name":"rpt:f-960","factDimensions":{"xbrl:concept":"us-gaap:GoodwillGross","xbrl:period":"2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"us-gaap:NonUsMember"},"factValues":[{"value":"1589500000","decimals":-5}]},{"name":"rpt:f-961","factDimensions":{"xbrl:concept":"us-gaap:GoodwillImpairedAccumulatedImpairmentLoss","xbrl:period":"2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"us-gaap:NonUsMember"},"factValues":[{"value":"1027300000","decimals":-5}]},{"name":"rpt:f-962","factDimensions":{"xbrl:concept":"us-gaap:Goodwill","xbrl:period":"2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"us-gaap:NonUsMember"},"factValues":[{"value":"562200000","decimals":-5}]},{"name":"rpt:f-963","factDimensions":{"xbrl:concept":"us-gaap:GoodwillGross","xbrl:period":"2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"4662100000","decimals":-5}]},{"name":"rpt:f-964","factDimensions":{"xbrl:concept":"us-gaap:GoodwillImpairedAccumulatedImpairmentLoss","xbrl:period":"2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2303400000","decimals":-5}]},{"name":"rpt:f-965","factDimensions":{"xbrl:concept":"us-gaap:Goodwill","xbrl:period":"2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2358700000","decimals":-5}]},{"name":"rpt:f-966","factDimensions":{"xbrl:concept":"amch:GoodwillImpairedForeignCurrencyTranslationGainLossGross","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"us-gaap:NonUsMember"},"factValues":[{"value":"-72500000","decimals":-5}]},{"name":"rpt:f-967","factDimensions":{"xbrl:concept":"amch:GoodwillImpairedAccumulatedImpairmentLossForeignCurrencyTranslationGainLoss","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"us-gaap:NonUsMember"},"factValues":[{"value":"14900000","decimals":-5}]},{"name":"rpt:f-968","factDimensions":{"xbrl:concept":"us-gaap:GoodwillForeignCurrencyTranslationGainLoss","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"us-gaap:NonUsMember"},"factValues":[{"value":"-57600000","decimals":-5}]},{"name":"rpt:f-969","factDimensions":{"xbrl:concept":"amch:GoodwillImpairedForeignCurrencyTranslationGainLossGross","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-72500000","decimals":-5}]},{"name":"rpt:f-970","factDimensions":{"xbrl:concept":"amch:GoodwillImpairedAccumulatedImpairmentLossForeignCurrencyTranslationGainLoss","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"14900000","decimals":-5}]},{"name":"rpt:f-971","factDimensions":{"xbrl:concept":"us-gaap:GoodwillForeignCurrencyTranslationGainLoss","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-57600000","decimals":-5}]},{"name":"rpt:f-972","factDimensions":{"xbrl:concept":"us-gaap:GoodwillGross","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"country:US"},"factValues":[{"value":"3072600000","decimals":-5}]},{"name":"rpt:f-973","factDimensions":{"xbrl:concept":"us-gaap:GoodwillImpairedAccumulatedImpairmentLoss","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"country:US"},"factValues":[{"value":"1276100000","decimals":-5}]},{"name":"rpt:f-974","factDimensions":{"xbrl:concept":"us-gaap:Goodwill","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"country:US"},"factValues":[{"value":"1796500000","decimals":-5}]},{"name":"rpt:f-975","factDimensions":{"xbrl:concept":"us-gaap:GoodwillGross","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"us-gaap:NonUsMember"},"factValues":[{"value":"1517000000","decimals":-5}]},{"name":"rpt:f-976","factDimensions":{"xbrl:concept":"us-gaap:GoodwillImpairedAccumulatedImpairmentLoss","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"us-gaap:NonUsMember"},"factValues":[{"value":"1012400000","decimals":-5}]},{"name":"rpt:f-977","factDimensions":{"xbrl:concept":"us-gaap:Goodwill","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"us-gaap:NonUsMember"},"factValues":[{"value":"504600000","decimals":-5}]},{"name":"rpt:f-978","factDimensions":{"xbrl:concept":"us-gaap:GoodwillGross","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"4589600000","decimals":-5}]},{"name":"rpt:f-979","factDimensions":{"xbrl:concept":"us-gaap:GoodwillImpairedAccumulatedImpairmentLoss","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2288500000","decimals":-5}]},{"name":"rpt:f-980","factDimensions":{"xbrl:concept":"us-gaap:Goodwill","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2301100000","decimals":-5}]},{"name":"rpt:f-981","factDimensions":{"xbrl:concept":"amch:GoodwillImpairedForeignCurrencyTranslationGainLossGross","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"us-gaap:NonUsMember"},"factValues":[{"value":"188200000","decimals":-5}]},{"name":"rpt:f-982","factDimensions":{"xbrl:concept":"amch:GoodwillImpairedAccumulatedImpairmentLossForeignCurrencyTranslationGainLoss","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"us-gaap:NonUsMember"},"factValues":[{"value":"-73200000","decimals":-5}]},{"name":"rpt:f-983","factDimensions":{"xbrl:concept":"us-gaap:GoodwillForeignCurrencyTranslationGainLoss","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"us-gaap:NonUsMember"},"factValues":[{"value":"115000000","decimals":-5}]},{"name":"rpt:f-984","factDimensions":{"xbrl:concept":"amch:GoodwillImpairedForeignCurrencyTranslationGainLossGross","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"188200000","decimals":-5}]},{"name":"rpt:f-985","factDimensions":{"xbrl:concept":"amch:GoodwillImpairedAccumulatedImpairmentLossForeignCurrencyTranslationGainLoss","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-73200000","decimals":-5}]},{"name":"rpt:f-986","factDimensions":{"xbrl:concept":"us-gaap:GoodwillForeignCurrencyTranslationGainLoss","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"115000000","decimals":-5}]},{"name":"rpt:f-987","factDimensions":{"xbrl:concept":"us-gaap:GoodwillGross","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"country:US"},"factValues":[{"value":"3072600000","decimals":-5}]},{"name":"rpt:f-988","factDimensions":{"xbrl:concept":"us-gaap:GoodwillImpairedAccumulatedImpairmentLoss","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"country:US"},"factValues":[{"value":"1276100000","decimals":-5}]},{"name":"rpt:f-989","factDimensions":{"xbrl:concept":"us-gaap:Goodwill","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"country:US"},"factValues":[{"value":"1796500000","decimals":-5}]},{"name":"rpt:f-990","factDimensions":{"xbrl:concept":"us-gaap:GoodwillGross","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"us-gaap:NonUsMember"},"factValues":[{"value":"1705200000","decimals":-5}]},{"name":"rpt:f-991","factDimensions":{"xbrl:concept":"us-gaap:GoodwillImpairedAccumulatedImpairmentLoss","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"us-gaap:NonUsMember"},"factValues":[{"value":"1085600000","decimals":-5}]},{"name":"rpt:f-992","factDimensions":{"xbrl:concept":"us-gaap:Goodwill","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","srt:StatementGeographicalAxis":"us-gaap:NonUsMember"},"factValues":[{"value":"619600000","decimals":-5}]},{"name":"rpt:f-993","factDimensions":{"xbrl:concept":"us-gaap:GoodwillGross","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"4777800000","decimals":-5}]},{"name":"rpt:f-994","factDimensions":{"xbrl:concept":"us-gaap:GoodwillImpairedAccumulatedImpairmentLoss","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2361700000","decimals":-5}]},{"name":"rpt:f-995","factDimensions":{"xbrl:concept":"us-gaap:Goodwill","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2416100000","decimals":-5}]},{"name":"rpt:f-996","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"
(In millions) | December\u00a031, 2025 | December\u00a031, 2024 | ||||
Non-amortizing intangible assets: | ||||||
AMC trademark | $ | 104.4 | $ | 104.4 | ||
Odeon trade names | 39.5 | 36.0 | ||||
Nordic trade names | 2.9 | 2.5 | ||||
Total non-amortizing intangible assets | $ | 146.8 | $ | 142.9 |
NOTE 6\u2014SUPPLEMENTAL BALANCE SHEET INFORMATION
Other assets and liabilities consist of the following:
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | ||
Other current assets: | ||||||
Income taxes receivable | $ | 1.3 | $ | 1.4 | ||
Prepaids | \u00a0 | 43.1 | \u00a0 | 36.0 | ||
Merchandise inventory | \u00a0 | 42.6 | \u00a0 | 51.2 | ||
Other | \u00a0 | 10.2 | \u00a0 | 9.7 | ||
$ | 97.2 | $ | 98.3 | |||
Other long-term assets: | ||||||
Investments in real estate | $ | 6.9 | $ | 3.5 | ||
Investments in equity method investees | \u00a0 | 61.1 | \u00a0 | 53.6 | ||
Computer software | \u00a0 | 97.2 | \u00a0 | 86.4 | ||
Investments in equity securities without readily determinable fair values | \u00a0 | 4.1 | \u00a0 | 10.4 | ||
Pension asset | 8.3 | 14.2 | ||||
Other | \u00a0 | 34.7 | \u00a0 | 24.4 | ||
$ | 212.3 | $ | 192.5 | |||
Accrued expenses and other liabilities: | ||||||
Taxes other than income | $ | 75.1 | $ | 79.8 | ||
Interest | \u00a0 | 31.0 | \u00a0 | 43.1 | ||
Payroll and vacation | \u00a0 | 38.9 | \u00a0 | 57.9 | ||
Current portion of casualty claims and premiums | \u00a0 | 12.4 | \u00a0 | 9.8 | ||
Accrued bonus | \u00a0 | 64.5 | \u00a0 | 47.7 | ||
Accrued licensing and variable rent | \u00a0 | 33.4 | \u00a0 | 27.5 | ||
Current portion of pension | \u00a0 | 0.2 | \u00a0 | 0.2 | ||
Group insurance reserve | 2.3 | 1.5 | ||||
Accrued tax payable | 1.1 | 1.5 | ||||
Other | \u00a0 | 79.3 | \u00a0 | 71.6 | ||
$ | 338.2 | $ | 340.6 | |||
Other long-term liabilities: | ||||||
Pension | $ | 24.7 | $ | 25.4 | ||
Lease incentive obligations | 26.9 | 19.7 | ||||
Casualty claims and premiums | \u00a0 | 21.9 | \u00a0 | 16.2 | ||
Contingencies | 13.2 | 9.4 | ||||
Other | \u00a0 | 8.5 | \u00a0 | 11.2 | ||
$ | 95.2 | $ | 81.9 |
"}]},{"name":"rpt:f-1008","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | ||
Other current assets: | ||||||
Income taxes receivable | $ | 1.3 | $ | 1.4 | ||
Prepaids | \u00a0 | 43.1 | \u00a0 | 36.0 | ||
Merchandise inventory | \u00a0 | 42.6 | \u00a0 | 51.2 | ||
Other | \u00a0 | 10.2 | \u00a0 | 9.7 | ||
$ | 97.2 | $ | 98.3 | |||
Other long-term assets: | ||||||
Investments in real estate | $ | 6.9 | $ | 3.5 | ||
Investments in equity method investees | \u00a0 | 61.1 | \u00a0 | 53.6 | ||
Computer software | \u00a0 | 97.2 | \u00a0 | 86.4 | ||
Investments in equity securities without readily determinable fair values | \u00a0 | 4.1 | \u00a0 | 10.4 | ||
Pension asset | 8.3 | 14.2 | ||||
Other | \u00a0 | 34.7 | \u00a0 | 24.4 | ||
$ | 212.3 | $ | 192.5 | |||
Accrued expenses and other liabilities: | ||||||
Taxes other than income | $ | 75.1 | $ | 79.8 | ||
Interest | \u00a0 | 31.0 | \u00a0 | 43.1 | ||
Payroll and vacation | \u00a0 | 38.9 | \u00a0 | 57.9 | ||
Current portion of casualty claims and premiums | \u00a0 | 12.4 | \u00a0 | 9.8 | ||
Accrued bonus | \u00a0 | 64.5 | \u00a0 | 47.7 | ||
Accrued licensing and variable rent | \u00a0 | 33.4 | \u00a0 | 27.5 | ||
Current portion of pension | \u00a0 | 0.2 | \u00a0 | 0.2 | ||
Group insurance reserve | 2.3 | 1.5 | ||||
Accrued tax payable | 1.1 | 1.5 | ||||
Other | \u00a0 | 79.3 | \u00a0 | 71.6 | ||
$ | 338.2 | $ | 340.6 | |||
Other long-term liabilities: | ||||||
Pension | $ | 24.7 | $ | 25.4 | ||
Lease incentive obligations | 26.9 | 19.7 | ||||
Casualty claims and premiums | \u00a0 | 21.9 | \u00a0 | 16.2 | ||
Contingencies | 13.2 | 9.4 | ||||
Other | \u00a0 | 8.5 | \u00a0 | 11.2 | ||
$ | 95.2 | $ | 81.9 |
"}]},{"name":"rpt:f-1009","factDimensions":{"xbrl:concept":"us-gaap:IncomeTaxesReceivable","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1300000","decimals":-5}]},{"name":"rpt:f-1010","factDimensions":{"xbrl:concept":"us-gaap:IncomeTaxesReceivable","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1400000","decimals":-5}]},{"name":"rpt:f-1011","factDimensions":{"xbrl:concept":"us-gaap:PrepaidExpenseCurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"43100000","decimals":-5}]},{"name":"rpt:f-1012","factDimensions":{"xbrl:concept":"us-gaap:PrepaidExpenseCurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"36000000","decimals":-5}]},{"name":"rpt:f-1013","factDimensions":{"xbrl:concept":"us-gaap:RetailRelatedInventoryMerchandise","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"42600000","decimals":-5}]},{"name":"rpt:f-1014","factDimensions":{"xbrl:concept":"us-gaap:RetailRelatedInventoryMerchandise","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"51200000","decimals":-5}]},{"name":"rpt:f-1015","factDimensions":{"xbrl:concept":"us-gaap:OtherAssetsMiscellaneousCurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"10200000","decimals":-5}]},{"name":"rpt:f-1016","factDimensions":{"xbrl:concept":"us-gaap:OtherAssetsMiscellaneousCurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"9700000","decimals":-5}]},{"name":"rpt:f-1017","factDimensions":{"xbrl:concept":"us-gaap:OtherAssetsCurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"97200000","decimals":-5}]},{"name":"rpt:f-1018","factDimensions":{"xbrl:concept":"us-gaap:OtherAssetsCurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"98300000","decimals":-5}]},{"name":"rpt:f-1019","factDimensions":{"xbrl:concept":"us-gaap:RealEstateInvestmentPropertyNet","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"6900000","decimals":-5}]},{"name":"rpt:f-1020","factDimensions":{"xbrl:concept":"us-gaap:RealEstateInvestmentPropertyNet","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"3500000","decimals":-5}]},{"name":"rpt:f-1021","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestments","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"61100000","decimals":-5}]},{"name":"rpt:f-1022","factDimensions":{"xbrl:concept":"us-gaap:EquityMethodInvestments","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"53600000","decimals":-5}]},{"name":"rpt:f-1023","factDimensions":{"xbrl:concept":"us-gaap:CapitalizedComputerSoftwareNet","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"97200000","decimals":-5}]},{"name":"rpt:f-1024","factDimensions":{"xbrl:concept":"us-gaap:CapitalizedComputerSoftwareNet","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"86400000","decimals":-5}]},{"name":"rpt:f-1025","factDimensions":{"xbrl:concept":"us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"4100000","decimals":-5}]},{"name":"rpt:f-1026","factDimensions":{"xbrl:concept":"us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"10400000","decimals":-5}]},{"name":"rpt:f-1027","factDimensions":{"xbrl:concept":"us-gaap:DeferredCompensationPlanAssets","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"8300000","decimals":-5}]},{"name":"rpt:f-1028","factDimensions":{"xbrl:concept":"us-gaap:DeferredCompensationPlanAssets","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"14200000","decimals":-5}]},{"name":"rpt:f-1029","factDimensions":{"xbrl:concept":"us-gaap:OtherAssetsMiscellaneousNoncurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"34700000","decimals":-5}]},{"name":"rpt:f-1030","factDimensions":{"xbrl:concept":"us-gaap:OtherAssetsMiscellaneousNoncurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"24400000","decimals":-5}]},{"name":"rpt:f-1031","factDimensions":{"xbrl:concept":"us-gaap:OtherAssetsNoncurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"212300000","decimals":-5}]},{"name":"rpt:f-1032","factDimensions":{"xbrl:concept":"us-gaap:OtherAssetsNoncurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"192500000","decimals":-5}]},{"name":"rpt:f-1033","factDimensions":{"xbrl:concept":"us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"75100000","decimals":-5}]},{"name":"rpt:f-1034","factDimensions":{"xbrl:concept":"us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"79800000","decimals":-5}]},{"name":"rpt:f-1035","factDimensions":{"xbrl:concept":"us-gaap:InterestPayableCurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"31000000","decimals":-5}]},{"name":"rpt:f-1036","factDimensions":{"xbrl:concept":"us-gaap:InterestPayableCurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"43100000","decimals":-5}]},{"name":"rpt:f-1037","factDimensions":{"xbrl:concept":"amch:AccruedPayrollAndVacationCurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"38900000","decimals":-5}]},{"name":"rpt:f-1038","factDimensions":{"xbrl:concept":"amch:AccruedPayrollAndVacationCurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"57900000","decimals":-5}]},{"name":"rpt:f-1039","factDimensions":{"xbrl:concept":"amch:AccruedCasualtyClaimsAndPremiumsCurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"12400000","decimals":-5}]},{"name":"rpt:f-1040","factDimensions":{"xbrl:concept":"amch:AccruedCasualtyClaimsAndPremiumsCurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"9800000","decimals":-5}]},{"name":"rpt:f-1041","factDimensions":{"xbrl:concept":"us-gaap:AccruedBonusesCurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"64500000","decimals":-5}]},{"name":"rpt:f-1042","factDimensions":{"xbrl:concept":"us-gaap:AccruedBonusesCurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"47700000","decimals":-5}]},{"name":"rpt:f-1043","factDimensions":{"xbrl:concept":"us-gaap:AccruedRentCurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"33400000","decimals":-5}]},{"name":"rpt:f-1044","factDimensions":{"xbrl:concept":"us-gaap:AccruedRentCurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"27500000","decimals":-5}]},{"name":"rpt:f-1045","factDimensions":{"xbrl:concept":"us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"200000","decimals":-5}]},{"name":"rpt:f-1046","factDimensions":{"xbrl:concept":"us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"200000","decimals":-5}]},{"name":"rpt:f-1047","factDimensions":{"xbrl:concept":"amch:GroupInsuranceReserveCurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2300000","decimals":-5}]},{"name":"rpt:f-1048","factDimensions":{"xbrl:concept":"amch:GroupInsuranceReserveCurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1500000","decimals":-5}]},{"name":"rpt:f-1049","factDimensions":{"xbrl:concept":"us-gaap:AccruedIncomeTaxesCurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1100000","decimals":-5}]},{"name":"rpt:f-1050","factDimensions":{"xbrl:concept":"us-gaap:AccruedIncomeTaxesCurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1500000","decimals":-5}]},{"name":"rpt:f-1051","factDimensions":{"xbrl:concept":"us-gaap:OtherLiabilitiesCurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"79300000","decimals":-5}]},{"name":"rpt:f-1052","factDimensions":{"xbrl:concept":"us-gaap:OtherLiabilitiesCurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"71600000","decimals":-5}]},{"name":"rpt:f-1053","factDimensions":{"xbrl:concept":"us-gaap:OtherAccruedLiabilitiesCurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"338200000","decimals":-5}]},{"name":"rpt:f-1054","factDimensions":{"xbrl:concept":"us-gaap:OtherAccruedLiabilitiesCurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"340600000","decimals":-5}]},{"name":"rpt:f-1055","factDimensions":{"xbrl:concept":"us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"24700000","decimals":-5}]},{"name":"rpt:f-1056","factDimensions":{"xbrl:concept":"us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"25400000","decimals":-5}]},{"name":"rpt:f-1057","factDimensions":{"xbrl:concept":"amch:LeaseIncentiveObligationsNoncurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"26900000","decimals":-5}]},{"name":"rpt:f-1058","factDimensions":{"xbrl:concept":"amch:LeaseIncentiveObligationsNoncurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"19700000","decimals":-5}]},{"name":"rpt:f-1059","factDimensions":{"xbrl:concept":"amch:AccruedCasualtyClaimsAndPremiumsNoncurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"21900000","decimals":-5}]},{"name":"rpt:f-1060","factDimensions":{"xbrl:concept":"amch:AccruedCasualtyClaimsAndPremiumsNoncurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"16200000","decimals":-5}]},{"name":"rpt:f-1061","factDimensions":{"xbrl:concept":"us-gaap:LiabilitiesOfBusinessTransferredUnderContractualArrangementNoncurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"13200000","decimals":-5}]},{"name":"rpt:f-1062","factDimensions":{"xbrl:concept":"us-gaap:LiabilitiesOfBusinessTransferredUnderContractualArrangementNoncurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"9400000","decimals":-5}]},{"name":"rpt:f-1063","factDimensions":{"xbrl:concept":"us-gaap:OtherSundryLiabilitiesNoncurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"8500000","decimals":-5}]},{"name":"rpt:f-1064","factDimensions":{"xbrl:concept":"us-gaap:OtherSundryLiabilitiesNoncurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"11200000","decimals":-5}]},{"name":"rpt:f-1065","factDimensions":{"xbrl:concept":"us-gaap:OtherLiabilitiesNoncurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"95200000","decimals":-5}]},{"name":"rpt:f-1066","factDimensions":{"xbrl:concept":"us-gaap:OtherLiabilitiesNoncurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"81900000","decimals":-5}]},{"name":"rpt:f-1067","factDimensions":{"xbrl:concept":"us-gaap:DebtDisclosureTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"
NOTE 7\u2014CORPORATE BORROWINGS AND FINANCE LEASE LIABILITIES
A summary of the carrying value of corporate borrowings and finance lease liabilities is as follows:
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December 31, 2024 | ||
Secured Debt: | ||||||
Credit Agreement-Term Loans due 2029 (10.731% as of December 31, 2025 and 11.356% as of December 31, 2024) | $ | 1,994.2 | $ | 2,014.2 | ||
12.75% Odeon Senior Secured Notes due 2027 | 400.0 | 400.0 | ||||
Senior Secured Exchangeable Notes due 2030 (1.5% cash interest) | 155.8 | \u2014 | ||||
Senior Secured Notes due 2029 (9.0% cash interest & 6.0% PIK interest as of December 31, 2025) | 877.1 | \u2014 | ||||
6.00%/8.00% Cash/PIK Toggle Senior Secured Exchangeable Notes due 2030 | 111.6 | 427.6 | ||||
7.5% First Lien Notes due 2029 | 360.0 | 950.0 | ||||
Unsecured/Retired Debt: | ||||||
10%/12% Cash/PIK Toggle Second Lien Subordinated Notes due 2026 | \u2014 | 131.2 | ||||
5.75% Senior Subordinated Notes due 2025 | \u2014 | 44.1 | ||||
5.875% Senior Subordinated Notes due 2026 | \u2014 | 41.9 | ||||
6.125% Senior Subordinated Notes due 2027 | 125.5 | 125.5 | ||||
Total principal amount of corporate borrowings | $ | 4,024.2 | $ | 4,134.5 | ||
Finance lease liabilities | \u00a0 | 52.5 | \u00a0 | 49.3 | ||
Accrued paid-in-kind interest | 2.7 | 1.5 | ||||
Deferred financing costs | (64.4) | (47.2) | ||||
Net discount (1) | (68.5) | (171.3) | ||||
Bifurcated embedded derivative \u2013 Senior Secured Exchangeable Notes due 2030 | 131.9 | \u2014 | ||||
Bifurcated embedded derivative \u2013 6.00%/8.00% Cash/PIK Toggle Senior Secured Exchangeable Notes due 2030 | 12.6 | 157.6 | ||||
Total carrying value of corporate borrowings and finance lease liabilities | $ | 4,091.0 | $ | 4,124.4 | ||
Less: | ||||||
Current maturities of corporate borrowings | (19.9) | \u00a0 | (64.2) | |||
Current maturities of finance lease liabilities | (5.8) | (4.4) | ||||
Total noncurrent carrying value of corporate borrowings and finance lease liabilities | $ | 4,065.3 | $ | 4,055.8 |
| (1) | The following table provides the net discount amounts of corporate borrowings: |
December\u00a031, | December\u00a031, | |||||
(In millions) | 2025 | 2024 | ||||
10%/12% Cash/PIK Toggle Second Lien Subordinated Notes due 2026 | $ | \u2014 | $ | 10.9 | ||
12.75% Odeon Senior Secured Notes due 2027 | (14.6) | (20.9) | ||||
Senior Secured Notes due 2029 | 62.5 | \u2014 | ||||
Senior Secured Exchangeable Notes due 2030 | (57.4) | \u2014 | ||||
Credit Agreement-Term Loans due 2029 | (32.6) | (43.4) | ||||
6.00%/8.00% Cash/PIK/Toggle Senior Secured Exchangeable Notes due 2030 | (26.4) | (117.9) | ||||
Net discount | $ | (68.5) | $ | (171.3) |
The following table provides the principal payments required and maturities of corporate borrowings as of December 31, 2025:
Principal | |||
Amount of | |||
Corporate | |||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Borrowings | |
2026 | $ | 19.9 | |
2027 | \u00a0 | 545.2 | |
2028 | \u00a0 | 19.5 | |
2029 | \u00a0 | 3,172.2 | |
2030 | \u00a0 | 267.4 | |
Total | $ | 4,024.2 |
Debt Repurchases and Exchanges
The table below summarizes the various cash debt repurchase transactions during the year ended December 31, 2025. It does not include the 2025 Refinancing Transactions described in further detail below.
Aggregate Principal | Reacquisition | (Gain)/Loss on | Accrued Interest | |||||||||
(In millions) | Repurchased | Cost | Extinguishment | Paid | ||||||||
5.75% Senior Subordinated Notes due 2025 | $ | 1.3 | $ | 1.3 | $ | \u2014 | $ | \u2014 |
The total carrying value of the debt extinguished in the above transactions during the year ended December 31, 2025 was $1.3 million.
The table below summarizes the various cash debt repurchase transactions, debt for equity exchange transactions, and cash and debt for equity exchange transactions that occurred during the year ended December 31, 2024. The debt for equity exchange transactions were treated as early extinguishments of debt. In accordance with ASC 470-50-40-3, the reacquisition price of the extinguished debt was determined to be the fair value of the Common Stock exchanged. It does not include the 2024 Refinancing Transactions described further below.
Shares of | |||||||||||||||
Aggregate Principal | Common Stock | Reacquisition | (Gain)/Loss on | Accrued Interest | |||||||||||
(In millions, except for share data) | Repurchased/Exchanged | Exchanged | Cost | Extinguishment | Paid/Exchanged | ||||||||||
Cash debt repurchase transactions: | |||||||||||||||
5.75% Senior Subordinated Notes due 2025 | $ | 8.9 | \u2014 | $ | 8.6 | $ | (0.3) | $ | 0.1 | ||||||
Second Lien Notes due 2026 | 50.0 | \u2014 | 50.5 | (4.4) | 1.4 | ||||||||||
Total cash debt repurchase transactions | 58.9 | \u2014 | 59.1 | (4.7) | 1.5 | ||||||||||
Debt for equity exchange transactions: | |||||||||||||||
5.75% Senior Subordinated Notes due 2025 | 36.7 | 9,017,297 | 39.8 | 3.2 | 0.8 | ||||||||||
Second Lien Notes due 2026 | 224.1 | 35,062,835 | 157.2 | (93.1) | 8.3 | ||||||||||
Total debt for equity exchange transactions | 260.8 | 44,080,132 | 197.0 | (89.9) | 9.1 | ||||||||||
Cash and debt for equity exchange transactions: | |||||||||||||||
5.75% Senior Subordinated Notes due 2025 | 8.6 | 447,829 | 8.4 | (0.2) | 0.1 | ||||||||||
5.875% Senior Subordinated Notes due 2026 | 9.6 | 432,777 | 8.1 | (1.3) | 0.2 | ||||||||||
Second Lien Notes due 2026 | 45.0 | 2,693,717 | 45.5 | (4.0) | 1.2 | ||||||||||
Total cash and debt for equity exchange transactions | 63.2 | 3,574,323 | 62.0 | (5.5) | 1.5 | ||||||||||
Total debt repurchases and exchanges | $ | 382.9 | 47,654,455 | $ | 318.1 | $ | (100.1) | $ | 12.1 |
The total carrying value of the debt extinguished in the above transactions during the year ended December 31, 2024 was $418.2 million.
The table below summarizes the various cash debt repurchase and debt for equity exchange transactions during the year ended December 31, 2023, including related party transactions. These transactions were executed at terms equivalent to an arms-length transaction.
Shares of | |||||||||||||||
Aggregate Principal | Common Stock | Reacquisition | (Gain) on | Accrued Interest | |||||||||||
(In millions, except for share data) | Repurchased/Exchanged | Exchanged | Cost | Extinguishment | Paid/Exchanged | ||||||||||
Cash debt repurchase transactions: | |||||||||||||||
Related party transactions: | |||||||||||||||
Second Lien Notes due 2026 | $ | 75.9 | \u2014 | $ | 48.5 | $ | (40.9) | $ | 1.1 | ||||||
5.875% Senior Subordinated Notes due 2026 | 4.1 | \u2014 | 1.7 | (2.3) | 0.1 | ||||||||||
Total related party transactions | 80.0 | \u2014 | 50.2 | (43.2) | 1.2 | ||||||||||
Non-related party transactions: | |||||||||||||||
Second Lien Notes due 2026 | 139.7 | \u2014 | 91.4 | (71.3) | 4.5 | ||||||||||
Total non-related party transactions | 139.7 | \u2014 | 91.4 | (71.3) | 4.5 | ||||||||||
Total cash debt repurchase transactions | $ | 219.7 | \u2014 | $ | 141.6 | $ | (114.5) | $ | 5.7 | ||||||
Debt for equity exchange transactions: | |||||||||||||||
Second Lien Notes due 2026 | 105.3 | 14,186,651 | 91.7 | (28.3) | 1.2 | ||||||||||
Total debt repurchases and exchanges | $ | 325.0 | 14,186,651 | $ | 233.3 | $ | (142.8) | $ | 6.9 |
The total carrying value of the debt extinguished in the above transactions during the year ended December 31, 2023 was $376.1 million.
6.00%/8.00% Cash/PIK Toggle Senior Secured Exchangeable Notes due 2030
Carrying Value | Carrying Value | |||||||||||
as of | (Increase) Decrease to | Debt | as of | |||||||||
(In millions) | December 31, 2024 | Net Earnings (Loss) | Extinguishment (1) | December\u00a031, 2025 | ||||||||
Principal balance | $ | 427.6 | $ | 21.4 | $ | (337.4) | $ | 111.6 | ||||
Discount | (117.9) | 5.0 | 86.5 | (26.4) | ||||||||
Debt issuance costs | (23.3) | 1.0 | 17.1 | (5.2) | ||||||||
Accrued paid-in-kind interest | 1.5 | 0.1 | (1.2) | 0.4 | ||||||||
Bifurcated embedded derivative | 157.6 | (56.7) | (88.3) | 12.6 | ||||||||
Carrying value | $ | 445.5 | $ | (29.2) | $ | (323.3) | $ | 93.0 |
| (1) | For more information on the loss on extinguishment see the 2025 Refinancing Transactions section below. |
The Existing Exchangeable Notes have an effective interest rate of 15.12%.
Senior Secured Exchangeable Notes due 2030
Carrying Value | Principal Cancellation | Additional | Carrying Value | ||||||||||||
as of | (Increase) Decrease to | & Interest Adjustment | Deferred | as of | |||||||||||
(In millions) | July 1, 2025 | Net Earnings (Loss) | Features | Charges | December\u00a031, 2025 | ||||||||||
Principal balance | $ | 194.4 | $ | 1.3 | $ | (39.9) | $ | \u2014 | $ | 155.8 | |||||
Discount | (35.4) | 2.7 | (24.7) | \u2014 | (57.4) | ||||||||||
Debt issuance costs | (6.4) | 0.5 | \u2014 | (8.9) | (14.8) | ||||||||||
Bifurcated embedded derivative | 41.7 | 19.3 | 64.6 | 6.3 | 131.9 | ||||||||||
Carrying value | $ | 194.3 | $ | 23.8 | $ | \u2014 | $ | (2.6) | $ | 215.5 |
The New Exchangeable Notes have an effective interest rate of 17.0%.
2025 Refinancing Transactions
On July 1, 2025, the Company and Muvico entered into a Transaction Support Agreement (the \u201cTransaction Support Agreement\u201d) providing for a series of refinancing transactions (the \u201c2025 Refinancing Transactions\u201d). The creditors party to the Transaction Support Agreement included certain holders of the Company\u2019s Existing 7.5% Notes (the \u201cConsenting 7.5% Noteholders\u201d), certain holders of the Existing Exchangeable Notes, (the \u201cConsenting Exchangeable Noteholders\u201d) and certain lenders of the Company\u2019s term loans outstanding under its credit agreement (the \u201cCredit Agreement\u201d, and any such consenting lenders, the \u201cConsenting Term Loan Lenders\u201d together with the Consenting 7.5% Noteholders and Consenting Exchangeable Noteholders, the \u201cConsenting Parties\u201d).
On July 1, 2025, the Consenting Exchangeable Noteholders exchanged $143.0 million aggregate principal amount of Existing Exchangeable Notes held by the Consenting Exchangeable Noteholders for 79,800,000 shares of Common Stock, which were reserved or authorized to be exchanged for the Existing Exchangeable Notes held by such holders.
On July 24, 2025 (the \u201c2025 Transactions Closing Date\u201d), the Company and Muvico completed the 2025 Refinancing Transactions as contemplated by the Transaction Support Agreement. In connection with the 2025 Refinancing Transactions, on the 2025 Transactions Closing Date:
| \u25cf | The Consenting 7.5% Noteholders (i) provided approximately $244.4 million of gross proceeds of incremental, new money financing and (ii) exchanged $590.0 million aggregate principal amount of Existing 7.5% Notes held by the Consenting 7.5% Noteholders on a dollar-for-dollar basis for a total of $857.0 million aggregate principal amount of new Senior Secured Notes due 2029 (the \u201cNew 2029 Notes\u201d). |
| \u25cf | The Consenting Exchangeable Noteholders exchanged approximately $194.4 million aggregate principal amount of the remaining Existing Exchangeable Notes held by the Consenting Exchangeable Noteholders, on a dollar-for-dollar basis, for New Exchangeable Notes. The principal amount of New Exchangeable Notes was subject to potential downward adjustment, depending on the trading price of the Company\u2019s Common Stock for a period following the initial exchange (the \u201cPrincipal Adjustment Feature\u201d). The Company also agreed to pay certain transaction fees, subject to certain conditions described in the Transaction Support Agreement, either in the form of Common Stock or as additional New Exchangeable Notes. |
| \u25cf | The Consenting Term Loan Lenders and certain other lenders party to the Credit Agreement (which constituted the \u201cRequired Lenders\u201d as defined in the Credit Agreement), the Company, Muvico and Wilmington Savings Fund Society, FSB, as administrative agent and as collateral agent under the Credit Agreement, entered into an amendment to the Credit Agreement permitting the 2025 Refinancing Transactions. The Consenting Term Loan Lenders were paid consent fees of approximately $22.3 million. |
| \u25cf | The Company and the Consenting Parties entered into a settlement and mutual release agreement with respect to the 2025 Refinancing Transactions, pursuant to which the parties have agreed that they will not directly or indirectly take any action in furtherance of the Intercreditor Litigation and to dismiss with prejudice any claims with respect to the Intercreditor Litigation. |
On September 30, 2025, $39.9 million aggregate principal of New Exchangeable Notes was cancelled pursuant to the Principal Adjustment Feature, representing the maximum possible downward adjustment.
At the 2025 Annual Meeting, our stockholders approved an amendment to the Company\u2019s Certificate of Incorporation for the Authorized Share Increase (the \u201cRequired Shareholder Approval\u201d) which allowed for the New Exchangeable Notes to become exchangeable and lowered the interest rate to 1.5% cash interest per annum. The Authorized Share increase also allowed for a $15.0 million consent fee payable to Consenting Existing Exchangeable Noteholders to be payable in the form of shares of Common Stock, based on a price determined based on the average of the daily volume weighted average price of our Common Stock for the sixty consecutive trading days commencing on December 22, 2025.
On December 22, 2025, the Company and the holders of the New Exchangeable Notes agreed to amend the New Exchangeable Notes Indenture to amend and restate the Exchange Rate and allow for up to $150.0 million of net proceeds from sales of at-the-market offerings. The amendments were memorialized in a supplemental indenture dated January 12, 2026 (the \u201cNew Exchangeable Notes Supplemental Indenture\u201d). As consideration for the indenture amendments the Company will pay the New Exchangeable Noteholders a consent fee of $6.25 million payable in shares of Common Stock. The number of shares will be based on the average of the daily volume weighted average price of our Common Stock for the sixty consecutive trading days commencing on December 22, 2025.
The following sections provide summaries of the key terms and provisions of the New 2029 Notes Indenture (as defined herein), the New Exchangeable Notes Indenture, and the Credit Agreement Amendment (as defined herein).
New 2029 Notes Indenture
Interest, Guarantees and Security
The New 2029 Notes were issued pursuant to an indenture (the \u201cNew 2029 Notes Indenture\u201d), dated as of the 2025 Transactions Closing Date, by and among Muvico, as issuer, the Company, as a guarantor, the other guarantors party thereto and CSC Delaware Trust Company, as trustee and as collateral agent (in such capacity, the \u201cNew 2029 Notes Collateral Agent\u201d).
The New 2029 Notes bear interest at a rate per annum equal to the Applicable Rate (as defined in the New 2029 Notes Indenture), payable semi-annually in arrears in cash and, to the extent required, in payment-in-kind (\u201cPIK\u201d) interest on June 15 and December 15 of each year, beginning on December 15, 2025. The Applicable Rate ranges from 11.5% cash interest to 15.0% total interest (comprised of 9.0% cash and 6.0% PIK) depending on the Company\u2019s Total Leverage Ratio. The New 2029 Notes will mature on February 19, 2029, unless redeemed in full prior to such maturity date, pursuant to the terms contained in the New 2029 Notes Indenture.
Muvico\u2019s obligations under the New 2029 Notes are fully and unconditionally guaranteed on a joint and several basis by the Company and each of the Company\u2019s subsidiaries that guarantee the Company\u2019s and Muvico\u2019s obligations under the Credit Agreement, and all of the Company\u2019s future subsidiaries that guarantee the Company\u2019s or any of the Company\u2019s subsidiaries other material indebtedness, including under the Credit Agreement. The New 2029 Notes are secured (a) on a first lien priority basis on the assets of the Company and the guarantors under the indenture governing the Company\u2019s Existing 7.5% Notes (the \u201cExisting 7.5% Notes Indenture\u201d) (such guarantors, collectively, the \u201cAMC Group Guarantors\u201d), pari passu with the liens securing the term loans under the Credit Agreement, and, other than with respect to any turnover in favor of the Credit Agreement by the Existing Exchangeable Notes, the Existing Exchangeable Notes, and (b) on a 1.5 lien priority basis on the assets of Muvico, Centertainment, and their guarantor subsidiaries under the Existing Exchangeable Notes Indenture (as defined herein) and AMC Theatres of UK Limited (together with Centertainment and such guarantor subsidiaries, collectively, the \u201cMuvico Group Guarantors\u201d; the Muvico Group Guarantors, together with the AMC Group Guarantors, collectively, the \u201cExisting Guarantors\u201d), which lien will only be junior to the liens securing the term loans under the Credit Agreement and the New Exchangeable Notes and senior to the liens securing any other funded debt of Muvico, including, but not limited to, the Existing Exchangeable Notes.
Covenants and Events of Default
The New 2029 Notes Indenture contains covenants that limit the ability of Muvico, the Company and its subsidiaries to, among other things: (i) incur additional indebtedness or guarantee indebtedness; (ii) create liens; (iii) declare or pay dividends, redeem stock or make other distributions to stockholders; (iv) make investments; (v) enter into transactions with its affiliates; (vi) consolidate, merge, sell or otherwise dispose of all or substantially all of their respective assets; and (vii) impair the security interest in the collateral. These covenants are subject to a number of important limitations and exceptions. The New 2029 Notes Indenture also provides for events of default, which, if any of
them occurs, would permit or require the principal, premium, if any, interest and any other monetary obligations on all the then outstanding New 2029 Notes to be due and payable immediately.
New Exchangeable Notes Indenture
Interest, Guarantees and Security
The New Exchangeable Notes were issued pursuant to an indenture (the \u201cNew Exchangeable Notes Indenture\u201d), dated as of the 2025 Transactions Closing Date, by and among Muvico, as issuer, the Company, as a guarantor, the other guarantors party thereto and GLAS Trust Company LLC, as trustee and as collateral agent (in such capacity, the \u201cNew Exchangeable Notes Collateral Agent\u201d).
The New Exchangeable Notes initially bore interest at a rate per annum of 6.00% cash interest and 2.00% PIK interest. Once the Required Shareholder Approval was obtained on December 10, 2025 (the \u201cInterest Adjustment Date\u201d), the interest rate was decreased, from and after the Interest Adjustment Date, to 1.50% cash interest (and no PIK interest) per annum payable semi-annually in arrears on June 15 and December 15 of each year, beginning on December 15, 2025. The New Exchangeable Notes will mature on April 30, 2030, unless redeemed or exchanged in full prior to such maturity date, pursuant to the terms contained in the New Exchangeable Notes Indenture.
Muvico\u2019s obligations under the New Exchangeable Notes are fully and unconditionally guaranteed on a joint and several basis by the Company and the Company\u2019s subsidiaries that guarantee the Company and Muvico\u2019s obligations under the Credit Agreement, and all of the Company\u2019s future subsidiaries that guarantee the Company\u2019s other material indebtedness, including under the Credit Agreement. The New Exchangeable Notes are secured (a) on a first lien priority basis on the assets of the Company and the guarantors under the Existing 7.5% Notes Indenture, pari passu with the liens securing the term loans under the Credit Agreement, the Existing Exchangeable Notes, the New 2029 Notes and the remaining Existing 7.5% Notes, subject to the Existing 1L Intercreditor Agreement, and will be subject to the same turnover provisions as the Existing Exchangeable Notes for the benefit of the term loans under the Credit Agreement and (b) on a 1.25 lien priority basis on the assets of Muvico, Centertainment and their guarantor subsidiaries under the Existing Exchangeable Notes Indenture and AMC Theatres of UK Limited, which lien will only be junior to the liens securing the term loans under the Credit Agreement and senior to the liens securing the New 2029 Notes and the liens securing any other funded debt of Muvico, including, but not limited to, the Existing Exchangeable Notes.
Exchange Mechanics; Soft Call; Fundamental Change; Redemption
The New Exchangeable Notes are exchangeable, at the option of the holders thereof, into Common Stock at a stock price (the \u201cExchange Price\u201d) calculated based on a formula described in the New Exchangeable Notes Indenture.
Under the terms of the New Exchangeable Notes Indenture, the Company has also agreed that for a period of six months following the Required Shareholder Approval, the Company will not engage in at-the-market offerings that exceed the lesser of 25,000,000 aggregate shares of Common Stock or $50,000,000 in aggregate net proceeds raised through such at-the-market offerings; provided, however, that if either (i) the share price of the Common Stock exceeds 200% of the Soft Call Trigger Price (as defined in the New Exchangeable Notes Indenture) at any time, determined based on the average of the Daily VWAPs (as defined in the New Exchangeable Notes Indenture) for any period of consecutive Trading Days (as defined in the New Exchangeable Notes Indenture) or (ii) at least 100,000,000 shares of Common Stock have traded above 200% of the Soft Call Trigger Price, then, in either case, all such restrictions with respect to the Company\u2019s ability to engage in at-the-market offerings will no longer apply, so long as any Common Stock sold in any such offering is sold at a price no less than 200% of the Soft Call Trigger Price.
At any time from and after the date that is business day following the date on which the Exchange Price has been initially determined until the close of business on the second Trading Day immediately preceding the maturity date of the New Exchangeable Notes, each holder of the New Exchangeable Notes will have the right, at its option, to surrender for exchange all or a portion of its New Exchangeable Notes at the Exchange Rate for Common Stock based on the applicable Exchange Rate (as defined in the New Exchangeable Notes Indenture) then in effect. During such period, Muvico will have the right, at its election, to redeem all (but not less than all) of the outstanding New Exchangeable Notes at a price equal to the aggregate principal amount of the New Exchangeable Notes, plus accrued and unpaid interest thereon to, but excluding, the date of such redemption if the Daily VWAP per share of Common Stock exceeds 110% of the Exchange Price for consecutive Trading Days ending on (and including) the Trading Day
immediately before the date on which Muvico sends a notice to holders calling such New Exchangeable Notes for redemption (a \u201cNew Exchangeable Notes Soft Call Notice\u201d). Any such New Exchangeable Notes Soft Call Notice will provide that the applicable redemption of the New Exchangeable Notes will occur on a business day of Muvico\u2019s choosing, not more than and not less than business days after the date of the New Exchangeable Notes Soft Call Notice. Notwithstanding the foregoing, holders of New Exchangeable Notes will be entitled within business days of such New Exchangeable Notes Soft Call Notice to submit their New Exchangeable Notes for exchange under the terms of the New Exchangeable Notes Indenture. On December 22, 2025, the Company and the holders of the New Exchangeable Notes agreed to amend the Exchange Rate which was memorialized in the New Exchangeable Notes Supplemental Indenture. The New Exchangeable Notes Supplemental Indenture also increases the limit on at-the-market offerings to $150.0 million of aggregate net proceeds. As consideration for the indenture amendments the Company will pay the New Exchangeable Noteholders a consent fee of $6.25 million payable in shares of Common Stock. The number of shares will be based on the average of the daily volume weighted average price of our Common Stock for the sixty consecutive trading days commencing on December 22, 2025.
In the event that holders of New Exchangeable Notes voluntarily elect to exchange their New Exchangeable Notes, such holders will also be entitled to a make-whole premium (the \u201cNew Exchangeable Notes Exchange Adjustment Consideration\u201d) equal to (i) prior to July 22, 2027, 21.0% of the aggregate principal amount of the New Exchangeable Notes being exchanged\u037e (ii) on or after July 22, 2027 and prior to July 22, 2028, 14.0% of the aggregate principal amount of the New Exchangeable Notes being exchanged; (iii) on or after July 22, 2028 and prior to July 22, 2029, 7.0% of the aggregate principal amount of the New Exchangeable Notes being exchanged; and (iv) on or after July 22, 2029, zero. Muvico, at its option, will be entitled to pay the New Exchangeable Notes Exchange Adjustment Consideration in the form of shares of Common Stock (using a modified exchange price equal to 110% of the Exchange Price), subject to restrictions under the Credit Agreement, or cash in twelve equal installments over the twelve-month period following the applicable exchange or a combination thereof.
If certain corporate events that constitute a Fundamental Change (as defined in the New Exchangeable Notes Indenture) occur, then holders will have the right to require Muvico to repurchase their New Exchangeable Notes at a cash repurchase price equal to 100% of the aggregate principal amount of the New Exchangeable Notes to be repurchased, plus accrued and unpaid interest, if any, thereon to, but excluding, the Fundamental Change Repurchase Date (as defined in the New Exchangeable Notes Indenture). The definition of Fundamental Change includes certain business combination transactions involving the Company, stockholder approval of any plan or proposal for the liquidation or dissolution of the Company and certain de-listing events with respect to Common Stock.
Muvico will also be required to mandatorily redeem all of the issued and outstanding New Exchangeable Notes at a purchase price equal to 100% of the aggregate principal amount thereof, plus accrued and unpaid interest to, but excluding, the date of purchase in the event that, as of November 17, 2028, the aggregate principal amount outstanding of the Existing 7.5% Notes and New 2029 Notes exceeds an aggregate principal amount of $190.0 million.
Covenants and Events of Default
The New Exchangeable Notes Indenture contains covenants that limit the ability of Centertainment and Muvico and their future respective subsidiaries to, among other things: (i) incur additional indebtedness or guarantee indebtedness; (ii) create liens; (iii) declare or pay dividends, redeem stock or make other distributions to stockholders; (iv) make investments; (v) enter into transactions with its affiliates; (vi) consolidate, merge, sell or otherwise dispose of all or substantially all of their respective assets; and (vii) impair the security interest in the collateral. These covenants are subject to a number of important limitations and exceptions. The New Exchangeable Notes Indenture also incorporates the other restrictive covenants contained in the New 2029 Notes Indenture. The New Exchangeable Notes Indenture also provides for events of default, which, if any of them occurs, would permit or require the principal, premium, if any, interest and any other monetary obligations on all the then outstanding New Exchangeable Notes to be due and payable immediately.
Embedded Derivatives
The New Exchangeable Notes contained a feature that would increase or decrease the interest rate on December 10, 2025, depending on the outcome of the Required Shareholder Approval (the \u201cInterest Reset Feature\u201d). The Company bifurcated the Interest Reset Feature as: (i) the economic characteristics and risks of the interest rate change are not clearly and closely related to the economic characteristics and risks of the host instrument because the change is dependent on authorization of additional Common Stock; (ii) the host debt instrument is not remeasured at fair value but
rather, is measured at amortized cost; and (iii) the Interest Reset Feature does not qualify for derivative scope exception under ASC 815-10-15-74(a).
The Company will pay a consent fee to an ad hoc group of creditors, in the form of $21.3 million payable in shares of Common Stock, based on a price determined during the sixty consecutive trading days commencing December 22, 2025 (the \u201cConsent Fee Feature\u201d). The Consent Fee Feature was also bifurcated for the same reasons as the Interest Reset Feature.
The Company also bifurcated the Principal Adjustment Feature as: (i) the economic characteristics and risks were not clearly and closely related to the economic characteristics and risks of the host instrument given that the Principal Adjustment Feature was tied to the price of the Company\u2019s Common Stock; (ii) the host debt instrument is not remeasured at fair value but rather, is measured at amortized cost; and (iii) the Principal Adjustment Feature does not qualify for derivative scope exception under ASC 815-10-15-74(a).
The Company analyzed the contingent conversion option and New Exchangeable Notes Exchange Adjustment Consideration as one single contingent conversion option (the \u201cContingent Conversion Option\u201d). The Company bifurcated the Contingent Conversion Option from the host contract as: (i) the economic characteristics of a conversion option embedded in a debt instrument are not clearly and closely related to the economic characteristics and risks of a debt host contract, as stated in ASC 815-15-25-51; (ii) the host debt instrument is not remeasured at fair value but rather, is measured at amortized cost; and (iii) the Contingent Conversion Option does not qualify for derivative scope exception under ASC 815-10-15-74(a). The New Exchangeable Notes Exchange Adjustment Consideration (i.e., make-whole payment) does not meet the criteria for indexation under ASC 815-40-15-7C because the design of the feature does not meet the time-value scope exception and as a result is accounted for as a derivative.
The Company combined the embedded derivatives for the Interest Reset Feature, Principal Adjustment Feature, Consent Fee Feature, and the Contingent Conversion Option into a single compound derivative liability. The derivative liability is remeasured at fair value each reporting period with changes in fair value recorded in the consolidated statement of operations as other expense or income.
The Principal Adjustment Feature was recorded at fair value and transferred to the carrying value of the New Exchangeable Notes upon cancellation of $39.9 million aggregate principal amount of New Exchangeable Notes on September 30, 2025. The Interest Reset Feature was recorded at fair value and transferred to the carrying value of the New Exchangeable Notes after the receipt of the Required Shareholder Approval on December 10, 2025. See Note 10\u2013Fair Value Measurements for a discussion of the valuation methodologies.
Credit Agreement Amendment
On the 2025 Transactions Closing Date, the Company entered into that certain First Amendment to Credit Agreement (the \u201cCredit Agreement Amendment\u201d), by and among the Company and Muvico, as borrowers, the Existing Guarantors, the lenders party thereto (which constituted the \u201cRequired Lenders\u201d as defined in the Credit Agreement) and Wilmington Savings Fund Society, FSB, as administrative agent and as collateral agent, which amends the Credit Agreement. Pursuant to the Credit Agreement Amendment, certain covenants were amended to permit the consummation of the 2025 Refinancing Transactions and directed Wilmington Savings Fund Society, FSB, as collateral agent in respect of the existing term loans (in such capacity, the \u201cCredit Agreement Collateral Agent\u201d), to enter into the A&R First Lien/Second Lien Centertainment Group Intercreditor Agreement (as defined below) and the First Lien/Intermediate Lien Intercreditor Agreement (as defined below).
Intercreditor Agreements
A&R First Lien/Second Lien Centertainment Group Intercreditor Agreement
On the 2025 Transactions Closing Date, the Company, Centertainment, Muvico and the other Existing Guarantors, the Credit Agreement Collateral Agent, the collateral agent for the noteholders of the Existing Exchangeable Notes (the \u201cExisting Exchangeable Notes Collateral Agent\u201d), the New Exchangeable Notes Collateral Agent and the New 2029 Notes Collateral Agent entered into that certain Amended and Restated First Lien/Second Lien Intercreditor Agreement (the \u201cA&R First Lien/Second Lien Centertainment Group Intercreditor Agreement\u201d) to govern the relative priorities of the security interests of the Credit Agreement Collateral Agent, the Existing Exchangeable Notes Collateral
Agent, the New Exchangeable Notes Collateral Agent and the New 2029 Notes Collateral Agent in the collateral granted by the Muvico Group Guarantors and certain other matters related to the administration of security interests.
Existing First Lien Restricted Group Intercreditor Joinder Agreement
On the 2025 Transactions Closing Date, the Company, the AMC Group Guarantors, the Credit Agreement Collateral Agent, in its capacity as controlling collateral agent, the New Exchangeable Notes Collateral Agent and the New 2029 Notes Collateral Agent entered into that certain Joinder No. 5 to the First Lien Intercreditor Agreement (the \u201cExisting First Lien Restricted Group Intercreditor Joinder Agreement\u201d), pursuant to which the New Exchangeable Notes Collateral Agent and the New 2029 Notes Collateral Agent joined that certain First Lien Intercreditor Agreement, dated as of April 24, 2020 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the \u201cExisting Restricted Group First Lien Intercreditor Agreement\u201d), among the Company, the AMC Group Guarantors, the Credit Agreement Collateral Agent and the other agents party thereto, and became bound by the Existing Restricted Group First Lien Intercreditor Agreement, which governs the relative priorities of the collateral agents party thereto and their respective security interests in the collateral granted by the Company and the AMC Group Guarantors and certain other matters related to the administration of security interests.
First Lien/Intermediate Lien Centertainment Group Intercreditor Agreement
On the 2025 Transactions Closing Date, the Company, Centertainment, Muvico and the other Existing Guarantors, the Credit Agreement Collateral Agent, the New Exchangeable Notes Collateral Agent and the New 2029 Notes Collateral Agent entered into that certain First Lien/Intermediate Lien Intercreditor Agreement (the \u201cFirst Lien/Intermediate Lien Centertainment Group Intercreditor Agreement\u201d) to govern the relative priorities of the security interests of the Credit Agreement Collateral Agent, the New Exchangeable Notes Collateral Agent and the New 2029 Notes Collateral Agent in the collateral granted by the Muvico Group Guarantors and certain other matters related to the administration of security interests.
1.25 Lien/1.5 Lien Centertainment Group Intercreditor Agreement
On the 2025 Transactions Closing Date, the Company, Muvico, Centertainment and the other Muvico Group Guarantors, the New Exchangeable Notes Collateral Agent and the New 2029 Notes Collateral Agent entered into that certain 1.25 Lien/1.5 Lien Intercreditor Agreement (the \u201c1.25 Lien/1.5 Lien Centertainment Group Intercreditor Agreement\u201d) to govern the relative priorities of the security interests of the New Exchangeable Notes Collateral Agent and the New 2029 Notes Collateral Agent in the collateral granted by the Muvico Group Guarantors and certain other matters related to the administration of security interests.
Supplemental Indentures
In connection with entering into the Transaction Support Agreement, with the consent of the holders of a majority of the Existing Exchangeable Notes, Muvico entered into a supplemental indenture (the \u201cSupplemental Indenture\u201d) to the indenture governing the Company\u2019s Existing Exchangeable Notes, with the guarantors party thereto and the trustee and notes collateral agent thereunder. Among other things, the Supplemental Indenture makes amendments to the indenture to permit the 2025 Refinancing Transactions.
Prior to the 2025 Refinancing Transactions, with the consent of the holders of a majority in aggregate principal amount of the outstanding Existing 7.5% Notes, the Company, the guarantors party thereto and CSC Delaware Trust Company, as trustee and collateral agent, entered into a supplemental indenture (the \u201cExisting 7.5% Notes Supplemental Indenture\u201d) to the Existing 7.5% Notes Indenture. Among other things, the Existing 7.5% Notes Supplemental Indenture made amendments to the Existing 7.5% Notes Indenture to permit the 2025 Refinancing Transactions.
Extinguishments & Subordinated Note Redemption
The Company determined that July 1, 2025 was the appropriate date to apply extinguishment accounting to the Existing Exchangeable Notes as it was the date that the Common Stock was issued and also the date the Company had a firm commitment to issue the New Exchangeable Notes. The exchanges of the Existing Exchangeable Notes for shares of Common Stock and New Exchangeable Notes resulted in a loss on extinguishment as follows:
(In\u00a0millions) | Amount | ||
Fair value of New Exchangeable Notes | $ | 159.0 | |
Fair value of bifurcated embedded derivatives New Exchangeable Notes | 41.7 | ||
Fair value of Common Stock issued | 225.0 | ||
Total consideration | 425.7 | ||
Principal Existing Exchangeable Notes | 337.4 | ||
Discount Existing Exchangeable Notes | (86.5) | ||
Debt issuance costs Existing Exchangeable Notes | (17.1) | ||
Gain on cash paid for PIK interest | 0.3 | ||
Bifurcated embedded derivatives Existing Exchangeable Notes | 88.3 | ||
Carrying value Existing Exchangeable Notes | 322.4 | ||
Loss on extinguishment of Existing Exchangeable Notes | $ | 103.3 |
The exchanges of the Existing 7.5% Notes for New 2029 Notes were accounted for as extinguishments and resulted in a loss on extinguishment as follows:
(In\u00a0millions) | Amount | ||
Fair value of New 2029 Notes (1) | $ | 925.4 | |
Gross proceeds | (244.4) | ||
Cash fee paid to Existing 7.5% Notes lenders | 2.4 | ||
Total consideration | 683.4 | ||
Principal Existing 7.5% Notes | 590.0 | ||
Debt issuance costs Existing 7.5% Notes | (5.6) | ||
Carrying value Existing 7.5% Notes | 584.4 | ||
Loss on extinguishment of Existing 7.5% Notes | $ | 99.0 |
| (1) | Fair value of the New 2029 Notes was estimated on July 24, 2025 using observed prices for transactions of the New 2029 Notes shortly after issuance. The market for the New 2029 Notes is considered an inactive market and the observed prices are considered a Level 2 input in the fair value hierarchy. |
On July 7, 2025, the Company delivered notices of conditional full redemption (the \u201cNotices\u201d) to holders of the Company\u2019s outstanding 5.875% Senior Subordinated Notes due 2026 (the \u201cSenior Subordinated Notes due 2026\u201d) and 10%/12% Cash/PIK Toggle Second Lien Subordinated Secured Notes due 2026 (the \u201cSecond Lien Notes\u201d) (collectively, the \u201cSubordinated Notes\u201d) to redeem the Subordinated Notes in full, in each case, at a redemption price of 100% of the principal amount of the Subordinated Notes outstanding, plus accrued and unpaid interest to the applicable redemption date (the \u201cRedemptions\u201d). On July 28, 2025, the Company used the proceeds from the issuance of the New 2029 Notes to fully redeem the Second Lien Notes. On August 6, 2025, the Company fully redeemed the Senior Subordinated Notes due 2026. The Company recorded a gain on extinguishment of $6.6 million and a loss on extinguishment of $0.3 million related to the Second Lien Notes redemption and Senior Subordinated Notes due 2026 redemption, respectively.
The Credit Agreement Amendment was accounted for as a modification and resulted in expense of approximately $3.1 million for costs paid to third parties.
2024 Refinancing Transactions
On July 22, 2024, the Company completed a series of refinancing transactions (the \u201c2024 Refinancing Transactions\u201d) with two creditor groups to refinance and extend to 2029 and 2030 the maturities of the Company\u2019s debt previously maturing in 2026.
In connection with the refinancing:
| \u25cf | The Company and Muvico, entered into the Credit Agreement, by and among the Company and Muvico, each, as a borrower, pursuant to which the Company and Muvico jointly and severally borrowed $2,024.3 million of new term loans maturing in 2029 (the \u201cNew Term Loans\u201d). |
| \u25cf | The New Term Loans were (i) used as consideration for the open market purchase of $1,895.0 million of Company\u2019s Term Loans due 2026 and (ii) exchanged for $104.2 million of the Company\u2019s Second Lien Notes. |
| \u25cf | Muvico also completed a private offering for cash of $414.4 million aggregate principal amount of Existing Exchangeable Notes and used the proceeds from the offering to repurchase $414.4 million aggregate principal amount of the Company\u2019s Second Lien Notes. |
The debt repurchases and exchanges for the Second Lien Notes were accounted for as extinguishments and resulted in a loss on extinguishment as follows:
(In\u00a0millions) | Amount | ||
Fair value of Exchangeable Notes due 2030 | $ | 293.6 | |
Fair value of Conversion Option | 233.4 | ||
Fair value of New Term Loans due 2029 | 104.2 | ||
PIK fee paid to Second Lien Lenders | 2.3 | ||
Cash fee paid to Second Lien Lenders | 2.3 | ||
Second Lien Notes consideration | 635.8 | ||
Principal Second Lien Notes | 518.6 | ||
Premium Second Lien Notes | 56.0 | ||
Carrying value Second Lien Notes | 574.6 | ||
Loss on extinguishment of Second Lien Notes | $ | 61.2 |
The debt exchanges for the Term Loans due 2026 were accounted for as modifications and resulted in expense of approximately $42.3 million for costs paid to third parties.
Existing Exchangeable Notes
On July 22, 2024, Muvico issued $414.4 million aggregate principal amount of its Existing Exchangeable Notes. The Existing Exchangeable Notes will bear interest at a rate of 6.00% per annum, if paid in cash, and 8.00% per annum, if paid in-kind by issuing PIK Notes having the same terms and conditions as the Existing Exchangeable Notes (\u201cPIK Interest\u201d) in each case, payable semi-annually in arrears on June 15 and December 15, beginning on December 15, 2024. The Existing Exchangeable Notes will mature on April 30, 2030, unless redeemed or exchanged in full prior to such maturity date, pursuant to the terms contained in the Existing Exchangeable Notes Indenture as further discussed below.
At the time prior to the close of business on the second Trading Day (as defined in the Existing Exchangeable Notes Indenture) immediately preceding the final maturity date of the Existing Exchangeable Notes, each holder of the Existing Exchangeable Notes shall have the right, at its option, to surrender for exchange all or a portion of its Existing Exchangeable Notes at the Exchange Rate (as defined in the Existing Exchangeable Notes Indenture) for Common Stock. The Exchange Rate is initially set at 176.6379 shares of the Common Stock per $1,000 principal amount of Existing Exchangeable Notes exchanged, which reflects a price of $5.66 per share Common Stock (\u201cExisting Exchangeable Notes Exchange Price\u201d), which price is equal to 113% of the closing price per share of the Common Stock
on July 19, 2024. The Exchange Rate is subject to customary adjustments and anti-dilution protections (as provided in the Existing Exchangeable Notes Indenture).
At any time prior to the close of business on the second Trading Day immediately preceding the final maturity date of the Existing Exchangeable Notes, Muvico will also have the right, at its election, to redeem all (but not less than all) of the outstanding Existing Exchangeable Notes at a price equal to the aggregate principal amount of the Existing Exchangeable Notes, plus accrued and unpaid interest thereon to, but excluding, the date of such redemption if the Daily VWAP (as defined in the Existing Exchangeable Notes Indenture) per share of Common Stock exceeds 140% of the Existing Exchangeable Notes Exchange Price for fifteen (15) consecutive Trading Days ending on (and including) the Trading Day immediately before the date on which Muvico sends a notice to holders calling such Existing Exchangeable Notes for redemption (a \u201cExisting Exchangeable Notes Soft Call Notice\u201d). Any such Existing Exchangeable Notes Soft Call Notice will provide that the applicable redemption of the Existing Exchangeable Notes will occur on a business day of Muvico\u2019s choosing, not more than ten (10) and not less than five (5) business days after the date of the Existing Exchangeable Notes Soft Call Notice. Notwithstanding the foregoing, holders of Existing Exchangeable Notes will be entitled within two (2) business days of such Existing Exchangeable Notes Soft Call Notice to submit their Existing Exchangeable Notes for exchange under the terms of the Existing Exchangeable Notes Indenture.
In the event that holders of Existing Exchangeable Notes voluntarily elect to exchange their Existing Exchangeable Notes, such holders will also be entitled to a make-whole premium (the \u201cExisting Exchangeable Notes Exchange Adjustment Consideration\u201d) equal to (i) prior to the third anniversary of the Issue Date, 18.0% of the aggregate principal amount of the Existing Exchangeable Notes being exchanged\u037e (ii) on or after the third anniversary and prior to the fourth anniversary of the Issue Date, 12.0% of the aggregate principal amount of the Existing Exchangeable Notes being exchanged; and (iii) on or after the fourth anniversary of the Issue Date and prior to the fifth anniversary, 6.0% of the aggregate principal amount of the Existing Exchangeable Notes being exchanged. Muvico, at its option, will be entitled to pay the Existing Exchangeable Notes Exchange Adjustment Consideration in the form of shares of Common Stock (using a modified exchange price equal to 140% of the Existing Exchangeable Notes Exchange Price), subject to restrictions under the Credit Agreement, cash in twelve (12) equal installments over the twelve-month period following the applicable exchange or a combination thereof.
If certain corporate events that constitute a Fundamental Change (as defined in the Existing Exchangeable Notes Indenture) occur, then holders will have the right to require Muvico to repurchase their Existing Exchangeable Notes at a cash repurchase price equal to 100% of the aggregate principal amount of the Existing Exchangeable Notes to be repurchased, plus accrued and unpaid interest, if any, thereon to, but excluding, the Fundamental Change Repurchase Date (as defined in the Existing Exchangeable Notes Indenture). The definition of Fundamental Change includes certain business combination transactions involving the Company, stockholder approval of any plan or proposal for the liquidation or dissolution of the Company and certain de-listing events with respect to the Common Stock.
Muvico will also be required to mandatorily redeem all of the issued and outstanding Existing Exchangeable Notes at a purchase price equal to 100% of the aggregate principal amount, plus accrued and unpaid interest to, but excluding, the date of purchase in the event that, as of ninety (90) days prior to the maturity date of the Existing 7.5% Notes, the aggregate principal amount outstanding of the Existing 7.5% Notes with a maturity date prior to April 30, 2030 exceeds $190,000,000.
The Existing Exchangeable Notes Indenture also provides for events of default, which, if any of them occur, would permit or require the principal, premium, if any, interest and any other monetary obligations on all the then outstanding Existing Exchangeable Notes to be due and payable immediately.
The Company analyzed the conversion option and Existing Exchangeable Notes Exchange Adjustment Consideration as one single conversion option (the \u201cConversion Option\u201d). The Company bifurcated the Conversion Option from the principal balance of the Existing Exchangeable Notes as a derivative liability. The Company bifurcated the Conversion Option as: (i) the economic characteristics of a conversion option embedded in a debt instrument are not clearly and closely related to the economic characteristics and risks of a debt host contract, as stated in ASC 815-15-25-51; (ii) the host debt instrument is not remeasured at fair value but rather, the Existing Exchangeable Notes are measured at amortized cost; and (iii) the Conversion Option does not qualify for derivative scope exception under ASC 815-10-15-74(a). The Conversion Option also includes a make-whole adjustment, the Existing Exchangeable Notes Exchange Adjustment Consideration. The Existing Exchangeable Notes Exchange Adjustment Consideration (i.e., make-whole payment) does not meet the criteria for indexation under ASC 815-40-15-7C because the design of the feature does not
meet the time-value scope exception and as a result is accounted for as a derivative. The derivative liability is remeasured at fair value each reporting period with changes in fair value recorded in the consolidated statement of operations as other expense or income. See Note 10\u2013Fair Value Measurements for a discussion of the valuation methodologies.
New Term Loans due 2029
The New Term Loans mature on January 4, 2029 (or, if at least $190,000,000 remains outstanding of the (i) Existing 7.5% Notes or (ii) any indebtedness in respect of any modification, refunding, replacement, substitution, restructuring or other refinancing of the Existing 7.5% Notes on or prior to October 5, 2028, then October 5, 2028). The New Term Loans are subject to amortization of principal, payable in quarterly installments on the last business day of each fiscal quarter, commencing on September 30, 2024, equal to 1.00% per annum. The remaining aggregate principal amount outstanding (together with accrued and unpaid interest on the principal amount) of the New Term Loans is payable at maturity.
The New Term Loans bear interest, at the option of the New Term Loan Borrowers, at rates equal to either (i) a base rate plus a margin of between 500 and 600 basis points depending on the Total Leverage Ratio or (ii) Term SOFR plus a margin of between 600 and 700 basis points depending on the Total Leverage Ratio.
The New Term Loans are guaranteed, subject to limited exceptions, by Centertainment and the future subsidiaries of Centertainment and Muvico (collectively with Muvico, the \u201cCentertainment Group Parties\u201d) and the Existing Guarantors, and are secured by liens on substantially all of the tangible and intangible assets owned by the Company, in each case, subject to limited exceptions set forth in the Credit Agreement.
The Credit Agreement contains covenants that limit the Company\u2019s ability to, among other things: (i) incur additional indebtedness or guarantee indebtedness; (ii) create liens; (iii) declare or pay dividends, redeem stock or make other distributions to stockholders; (iv) make investments; (v) enter into transactions with its affiliates; (vi) consolidate, merge, sell or otherwise dispose of all or substantially all of their respective assets; and (vii) maintain cash in the accounts of the Company (other than the Centertainment Group Parties). These covenants are subject to a number of limitations and exceptions. The Credit Agreement also provides for events of default, which, if any of them occur, would permit or require the principal, premium, if any, interest and any other monetary obligations on all the then outstanding New Term Loans to become immediately due and payable.
Unamortized discounts and deferred charges related to the Term Loans due 2026 of $6.5 million and fees paid to Term Loans due 2026 lenders of $45.7 million were recorded as deferred charges related to the New Term Loans and the Company will amortize those costs to interest expense following the effective interest method over the term of the New Term Loans.
Senior Secured Credit Facilities
Holdings entered into the 2013 Credit Agreement. The 2013 Credit Agreement (as amended, restated, amended and restated, supplemented or otherwise modified) provided senior secured financing of $2,225.0 million in aggregate, consisting of (i) $2,000.0 million Term Loans due 2026 and (ii) a $225.0 million senior secured revolving credit facility (which was also available for letters of credit and for swingline borrowings on same-day notice) maturing April 22, 2024 (the \u201cSenior Secured Revolving Credit Facility\u201d and together with the Term Loans due 2026, the \u201cSenior Secured Credit Facilities\u201d).
The Term Loans due 2026 bore interest at a rate per annum equal to, at Holdings\u2019 option, either (1)\u00a0a base rate determined by reference to the highest of (a)\u00a00.50% per annum plus the Federal Funds Effective Rate, (b)\u00a0the prime rate announced by the Administrative Agent from time to time and (c)\u00a01.00% per annum plus Adjusted Term SOFR for a 1-month tenor, or (2) Adjusted Term SOFR plus (x) in the case of the Term Loans due 2026, 2.0% for base rate loans or 3.0% for SOFR loans or (y) in the case of the Senior Secured Revolving Credit Facility, an applicable margin based on the Secured Leverage Ratio (as defined in the 2013 Credit Agreement).
The Company\u2019s obligations under the Senior Secured Credit Facilities were completely repaid following the completion of the 2024 Refinancing Transactions.
Existing 7.5% Notes
On February 14, 2022, Holdings issued $950.0 million aggregate principal amount of its 7.5% First Lien Senior Secured Notes due 2029 (\u201cExisting 7.5% Notes\u201d), pursuant to an indenture, dated as of February 14, 2022, among Holdings, the guarantors named therein and U.S. Bank Trust Company, National Association, as trustee and collateral agent.
The Existing 7.5% Notes bear cash interest at a rate of 7.5% per annum payable semi-annually in arrears on February 15 and August 15. The Existing 7.5% Notes have not been registered under the Securities Act and will mature on February 15, 2029. Holdings may redeem some or all of the Existing 7.5% Notes at any time on or after February 15, 2025, at the redemption prices equal to (i) 103.750% for the twelve-month period beginning on February 15, 2025; (ii) 101.875% for the twelve-month period beginning on February 15, 2026; and (iii) 100.0% at any time thereafter, plus accrued and unpaid interest. Upon a Change of Control (as defined in the indenture governing the Existing 7.5% Notes), Holdings must offer to purchase the Existing 7.5% Notes at a purchase price equal to 101% of the principal amounts, plus accrued and unpaid interest.
The Existing 7.5% Notes are guaranteed by the Existing Guarantors and are secured by liens on substantially all of the tangible and intangible assets owned by Holdings and the Existing Guarantors, subject to certain thresholds, exceptions and permitted liens.
On July 24, 2025, the Company entered into a supplemental indenture to the indenture governing the Existing 7.5% Notes that, among other things, (i) permit the 2025 Refinancing Transactions, and (ii) eliminated many of the restrictive covenants contained in the indenture governing the Existing 7.5% Notes. The indenture governing the Existing 7.5% Notes, as amended, contains covenants that restrict the ability of the Company to, among other things: (i) create liens ranking pari passu in right of payment with or subordinated in right of payment to Existing 7.5% Notes; and (ii) merge or consolidate with other companies or transfer all or substantially all of their respective assets. These covenants are subject to a number of important limitations and exceptions. The indenture governing the Existing 7.5% Notes also provides for events of default, which, if any occur, would permit or require the principal, interest and any other monetary obligations on all the then outstanding Existing 7.5% Notes to be due and payable immediately.
Odeon Senior Secured Notes due 2027
On October 20, 2022, Odeon Finco PLC, a direct subsidiary of OCGL and an indirect subsidiary of Holdings, issued $400.0 million aggregate principal amount of its Odeon Notes due 2027, at an issue price of 92.00%. The Odeon Notes due 2027 bear a cash interest rate of 12.75% per annum and will be payable semi-annually in arrears on May 1 and November 1, beginning on May 1, 2023. The Odeon Notes due 2027 are guaranteed on a senior secured basis by OCGL and certain of its subsidiaries and by Holdings on a standalone and unsecured basis. The indenture governing the Odeon Notes due 2027 contains covenants that limit OCGL and certain of its subsidiaries\u2019 ability to, among other things: (i) incur additional indebtedness or guarantee indebtedness; (ii) create liens; (iii) declare or pay dividends, redeem stock or make other distributions to stockholders; (iv) make investments; (v) enter into transactions with affiliates; (vi) consolidate, merge, sell or otherwise dispose of all or substantially all of their respective assets; and (vii) impair the security interest in the collateral. These covenants are subject to several important limitations and exceptions. The indenture governing the Odeon Notes due 2027 also provides for events of default, which, if any occur, would permit or require principal, interest and any other monetary obligations on all the then outstanding Odeon Notes due 2027 to be due and payable immediately.
On or after November 1, 2024, the Odeon Notes due 2027 will be redeemable, in whole or in part, at redemption prices equal to (i) 106.375% for the twelve-month period beginning on November 1, 2024; (ii) 103.188% for the twelve-month period beginning on November 1, 2025; and (iii) 100.000% at any time thereafter, plus accrued and unpaid interest, if any. If the Company or its restricted subsidiaries sell assets under certain circumstances, the Company will be required to use the net proceeds to repay the Odeon Notes due 2027 or any additional First Lien Obligations at a price no less than 100% of the issue price of the Odeon Notes due 2027, plus accrued and unpaid interest, if any. Upon a Change of Control (as defined in the indenture governing the Odeon Notes due 2027), the Company must offer to purchase the Odeon Notes due 2027 at a purchase price equal to 101% of the principal amount, plus accrued and unpaid interest, if any. On December 14, 2022, the Odeon Notes due 2027 were admitted to the official list of The International Stock Exchange (\u201cTISE\u201d). The Odeon Notes due 2027 will automatically delist from TISE on the business day following the maturity date of November 1, 2027, unless adequate notice is given together with supporting documents setting out any changes to the date of maturity or confirmation that the Odeon Notes due 2027 have not been fully repaid.
Second Lien Notes due 2026
On July 31, 2020, Holdings issued $1,462.3 million aggregate principal amount of its Second Lien Notes in exchange for the 6.375% Senior Subordinated Notes due 2024 (the \u201cSterling Notes due 2024\u201d), 5.75% Senior Subordinated Notes due 2025, Senior Subordinated Notes due 2026, and Senior Subordinated Notes due 2027. The Second Lien Notes were issued pursuant to an indenture, dated as of July 31, 2020, among Holdings, the guarantors named therein and GLAS Trust Company LLC, as trustee and collateral agent (the \u201cSecond Lien Notes Indenture\u201d). The Company recorded a premium of $535.1 million on the Second Lien Notes as the difference between the principal balance of the Second Lien Notes and the $1,997.4 million carrying value of the notes exchanged.
The Second Lien Notes bore cash interest at a rate of 10% or 12% PIK per annum payable semi-annually in arrears on June 15 and December 15. For the first two interest periods Holdings elected to pay in PIK interest. For all interest periods after the first three interest periods, interest was payable solely in cash at a rate of 10% per annum.
On July 28, 2025, the Company redeemed the remaining outstanding $131.2 million principal in full.
Senior Subordinated Notes due 2027
On March\u00a017, 2017, Holdings issued $475.0\u00a0million aggregate principal amount of its Senior Subordinated Notes due 2027. The Company recorded deferred financing costs of approximately $19.8\u00a0million related to the issuance of the Senior Subordinated Notes due 2027. The Senior Subordinated Notes due 2027 mature on May\u00a015, 2027. Holdings pays interest on the Senior Subordinated Notes due 2027 at 6.125% per annum, semi-annually in arrears on May\u00a015\u00a0and November\u00a015. Holdings may redeem some or all of the Senior Subordinated Notes due 2027 at any time on or after May 15, 2025 at 100.0% plus accrued and unpaid interest, if any.
On March\u00a017, 2017, in connection with the issuance of the Senior Subordinated Notes due 2027, Holdings entered into a registration rights agreement. Subject to the terms of the registration rights agreement, Holdings filed a registration statement with the SEC on April 19, 2017 pursuant to the Securities Act relating to an offer to exchange the original Senior Subordinated Notes due 2027 for exchange Senior Subordinated Notes due 2027; the registration statement was declared effective on June 7, 2017, and Holdings commenced the exchange offer. The exchange notes have terms substantially identical to the original notes except that the exchange notes do not contain terms with respect to transfer restrictions and registration rights and additional interest payable for the failure to consummate the exchange offer. All of the original notes were exchanged as of July\u00a012, 2017.
On July 31, 2020, as part of the exchange for the Second Lien Notes, the Company reduced the aggregate principal amount of the Senior Subordinated Notes due 2027 by approximately $344.3 million, or 72.48% of the then outstanding Senior Subordinated Notes due 2027.
Senior Subordinated Notes due 2026
On November\u00a08, 2016, Holdings issued $595.0 million aggregate principal amount of its Senior Subordinated Notes due 2026 in a private offering. Holdings paid interest on the Senior Subordinated Notes due 2026 at 5.875% per annum, semi-annually in arrears on May\u00a015\u00a0and November\u00a015.
On July 31, 2020, as part of the exchange for the Second Lien Notes, the Company reduced the aggregate principal amount of the Senior Subordinated Notes due 2026 by approximately $539.4 million, or 90.65% of the then outstanding Senior Subordinated Notes due 2026.
On August 6, 2025, the Company redeemed the remaining outstanding $41.9 million principal in full.
Senior Subordinated Notes due 2025
On June\u00a05, 2015, Holdings issued $600.0 million aggregate principal amount of its 5.75% Senior Subordinated Notes due 2025 (the \u201cSenior Subordinated Notes due 2025\u201d) in a private offering. Holdings paid interest on the Senior Subordinated Notes due 2025 at 5.75% per annum, semi-annually in arrears on June\u00a015 and December\u00a015.
On July 31, 2020, as part of the exchange for the Second Lien Notes, the Company reduced the aggregate principal amount of the Senior Subordinated Notes due 2025 by approximately $501.7 million, or 83.61% of the then outstanding Senior Subordinated Notes due 2025.
On June 15, 2025, the maturity date, the Company redeemed the remaining outstanding $42.8 million principal in full.
Sterling Notes due 2024
On November\u00a08, 2016, Holdings issued \u00a3250.0 million aggregate principal amount of its Sterling Notes due 2024 in a private offering. Holdings paid interest on the Sterling Notes due 2024 at 6.375% per annum, semi-annually in arrears on May\u00a015\u00a0and November\u00a015.
On March\u00a017, 2017, Holdings issued \u00a3250.0\u00a0million additional aggregate principal amount of its Sterling Notes due 2024 at 106% plus accrued interest from November\u00a08, 2016 in a private offering. These additional Sterling Notes due 2024 were offered as additional notes under an indenture pursuant to which Holdings had previously issued its Sterling Notes due 2024.
On July 31, 2020, as part of the exchange for the Second Lien Notes, the Company reduced the aggregate principal amount of Sterling Notes due 2024 by approximately $632.1 million (\u00a3496.0 million par value), or 99.2% of the then outstanding Sterling Notes due 2024.
On November 15, 2024, the maturity date, Holdings repaid the remaining \u00a34.0 million ($5.0 million) principal in full.
Covenant Compliance
As of December 31, 2025, the Company believes that it was in full compliance with all agreements, including related covenants, governing its outstanding debt.
"}]},{"name":"rpt:f-1068","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfDebtInstrumentsTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December 31, 2024 | ||
Secured Debt: | ||||||
Credit Agreement-Term Loans due 2029 (10.731% as of December 31, 2025 and 11.356% as of December 31, 2024) | $ | 1,994.2 | $ | 2,014.2 | ||
12.75% Odeon Senior Secured Notes due 2027 | 400.0 | 400.0 | ||||
Senior Secured Exchangeable Notes due 2030 (1.5% cash interest) | 155.8 | \u2014 | ||||
Senior Secured Notes due 2029 (9.0% cash interest & 6.0% PIK interest as of December 31, 2025) | 877.1 | \u2014 | ||||
6.00%/8.00% Cash/PIK Toggle Senior Secured Exchangeable Notes due 2030 | 111.6 | 427.6 | ||||
7.5% First Lien Notes due 2029 | 360.0 | 950.0 | ||||
Unsecured/Retired Debt: | ||||||
10%/12% Cash/PIK Toggle Second Lien Subordinated Notes due 2026 | \u2014 | 131.2 | ||||
5.75% Senior Subordinated Notes due 2025 | \u2014 | 44.1 | ||||
5.875% Senior Subordinated Notes due 2026 | \u2014 | 41.9 | ||||
6.125% Senior Subordinated Notes due 2027 | 125.5 | 125.5 | ||||
Total principal amount of corporate borrowings | $ | 4,024.2 | $ | 4,134.5 | ||
Finance lease liabilities | \u00a0 | 52.5 | \u00a0 | 49.3 | ||
Accrued paid-in-kind interest | 2.7 | 1.5 | ||||
Deferred financing costs | (64.4) | (47.2) | ||||
Net discount (1) | (68.5) | (171.3) | ||||
Bifurcated embedded derivative \u2013 Senior Secured Exchangeable Notes due 2030 | 131.9 | \u2014 | ||||
Bifurcated embedded derivative \u2013 6.00%/8.00% Cash/PIK Toggle Senior Secured Exchangeable Notes due 2030 | 12.6 | 157.6 | ||||
Total carrying value of corporate borrowings and finance lease liabilities | $ | 4,091.0 | $ | 4,124.4 | ||
Less: | ||||||
Current maturities of corporate borrowings | (19.9) | \u00a0 | (64.2) | |||
Current maturities of finance lease liabilities | (5.8) | (4.4) | ||||
Total noncurrent carrying value of corporate borrowings and finance lease liabilities | $ | 4,065.3 | $ | 4,055.8 |
| (1) | The following table provides the net discount amounts of corporate borrowings: |
December\u00a031, | December\u00a031, | |||||
(In millions) | 2025 | 2024 | ||||
10%/12% Cash/PIK Toggle Second Lien Subordinated Notes due 2026 | $ | \u2014 | $ | 10.9 | ||
12.75% Odeon Senior Secured Notes due 2027 | (14.6) | (20.9) | ||||
Senior Secured Notes due 2029 | 62.5 | \u2014 | ||||
Senior Secured Exchangeable Notes due 2030 | (57.4) | \u2014 | ||||
Credit Agreement-Term Loans due 2029 | (32.6) | (43.4) | ||||
6.00%/8.00% Cash/PIK/Toggle Senior Secured Exchangeable Notes due 2030 | (26.4) | (117.9) | ||||
Net discount | $ | (68.5) | $ | (171.3) |
Principal | |||
Amount of | |||
Corporate | |||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Borrowings | |
2026 | $ | 19.9 | |
2027 | \u00a0 | 545.2 | |
2028 | \u00a0 | 19.5 | |
2029 | \u00a0 | 3,172.2 | |
2030 | \u00a0 | 267.4 | |
Total | $ | 4,024.2 |
Aggregate Principal | Reacquisition | (Gain)/Loss on | Accrued Interest | |||||||||
(In millions) | Repurchased | Cost | Extinguishment | Paid | ||||||||
5.75% Senior Subordinated Notes due 2025 | $ | 1.3 | $ | 1.3 | $ | \u2014 | $ | \u2014 |
Shares of | |||||||||||||||
Aggregate Principal | Common Stock | Reacquisition | (Gain)/Loss on | Accrued Interest | |||||||||||
(In millions, except for share data) | Repurchased/Exchanged | Exchanged | Cost | Extinguishment | Paid/Exchanged | ||||||||||
Cash debt repurchase transactions: | |||||||||||||||
5.75% Senior Subordinated Notes due 2025 | $ | 8.9 | \u2014 | $ | 8.6 | $ | (0.3) | $ | 0.1 | ||||||
Second Lien Notes due 2026 | 50.0 | \u2014 | 50.5 | (4.4) | 1.4 | ||||||||||
Total cash debt repurchase transactions | 58.9 | \u2014 | 59.1 | (4.7) | 1.5 | ||||||||||
Debt for equity exchange transactions: | |||||||||||||||
5.75% Senior Subordinated Notes due 2025 | 36.7 | 9,017,297 | 39.8 | 3.2 | 0.8 | ||||||||||
Second Lien Notes due 2026 | 224.1 | 35,062,835 | 157.2 | (93.1) | 8.3 | ||||||||||
Total debt for equity exchange transactions | 260.8 | 44,080,132 | 197.0 | (89.9) | 9.1 | ||||||||||
Cash and debt for equity exchange transactions: | |||||||||||||||
5.75% Senior Subordinated Notes due 2025 | 8.6 | 447,829 | 8.4 | (0.2) | 0.1 | ||||||||||
5.875% Senior Subordinated Notes due 2026 | 9.6 | 432,777 | 8.1 | (1.3) | 0.2 | ||||||||||
Second Lien Notes due 2026 | 45.0 | 2,693,717 | 45.5 | (4.0) | 1.2 | ||||||||||
Total cash and debt for equity exchange transactions | 63.2 | 3,574,323 | 62.0 | (5.5) | 1.5 | ||||||||||
Total debt repurchases and exchanges | $ | 382.9 | 47,654,455 | $ | 318.1 | $ | (100.1) | $ | 12.1 |
Shares of | |||||||||||||||
Aggregate Principal | Common Stock | Reacquisition | (Gain) on | Accrued Interest | |||||||||||
(In millions, except for share data) | Repurchased/Exchanged | Exchanged | Cost | Extinguishment | Paid/Exchanged | ||||||||||
Cash debt repurchase transactions: | |||||||||||||||
Related party transactions: | |||||||||||||||
Second Lien Notes due 2026 | $ | 75.9 | \u2014 | $ | 48.5 | $ | (40.9) | $ | 1.1 | ||||||
5.875% Senior Subordinated Notes due 2026 | 4.1 | \u2014 | 1.7 | (2.3) | 0.1 | ||||||||||
Total related party transactions | 80.0 | \u2014 | 50.2 | (43.2) | 1.2 | ||||||||||
Non-related party transactions: | |||||||||||||||
Second Lien Notes due 2026 | 139.7 | \u2014 | 91.4 | (71.3) | 4.5 | ||||||||||
Total non-related party transactions | 139.7 | \u2014 | 91.4 | (71.3) | 4.5 | ||||||||||
Total cash debt repurchase transactions | $ | 219.7 | \u2014 | $ | 141.6 | $ | (114.5) | $ | 5.7 | ||||||
Debt for equity exchange transactions: | |||||||||||||||
Second Lien Notes due 2026 | 105.3 | 14,186,651 | 91.7 | (28.3) | 1.2 | ||||||||||
Total debt repurchases and exchanges | $ | 325.0 | 14,186,651 | $ | 233.3 | $ | (142.8) | $ | 6.9 |
Carrying Value | Carrying Value | |||||||||||
as of | (Increase) Decrease to | Debt | as of | |||||||||
(In millions) | December 31, 2024 | Net Earnings (Loss) | Extinguishment (1) | December\u00a031, 2025 | ||||||||
Principal balance | $ | 427.6 | $ | 21.4 | $ | (337.4) | $ | 111.6 | ||||
Discount | (117.9) | 5.0 | 86.5 | (26.4) | ||||||||
Debt issuance costs | (23.3) | 1.0 | 17.1 | (5.2) | ||||||||
Accrued paid-in-kind interest | 1.5 | 0.1 | (1.2) | 0.4 | ||||||||
Bifurcated embedded derivative | 157.6 | (56.7) | (88.3) | 12.6 | ||||||||
Carrying value | $ | 445.5 | $ | (29.2) | $ | (323.3) | $ | 93.0 |
| (1) | For more information on the loss on extinguishment see the 2025 Refinancing Transactions section below. |
Carrying Value | Principal Cancellation | Additional | Carrying Value | ||||||||||||
as of | (Increase) Decrease to | & Interest Adjustment | Deferred | as of | |||||||||||
(In millions) | July 1, 2025 | Net Earnings (Loss) | Features | Charges | December\u00a031, 2025 | ||||||||||
Principal balance | $ | 194.4 | $ | 1.3 | $ | (39.9) | $ | \u2014 | $ | 155.8 | |||||
Discount | (35.4) | 2.7 | (24.7) | \u2014 | (57.4) | ||||||||||
Debt issuance costs | (6.4) | 0.5 | \u2014 | (8.9) | (14.8) | ||||||||||
Bifurcated embedded derivative | 41.7 | 19.3 | 64.6 | 6.3 | 131.9 | ||||||||||
Carrying value | $ | 194.3 | $ | 23.8 | $ | \u2014 | $ | (2.6) | $ | 215.5 |
(In\u00a0millions) | Amount | ||
Fair value of New Exchangeable Notes | $ | 159.0 | |
Fair value of bifurcated embedded derivatives New Exchangeable Notes | 41.7 | ||
Fair value of Common Stock issued | 225.0 | ||
Total consideration | 425.7 | ||
Principal Existing Exchangeable Notes | 337.4 | ||
Discount Existing Exchangeable Notes | (86.5) | ||
Debt issuance costs Existing Exchangeable Notes | (17.1) | ||
Gain on cash paid for PIK interest | 0.3 | ||
Bifurcated embedded derivatives Existing Exchangeable Notes | 88.3 | ||
Carrying value Existing Exchangeable Notes | 322.4 | ||
Loss on extinguishment of Existing Exchangeable Notes | $ | 103.3 |
The exchanges of the Existing 7.5% Notes for New 2029 Notes were accounted for as extinguishments and resulted in a loss on extinguishment as follows:
(In\u00a0millions) | Amount | ||
Fair value of New 2029 Notes (1) | $ | 925.4 | |
Gross proceeds | (244.4) | ||
Cash fee paid to Existing 7.5% Notes lenders | 2.4 | ||
Total consideration | 683.4 | ||
Principal Existing 7.5% Notes | 590.0 | ||
Debt issuance costs Existing 7.5% Notes | (5.6) | ||
Carrying value Existing 7.5% Notes | 584.4 | ||
Loss on extinguishment of Existing 7.5% Notes | $ | 99.0 |
| (1) | Fair value of the New 2029 Notes was estimated on July 24, 2025 using observed prices for transactions of the New 2029 Notes shortly after issuance. The market for the New 2029 Notes is considered an inactive market and the observed prices are considered a Level 2 input in the fair value hierarchy. |
The debt repurchases and exchanges for the Second Lien Notes were accounted for as extinguishments and resulted in a loss on extinguishment as follows:
(In\u00a0millions) | Amount | ||
Fair value of Exchangeable Notes due 2030 | $ | 293.6 | |
Fair value of Conversion Option | 233.4 | ||
Fair value of New Term Loans due 2029 | 104.2 | ||
PIK fee paid to Second Lien Lenders | 2.3 | ||
Cash fee paid to Second Lien Lenders | 2.3 | ||
Second Lien Notes consideration | 635.8 | ||
Principal Second Lien Notes | 518.6 | ||
Premium Second Lien Notes | 56.0 | ||
Carrying value Second Lien Notes | 574.6 | ||
Loss on extinguishment of Second Lien Notes | $ | 61.2 |
NOTE 8\u2014STOCKHOLDERS\u2019 DEFICIT
Share Rights and Privileges
Common Stock
Holders of the Company\u2019s Common Stock are entitled to one vote per each share. Holders of Common Stock share ratably (based on the number of shares of Common Stock held) in any dividend declared by its board of directors, subject to any preferential rights of any outstanding preferred stock. The Common Stock is not convertible into any other shares of the Company\u2019s capital stock.
At the 2025 Annual Meeting of Stockholders held on December 10, 2025, the Company\u2019s stockholders approved an amendment to the Company\u2019s certificate of incorporation to increase the total number of authorized shares of the Company\u2019s Common Stock from 550,000,000 to 1,100,000,000 shares of Common Stock.
AMC Preferred Equity Units
Each AMC Preferred Equity Unit was a depositary share and represented an interest in a share of Series A Convertible Participating Preferred Stock evidenced by a depositary receipt pursuant to a deposit agreement. Each AMC Preferred Equity Unit was designed to have the same economic and voting rights as a share of Common Stock.
Preferred Stock
The Company has 50,000,000 authorized shares of preferred stock, none of which are issued or as of December 31, 2025 and December 31, 2024, respectively.
Shareholder Litigation
Two putative stockholder class actions were filed in the Delaware Chancery Court that assert a breach of fiduciary duty against certain of the Company\u2019s directors and a claim for breach of 8 Del. C. \u00a7 242 against those directors and the Company, arising out of the Company\u2019s creation of AMC Preferred Equity Units, the transactions between the Company and Antara Capital LP (\u201cAntara\u201d) that the Company announced on December 22, 2022 (the \u201cAntara Transactions\u201d), and the Charter Amendments.
This litigation prevented the Company from immediately implementing the Charter Amendments. On April 2, 2023, the parties entered into a binding settlement term sheet to settle the litigation and allow implementation of the Charter Amendments. Pursuant to the settlement term sheet, record holders of Common Stock at the close of business on August 24, 2023, after giving effect to the Reverse Stock Split, but prior to the conversion of AMC Preferred Equity Units into Common Stock (\u201cSettlement Payment Recipients\u201d), received a payment of share of Common Stock for every 7.5 shares of Common Stock owned by such Settlement Payment Recipients. On August 28, 2023, the Company made the settlement payment and issued 6,897,018 shares of Common Stock.
Charter Amendments and AMC Preferred Equity Unit Conversion
On August 14, 2023, the Company filed the third amendment to its certificate of incorporation to effectuate the Charter Amendments as of August 24, 2023. The Charter Amendments permitted the conversion of all of the Company\u2019s outstanding AMC Preferred Equity Units into shares of Common Stock (the \u201cConversion\u201d). On August 25, 2023, 99,540,642 shares of Common Stock were issued as part of the Conversion, the AMC Preferred Equity Units ceased trading and were subsequently delisted from the NYSE, and the Company filed a Certificate of Elimination of Series A Convertible Participating Preferred Stock with the Secretary of State of Delaware that eliminated the Series A Convertible Participating Preferred Stock from the Company\u2019s certificate of incorporation.
Reverse Stock Split
On August 24, 2023, the Company effectuated a reverse stock split at a ratio of share of Common Stock for every ten shares of Common Stock. As a result of the reverse stock split, each share of Series A Convertible Participating Preferred Stock became convertible into ten shares of Common Stock, and by extension each AMC Preferred Equity Unit became equivalent to -tenth (1/10th) of a share of Common Stock. The reverse stock split did not impact the
number of AMC Preferred Equity Units outstanding. The Company concluded that this change in conversion ratio is analogous to a reverse stock split of the AMC Preferred Equity Units even though the reverse stock split did not have an effect on the number of AMC Preferred Equity Units outstanding.
Accordingly, all references made to share, per share, unit, per unit, or common share amounts in the accompanying consolidated financial statements and applicable disclosures have been retroactively adjusted to reflect the effect of the subsequent reverse stock split. References made to AMC Preferred Equity Units have been retroactively adjusted to reflect the effect of the reverse stock split on their equivalent Common Stock shares.
Share Issuances
On December 6, 2024, the Company entered into a sales and registration agreement (the \u201c2024 Sales and Registration Agreement\u201d) with Goldman Sachs & Co. LLC (the \u201cSales Agent\u201d) relating to an aggregate of up to 50,000,000 shares of Common Stock of the Company.
In accordance with the terms of the 2024 Sales and Registration Agreement, the Company issued and sold shares of Common Stock covered by the prospectus supplement from time to time through the Sales Agent. The Sales Agent either acted as agent on the Company\u2019s behalf or purchased shares of Common Stock from the Company as principal for its own account.
In December 2024, the Company entered into forward sales to sell 30,000,000 shares of Common Stock in the aggregate. The Company evaluated the forwards under ASC 815\u2014Derivatives and Hedging and concluded that the transactions consist of a subscription receivable accounted for under ASC 505-10-45-2 reflecting the Company\u2019s right to receive prepayments and to deliver shares to the forward counterparty. Accordingly, pursuant to Regulation S-X 5-02.29, the Company recorded the prepayment as an increase to additional paid-in capital with an equal and offsetting subscription receivable as a decrease to additional paid-in capital. The subscription receivable was considered a debt-like host and the Company\u2019s right to receive additional cash consideration up to a cap price based on the movement of the share price during a valuation period is an embedded feature that meets the definition of a derivative that meets the equity classification scope exception in ASC 815-40 and is not accounted for outside of equity.
In January 2025, the Company was paid $108.7 million for prepayments in respect of the forwards. The Company reduced the subscription receivable which resulted in an increase in total additional paid-in capital. The valuation period ended on March 17, 2025 with no additional consideration owed to the Company.
During the years ended December 31, 2025, December 31, 2024, and December 31, 2023, the Company entered into various equity distribution agreements with sales agents to sell shares of the Company\u2019s Common Stock and AMC Preferred Equity Units, from time to time, through \u201cat-the-market\u201d offering programs. Subject to the terms and conditions of the equity distribution agreements, the sales agents used reasonable efforts consistent with their normal trading and sales practices, applicable law and regulations, and the rules of the NYSE to sell the Common Stock and AMC Preferred Equity Units from time to time based upon the Company\u2019s instructions for the sales, including any price, time or size limits specified by the Company.
The below table summarizes the activity of the various \u201cat-the-market\u201d offerings for the years ending December 31, 2025, December 31, 2024, and December 31, 2023.
Common Stock | AMC Preferred Equity Units | |||||||||
December 31, | December 31, | |||||||||
(In millions) | 2025 | 2024 | 2023 | 2025 | 2024 | 2023 | ||||
Shares or units issued | 17.1 | 75.5 | 88.0 | - | - | 7.1 | ||||
Gross proceeds | $ | 63.0 | 261.8 | 675.5 | $ | - | - | 114.5 | ||
Sales agent fees paid | $ | 0.6 | 6.4 | 16.9 | $ | - | - | 2.9 | ||
Other third-party issuance costs incurred | $ | 0.3 | 1.9 | 1.1 | $ | - | - | 8.8 | ||
Other third-party issuance costs paid | $ | 1.5 | 0.8 | 0.9 | $ | - | - | 11.7 |
The Company has used and intends to use the net proceeds from the sale of Common Stock and AMC Preferred Equity Units pursuant to the equity distribution agreements to repay, refinance, redeem or repurchase the Company\u2019s existing indebtedness (including expenses, accrued interest and premium, if any), capital expenditures and otherwise for general corporate purposes.
Antara Transactions
On February 7, 2023, the Company issued 19,762,130 AMC Preferred Equity Units to Antara in exchange for $75.1 million in cash and $100.0 million aggregate principal amount of the Company\u2019s Second Lien Notes. The Company recorded $193.7 million to stockholders\u2019 deficit as a result of the transaction. The Company paid $1.4 million of accrued interest in cash upon exchange of the notes.
Stock-Based Compensation
Equity Incentive Plans
On June 5, 2024, the Company\u2019s shareholders approved a new equity incentive plan (\u201c2024 EIP\u201d). Awards that may be granted under the 2024 EIP include options, stock appreciation rights, restricted stock awards, restricted stock units (\u201cRSUs\u201d), performance stock units (\u201cPSUs\u201d), cash awards, and other equity-based awards. The 2024 EIP will be unlimited in duration and, in the event of termination, will remain in effect as long as any shares of awards under it are outstanding and not fully vested.
The 2013 equity incentive plan, as amended (\u201c2013 EIP\u201d), provided for grants of non-qualified stock options, incentive stock options, stock appreciation rights, restricted stock awards, RSUs, PSUs, stock awards, and cash performance awards. The 2013 EIP expired on December 17, 2023 and was replaced by the 2024 EIP. Awards granted under the 2013 EIP will continue to vest over their remaining requisite service periods, the latest of which ends in January 2026.
In 2023, AMC\u2019s Board approved equitable adjustments to all outstanding awards under the 2013 EIP subsequent to the effectiveness of the Charter Amendments. The outstanding awards were proportionally adjusted consistent with the ratio used for the Reverse Stock Split and all awards previously convertible into AMC Preferred Equity Units are now convertible into Common Stock.
The following table presents the stock-based compensation expense recorded within general and administrative: other:
Year Ended | |||||||||
December\u00a031, | December\u00a031, | December\u00a031, | |||||||
(In millions) | 2025 | 2024 | 2023 | ||||||
Special awards expense | $ | 1.0 | $ | 2.1 | $ | 20.2 | |||
Board of director stock award expense | 1.3 | 1.0 | 0.9 | ||||||
Restricted stock unit expense | 13.4 | 12.3 | 14.3 | ||||||
Performance stock unit expense | 1.2 | 6.5 | 6.7 | ||||||
Total equity classified awards: | 16.9 | 21.9 | 42.1 | ||||||
Liability classified awards: | |||||||||
Restricted and performance stock unit expense | \u2014 | 0.1 | 0.4 | ||||||
Total liability classified awards: | \u2014 | 0.1 | 0.4 | ||||||
Total stock-based compensation expense | $ | 16.9 | $ | 22.0 | $ | 42.5 |
As of December 31, 2025, the estimated remaining unrecognized compensation cost related to stock-based compensation arrangements was approximately $8.1 million. The weighted average period over which this remaining compensation expense will be recognized is approximately 1.3 years. The Company accounts for forfeitures when they occur.
Awards Granted
The Compensation Committee granted awards of stock, RSUs, and PSUs to certain of the Company\u2019s employees and directors under the Company\u2019s equity incentive plans. Each RSU or PSU is convertible into one share of Common Stock upon vesting.
Each RSU and PSU held by a participant as of a dividend record date is entitled to a dividend equivalent equal to the amount paid in respect to one share of Common Stock underlying the unit. Any such accrued dividend equivalents
are paid to the holder only upon vesting of the units. The grant date fair value of the awards are based on the closing share price of the Company\u2019s Common Stock on such grant date.
The awards granted under the Company\u2019s equity incentive plans generally had the following features:
| \u25cf | Board of Directors Stock Awards: The Company granted fully vested shares of Common Stock and AMC Preferred Equity Units to the independent members of its Board of Directors during the years ended December 31, 2025, Decembers 31, 2024, and December 31, 2023 as follows: |
Year Ended | ||||||
December\u00a031, 2025 | December\u00a031, 2024 | December\u00a031, 2023 | ||||
Common Stock | 370,586 | 202,392 | 8,560 | |||
AMC Preferred Equity Units | \u2014 | \u2014 | 15,376 |
| \u25cf | Restricted Stock Unit Awards: Each vested RSU will be settled by delivery of a single share of the Company\u2019s Common Stock and therefore accounted for as equity instruments. Awards are generally settled as each individual tranche vests under the relevant agreements. The Company records stock-based compensation expense on a straight-line recognition method over the requisite vesting period. The RSUs granted during 2025, 2024, and 2023 vest over three years with 1/3 vesting in each year. These RSUs will be settled within 30 days of vesting. |
| \u25cf | Performance Stock Unit Awards: PSUs awards are granted to certain members of management and executive officers. The total PSUs divided into three separate year tranches, with each tranche allocated to a fiscal year within the performance period (\u201cTranche Year\u201d). The PSUs within each Tranche Year are further divided between three performance targets; the Adjusted EBITDA performance target, the free cash flow performance target and various strategic initiatives. The PSU awards will vest if 80% to 120% of the performance targets are attained, with the corresponding vested unit amount ranging from 50% to 200% of the PSUs awarded. The strategic initiative based 2025 PSU awards will vest if three to seven one-year strategic initiatives are achieved by the end of the 2025 Tranche Year and/or if four to ten two-year strategic initiatives are achieved by the end of the 2026 Tranche Year, with the corresponding vested unit amount ranging from 50% to 200% of the PSUs awarded. |
The Compensation Committee establishes the annual performance targets at the beginning of each year. Therefore, in accordance with ASC 718, Compensation - Stock Compensation, the grant date (and fair value measurement date) for each Tranche Year is the date at the beginning of each year when a mutual understanding of the key terms and conditions are reached.
Special Awards
On February 19, 2025, the compensation committee of AMC\u2019s Board of Directors (\u201cCompensation Committee\u201d) approved modification of the performance goals applicable to all 2024 Tranche Year PSU awards. This was accounted for as a modification to the 2024 Tranche Year PSU awards which lowered the Adjusted EBITDA performance target such that 146% vesting was achieved. This modification resulted in the immediate additional vesting of 270,093 of the 2024 Tranche Year PSUs (4,181 cash settled units and 265,912 equity settled units). This was treated as a Type 3 modification (improbable-to-probable) which required the Company to recognize additional stock compensation expense based on the modification date fair values of the incremental PSUs. During the year ended December 31, 2025, the Company recognized $1.0 million of stock compensation expense related to these awards.
On February 22, 2024, the Compensation Committee approved modification of the performance goals applicable to all 2023 Tranche Year PSU awards. This was accounted for as a modification to the 2023 Tranche Year PSU awards which lowered the Adjusted EBITDA and free cash flow performance targets such that 200% vesting was achieved for both targets. This modification resulted in the immediate additional vesting of 478,055 of the 2023 Tranche Year PSUs (21,829 cash settled units and 456,226 equity settled units). This was treated as a Type 3 modification (improbable-to-probable) which required the Company to recognize additional stock compensation expense based on the modification date fair values of the incremental PSUs. During the year ended December 31, 2024, the Company recognized $2.1 million of stock compensation expense related to these awards.
On February 23, 2023, the Compensation Committee approved special awards in lieu of vesting of the 2022 Tranche Year PSU awards. The special awards were accounted for as modification to the 2022 Tranche Year PSU awards which lowered the Adjusted EBITDA and free cash flow performance targets such that 200% vesting was achieved for both tranches. This modification resulted in the immediate additional vesting of 238,959 Common Stock 2022 PSUs and 238,959 AMC Preferred Equity Unit PSUs. This was treated as a Type 3 modification (improbable-to-probable) which requires the Company to recognize additional stock compensation expense based on the modification date fair values of the Common Stock PSUs and AMC Preferred Equity Units PSUs of $14.9 million and $5.3 million, respectively. During the year ended December 31, 2023, the Company recognized $20.2 million of stock compensation expense related to these awards.
The activity related to the Company\u2019s RSU and PSU awards for the year ended December\u00a031, 2025 consisted of the following:
RSUs | PSUs | |||||||||
Weighted | Weighted | |||||||||
Average | Average | |||||||||
Number of | Grant\u00a0Date | Number of | Grant\u00a0Date | |||||||
RSUs | Fair\u00a0Value | PSUs | Fair\u00a0Value | |||||||
Nonvested at December 31, 2024 | 2,594,497 | $ | 9.35 | 1,281,617 | $ | 5.03 | ||||
Granted (1) | 3,122,126 | 3.57 | 324,969 | 3.57 | ||||||
Granted - Special Award | \u2014 | \u2014 | 265,912 | 3.57 | ||||||
Vested | (479,247) | 13.03 | (682,193) | 5.03 | ||||||
Vested - Special Award | \u2014 | \u2014 | (140,982) | 3.57 | ||||||
Forfeited (1) | (211,485) | 7.02 | \u2014 | \u2014 | ||||||
Cancelled (2) | (452,813) | 13.36 | (599,424) | 5.03 | ||||||
Cancelled - Special Award (2) | \u2014 | \u2014 | (124,930) | 3.57 | ||||||
Nonvested at December 31, 2025 | 4,573,078 | 4.73 | 324,969 | 3.57 | ||||||
Tranche Years 2026 and 2027 awarded under the 2025 PSU award and Tranche Year 2026 awarded under the 2024 PSU award with grant date fair values to be determined in year 2026 and 2027, respectively | \u2014 | 3,000,921 | ||||||||
Total nonvested at December 31, 2025 | 4,573,078 | 3,325,890 |
| (1) | The number of PSUs granted and forfeited under the Tranche Year 2025 is based on attainment of performance targets at 0% for the Adjusted EBITDA target, 0% for the free cash flow target and 200% for the strategic initiatives. The number of PSUs granted under the Tranche Year 2026 assumes the Company will attain a performance target at 100% for strategic initiatives. |
| (2) | Represents vested RSUs and PSUs surrendered in lieu of taxes and cancelled awards returned. As a result, the Company paid taxes for restricted unit withholdings of approximately $4.4 million during the year ended December 31, 2025. |
The weighted-average grant date fair values of the RSU awards granted during the years ended December 31, 2025, December 31, 2024, and December 31, 2023 was $3.57, $5.15 and $35.04, respectively. The weighted-average grant date fair values for the PSU awards granted during the years ended December 31, 2025, December 31, 2024, and December 31, 2023 was $3.57, $5.03 and $40.40, respectively.
"}]},{"name":"rpt:f-1480","factDimensions":{"xbrl:concept":"amch:CommonStockNumberOfVotesPerCommonStockHeld","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"amch:item","us-gaap:StatementClassOfStockAxis":"amch:CommonStockAndAmcPreferredEquityUnitsMember"},"factValues":[{"value":"1"}]},{"name":"rpt:f-1481","factDimensions":{"xbrl:concept":"us-gaap:CommonStockSharesAuthorized","xbrl:period":"2025-12-10T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"550000000"}]},{"name":"rpt:f-1482","factDimensions":{"xbrl:concept":"us-gaap:CommonStockSharesAuthorized","xbrl:period":"2025-12-11T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"1100000000"}]},{"name":"rpt:f-1483","factDimensions":{"xbrl:concept":"us-gaap:PreferredStockSharesAuthorized","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"50000000"}]},{"name":"rpt:f-1484","factDimensions":{"xbrl:concept":"us-gaap:PreferredStockSharesIssued","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"0"}]},{"name":"rpt:f-1485","factDimensions":{"xbrl:concept":"us-gaap:LossContingencyNewClaimsFiledNumber","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"amch:item","srt:LitigationCaseAxis":"amch:ShareholderLitigationMember"},"factValues":[{"value":"2"}]},{"name":"rpt:f-1486","factDimensions":{"xbrl:concept":"amch:SharesIssuedDuringPeriodSettlementPayment","xbrl:period":"2023-08-28T00:00:00/2023-08-29T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"6897018"}]},{"name":"rpt:f-1487","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities","xbrl:period":"2023-08-25T00:00:00/2023-08-26T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"xbrla:shares"},"factValues":[{"value":"99540642"}]},{"name":"rpt:f-1488","factDimensions":{"xbrl:concept":"us-gaap:CommonStockSharesAuthorized","xbrl:period":"2024-12-07T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"xbrla:shares","us-gaap:SubsidiarySaleOfStockAxis":"amch:SalesAndRegistrationAgreementMember"},"factValues":[{"value":"50000000"}]},{"name":"rpt:f-1489","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesNewIssues","xbrl:period":"2024-12-06T00:00:00/2024-12-07T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"xbrla:shares","us-gaap:SubsidiarySaleOfStockAxis":"amch:ForwardPurchaseAgreementMember"},"factValues":[{"value":"30000000"}]},{"name":"rpt:f-1490","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodValueNewIssues","xbrl:period":"2025-01-01T00:00:00/2025-02-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AdditionalPaidInCapitalMember","us-gaap:SubsidiarySaleOfStockAxis":"amch:ForwardPurchaseAgreementMember"},"factValues":[{"value":"108700000","decimals":-5}]},{"name":"rpt:f-1491","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfStockholdersEquityTableTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Common Stock | AMC Preferred Equity Units | |||||||||
December 31, | December 31, | |||||||||
(In millions) | 2025 | 2024 | 2023 | 2025 | 2024 | 2023 | ||||
Shares or units issued | 17.1 | 75.5 | 88.0 | - | - | 7.1 | ||||
Gross proceeds | $ | 63.0 | 261.8 | 675.5 | $ | - | - | 114.5 | ||
Sales agent fees paid | $ | 0.6 | 6.4 | 16.9 | $ | - | - | 2.9 | ||
Other third-party issuance costs incurred | $ | 0.3 | 1.9 | 1.1 | $ | - | - | 8.8 | ||
Other third-party issuance costs paid | $ | 1.5 | 0.8 | 0.9 | $ | - | - | 11.7 |
Year Ended | |||||||||
December\u00a031, | December\u00a031, | December\u00a031, | |||||||
(In millions) | 2025 | 2024 | 2023 | ||||||
Special awards expense | $ | 1.0 | $ | 2.1 | $ | 20.2 | |||
Board of director stock award expense | 1.3 | 1.0 | 0.9 | ||||||
Restricted stock unit expense | 13.4 | 12.3 | 14.3 | ||||||
Performance stock unit expense | 1.2 | 6.5 | 6.7 | ||||||
Total equity classified awards: | 16.9 | 21.9 | 42.1 | ||||||
Liability classified awards: | |||||||||
Restricted and performance stock unit expense | \u2014 | 0.1 | 0.4 | ||||||
Total liability classified awards: | \u2014 | 0.1 | 0.4 | ||||||
Total stock-based compensation expense | $ | 16.9 | $ | 22.0 | $ | 42.5 |
"}]},{"name":"rpt:f-1518","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:AwardTypeAxis":"amch:SpecialAwardsMember"},"factValues":[{"value":"1000000","decimals":-5}]},{"name":"rpt:f-1519","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:AwardTypeAxis":"amch:SpecialAwardsMember"},"factValues":[{"value":"2100000","decimals":-5}]},{"name":"rpt:f-1520","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:AwardTypeAxis":"amch:SpecialAwardsMember"},"factValues":[{"value":"20200000","decimals":-5}]},{"name":"rpt:f-1521","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:GranteeStatusAxis":"srt:DirectorMember"},"factValues":[{"value":"1300000","decimals":-5}]},{"name":"rpt:f-1522","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:GranteeStatusAxis":"srt:DirectorMember"},"factValues":[{"value":"1000000","decimals":-5}]},{"name":"rpt:f-1523","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:GranteeStatusAxis":"srt:DirectorMember"},"factValues":[{"value":"900000","decimals":-5}]},{"name":"rpt:f-1524","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:AwardTypeAxis":"us-gaap:RestrictedStockUnitsRSUMember"},"factValues":[{"value":"13400000","decimals":-5}]},{"name":"rpt:f-1525","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:AwardTypeAxis":"us-gaap:RestrictedStockUnitsRSUMember"},"factValues":[{"value":"12300000","decimals":-5}]},{"name":"rpt:f-1526","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:AwardTypeAxis":"us-gaap:RestrictedStockUnitsRSUMember"},"factValues":[{"value":"14300000","decimals":-5}]},{"name":"rpt:f-1527","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:AwardTypeAxis":"amch:PerformanceStockUnitsMember"},"factValues":[{"value":"1200000","decimals":-5}]},{"name":"rpt:f-1528","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:AwardTypeAxis":"amch:PerformanceStockUnitsMember"},"factValues":[{"value":"6500000","decimals":-5}]},{"name":"rpt:f-1529","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:AwardTypeAxis":"amch:PerformanceStockUnitsMember"},"factValues":[{"value":"6700000","decimals":-5}]},{"name":"rpt:f-1530","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:AwardTypeAxis":"amch:EquityClassifiedAwardsMember"},"factValues":[{"value":"16900000","decimals":-5}]},{"name":"rpt:f-1531","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:AwardTypeAxis":"amch:EquityClassifiedAwardsMember"},"factValues":[{"value":"21900000","decimals":-5}]},{"name":"rpt:f-1532","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:AwardTypeAxis":"amch:EquityClassifiedAwardsMember"},"factValues":[{"value":"42100000","decimals":-5}]},{"name":"rpt:f-1533","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:AwardTypeAxis":"amch:RestrictedAndPerformanceStockUnitExpenseMember"},"factValues":[{"value":"100000","decimals":-5}]},{"name":"rpt:f-1534","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:AwardTypeAxis":"amch:RestrictedAndPerformanceStockUnitExpenseMember"},"factValues":[{"value":"400000","decimals":-5}]},{"name":"rpt:f-1535","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:AwardTypeAxis":"amch:LiabilityClassifiedAwardsMember"},"factValues":[{"value":"100000","decimals":-5}]},{"name":"rpt:f-1536","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:AwardTypeAxis":"amch:LiabilityClassifiedAwardsMember"},"factValues":[{"value":"400000","decimals":-5}]},{"name":"rpt:f-1537","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"16900000","decimals":-5}]},{"name":"rpt:f-1538","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"22000000","decimals":-5}]},{"name":"rpt:f-1539","factDimensions":{"xbrl:concept":"us-gaap:AllocatedShareBasedCompensationExpense","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"42500000","decimals":-5}]},{"name":"rpt:f-1540","factDimensions":{"xbrl:concept":"us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"8100000","decimals":-5}]},{"name":"rpt:f-1541","factDimensions":{"xbrl:concept":"us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"P1Y3M18D"}]},{"name":"rpt:f-1542","factDimensions":{"xbrl:concept":"amch:ConversionRatioForShareBasedPaymentAwardsIntoCommonStock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"1"}]},{"name":"rpt:f-1543","factDimensions":{"xbrl:concept":"amch:ConversionRatioForShareBasedPaymentAwardsIntoCommonStock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"1"}]},{"name":"rpt:f-1544","factDimensions":{"xbrl:concept":"amch:ScheduleOfStockAwardGrantedTableTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"
Year Ended | ||||||
December\u00a031, 2025 | December\u00a031, 2024 | December\u00a031, 2023 | ||||
Common Stock | 370,586 | 202,392 | 8,560 | |||
AMC Preferred Equity Units | \u2014 | \u2014 | 15,376 |
RSUs | PSUs | |||||||||
Weighted | Weighted | |||||||||
Average | Average | |||||||||
Number of | Grant\u00a0Date | Number of | Grant\u00a0Date | |||||||
RSUs | Fair\u00a0Value | PSUs | Fair\u00a0Value | |||||||
Nonvested at December 31, 2024 | 2,594,497 | $ | 9.35 | 1,281,617 | $ | 5.03 | ||||
Granted (1) | 3,122,126 | 3.57 | 324,969 | 3.57 | ||||||
Granted - Special Award | \u2014 | \u2014 | 265,912 | 3.57 | ||||||
Vested | (479,247) | 13.03 | (682,193) | 5.03 | ||||||
Vested - Special Award | \u2014 | \u2014 | (140,982) | 3.57 | ||||||
Forfeited (1) | (211,485) | 7.02 | \u2014 | \u2014 | ||||||
Cancelled (2) | (452,813) | 13.36 | (599,424) | 5.03 | ||||||
Cancelled - Special Award (2) | \u2014 | \u2014 | (124,930) | 3.57 | ||||||
Nonvested at December 31, 2025 | 4,573,078 | 4.73 | 324,969 | 3.57 | ||||||
Tranche Years 2026 and 2027 awarded under the 2025 PSU award and Tranche Year 2026 awarded under the 2024 PSU award with grant date fair values to be determined in year 2026 and 2027, respectively | \u2014 | 3,000,921 | ||||||||
Total nonvested at December 31, 2025 | 4,573,078 | 3,325,890 |
| (1) | The number of PSUs granted and forfeited under the Tranche Year 2025 is based on attainment of performance targets at 0% for the Adjusted EBITDA target, 0% for the free cash flow target and 200% for the strategic initiatives. The number of PSUs granted under the Tranche Year 2026 assumes the Company will attain a performance target at 100% for strategic initiatives. |
| (2) | Represents vested RSUs and PSUs surrendered in lieu of taxes and cancelled awards returned. As a result, the Company paid taxes for restricted unit withholdings of approximately $4.4 million during the year ended December 31, 2025. |
NOTE 9\u2014INCOME TAXES
Current income tax expense represents the amounts expected to be reported on the Company\u2019s income tax returns, and deferred tax expense or benefit represents the change in net deferred tax assets and liabilities. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and
liabilities as measured by the enacted tax rates that will be in effect when these differences reverse. Valuation allowances are recorded as appropriate to reduce deferred tax assets to the amount considered likely to be realized.
The Company evaluates its deferred tax assets each period to determine if a valuation allowance is required based on whether it is \u201cmore likely than not\u201d that some portion of the deferred tax assets would not be realized. The ultimate realization of these deferred tax assets is dependent upon the generation of sufficient taxable income during future periods on a federal, state and foreign jurisdiction basis. The Company conducts its evaluation by considering all available positive and negative evidence, including historical operating results, forecasts of future profitability, the duration of statutory carryforward periods, and the outlooks for the motion picture industry and broader economy, among others. A significant piece of objective negative evidence evaluated was the cumulative losses incurred over the three-year period ended December 31, 2025 for each taxing jurisdiction. Such objective evidence limits the ability to consider other subjective evidence, such as the Company\u2019s projections of future taxable income.
The Company maintains a valuation allowance against U.S. deferred tax assets as well as international jurisdictions in which it operates, with the exception of Finland.
The income tax provision reflected in the consolidated statements of operations consists of the following components:
Year\u00a0Ended | |||||||||
(In\u00a0millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2023 | |||
Current: | |||||||||
Federal | $ | \u2014 | $ | \u2014 | $ | \u2014 | |||
Foreign | \u00a0 | 1.4 | \u00a0 | 2.4 | \u00a0 | 1.9 | |||
State | \u00a0 | 1.3 | \u00a0 | (1.8) | \u00a0 | 0.8 | |||
Total current | \u00a0 | 2.7 | \u00a0 | 0.6 | \u00a0 | 2.7 | |||
Deferred: | |||||||||
Federal | \u00a0 | 0.4 | \u00a0 | 0.5 | \u00a0 | 0.4 | |||
Foreign | \u00a0 | 0.4 | \u00a0 | (0.3) | \u00a0 | (0.2) | |||
State | \u00a0 | 1.0 | \u00a0 | 1.3 | \u00a0 | 0.5 | |||
Total deferred | \u00a0 | 1.8 | \u00a0 | 1.5 | \u00a0 | 0.7 | |||
Total provision | $ | 4.5 | $ | 2.1 | $ | 3.4 |
Pre-tax losses consisted of the following:
Year\u00a0Ended | |||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2023 | |||
Domestic | $ | (445.9) | $ | (192.4) | $ | (216.7) | |||
Foreign | \u00a0 | (182.0) | \u00a0 | (158.1) | \u00a0 | (176.5) | |||
Total | $ | (627.9) | $ | (350.5) | $ | (393.2) |
The difference between the effective tax rate on net loss from continuing operations before income taxes and the U.S. federal income tax statutory rate is as follows:
Year Ended | |||||||||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2023 | |||||||||
Income tax expense (benefit) at the federal statutory rate | $ | (131.9) | 21.0 | % | $ | (73.6) | 21.0 | % | $ | (82.5) | 21.0 | % | |||
State and Local Income Taxes (1) | (21.1) | 3.4 | % | (5.8) | 1.7 | % | (16.8) | 4.3 | % | ||||||
State Valuation allowance adjustments | 23.4 | (3.7) | % | 5.0 | (1.4) | % | 18.1 | (4.6) | % | ||||||
Foreign Tax Effects | |||||||||||||||
United Kingdom | |||||||||||||||
Statutory Tax Rate Difference between the UK and the United States | (5.4) | 0.9 | % | (5.0) | 1.4 | % | (3.7) | 0.9 | % | ||||||
Valuation allowance adjustments | 33.5 | (5.3) | % | 29.6 | (8.4) | % | 35.2 | (9.0) | % | ||||||
Other | 5.4 | (0.9) | % | 2.1 | (0.6) | % | \u2014 | \u2014 | % | ||||||
Italy | |||||||||||||||
Valuation allowance adjustments | 1.4 | (0.2) | % | 6.0 | (1.7) | % | 12.1 | (3.1) | % | ||||||
Return-to-provision | (0.2) | 0.0 | % | (3.9) | 1.1 | % | (7.0) | 1.8 | % | ||||||
Other | (0.3) | 0.0 | % | (2.4) | 0.7 | % | (3.1) | 0.8 | % | ||||||
Germany | |||||||||||||||
Nondeductible items | 3.3 | (0.5) | % | 0.9 | (0.3) | % | 0.9 | (0.2) | % | ||||||
Valuation allowance adjustments | (5.5) | 0.9 | % | 0.2 | (0.1) | % | (1.4) | 0.4 | % | ||||||
Other | 1.4 | (0.2) | % | 1.5 | (0.4) | % | (2.5) | 0.6 | % | ||||||
Other Foreign Jurisdictions | 6.4 | (1.0) | % | 6.4 | (1.8) | % | 8.2 | (2.1) | % | ||||||
Enactment of New Tax Laws | |||||||||||||||
Change in Tax Rate | \u2014 | \u2014 | % | \u2014 | \u2014 | % | \u2014 | \u2014 | % | ||||||
Enactment of Cross-Border Tax Laws | \u00a0 | \u00a0 | \u00a0 | ||||||||||||
Global Intangible low-taxed income (GILTI) | \u00a0 | \u2014 | \u2014 | % | \u00a0 | \u2014 | \u2014 | % | \u00a0 | \u2014 | \u2014 | % | |||
Tax Credits | \u00a0 | (1.4) | 0.2 | % | \u00a0 | (1.5) | 0.4 | % | \u00a0 | (1.3) | 0.3 | % | |||
Change in Valuation Allowances | 78.9 | (12.6) | % | 37.1 | (10.6) | % | 51.7 | (13.2) | % | ||||||
Nontaxable or nondeductible items | |||||||||||||||
Nondeductible compensation | \u00a0 | 4.3 | (0.7) | % | \u00a0 | 9.5 | (2.7) | % | 3.9 | (1.0) | % | ||||
Litigation | \u2014 | \u2014 | % | (8.4) | 2.4 | % | 20.8 | (5.3) | % | ||||||
Disqualified debt interest | 7.5 | (1.2) | % | 3.8 | (1.1) | % | (38.4) | 9.8 | % | ||||||
Other | 0.5 | (0.1) | % | 0.6 | (0.2) | % | \u00a0 | (2.7) | 0.7 | % | |||||
Changes in unrecognized tax benefits | \u00a0 | \u2014 | \u2014 | % | \u00a0 | \u2014 | \u2014 | % | \u00a0 | (0.2) | 0.1 | % | |||
Other Adjustments | 4.3 | (0.7) | % | \u2014 | \u2014 | % | 12.1 | (3.1) | % | ||||||
Income tax expense/Effective income tax rate | $ | 4.5 | (0.7) | % | $ | 2.1 | (0.6) | % | $ | 3.4 | (0.9) | % |
| (1) | California, Illinois and New York made up the majority in 2024 and 2023. |
The significant components of deferred income tax assets and liabilities as of December\u00a031, 2025 and December\u00a031, 2024 are as follows:
December\u00a031, 2025 | December\u00a031, 2024 | |||||||||||
Deferred Income Tax | Deferred Income Tax | |||||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Assets | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Liabilities | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Assets | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Liabilities | ||||
Tangible assets | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | $ | \u2014 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | $ | (55.9) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | $ | \u2014 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | $ | (60.8) |
Right-of-use assets | \u2014 | (802.2) | \u2014 | (831.5) | ||||||||
Accrued liabilities | \u00a0 | 13.7 | \u00a0 | \u2014 | \u00a0 | 11.2 | \u00a0 | \u2014 | ||||
Intangible assets | \u00a0 | \u2014 | \u00a0 | (135.5) | \u00a0 | \u2014 | \u00a0 | (128.0) | ||||
Receivables | \u00a0 | \u2014 | \u00a0 | (2.2) | \u00a0 | 12.1 | \u00a0 | \u2014 | ||||
Investments | \u00a0 | 2.5 | \u00a0 | \u2014 | \u00a0 | 44.4 | \u00a0 | \u2014 | ||||
Capital loss carryforwards | \u00a0 | 2.1 | \u00a0 | \u2014 | \u00a0 | 4.6 | \u00a0 | \u2014 | ||||
Pension and deferred compensation | \u00a0 | 16.1 | \u00a0 | \u2014 | \u00a0 | 15.5 | \u00a0 | \u2014 | ||||
Corporate borrowings | \u00a0 | \u2014 | \u00a0 | (1.1) | \u00a0 | \u2014 | \u00a0 | (52.8) | ||||
Disallowed interest | 785.1 | \u2014 | 663.2 | \u2014 | ||||||||
Deferred revenue | \u00a0 | 164.9 | \u00a0 | \u2014 | \u00a0 | 163.2 | \u00a0 | \u2014 | ||||
Lease liabilities | \u00a0 | 1,041.5 | \u00a0 | \u2014 | \u00a0 | 1,077.5 | \u00a0 | \u2014 | ||||
Other credit carryovers | \u00a0 | 32.6 | \u00a0 | \u2014 | \u00a0 | 31.1 | \u00a0 | \u2014 | ||||
Net operating loss carryforwards | \u00a0 | 769.3 | \u00a0 | \u2014 | \u00a0 | 727.9 | \u00a0 | \u2014 | ||||
Total | $ | 2,827.8 | $ | (996.9) | $ | 2,750.7 | $ | (1,073.1) | ||||
Less: Valuation allowance | \u00a0 | (1,866.6) | \u00a0 | \u2014 | \u00a0 | (1,711.5) | \u00a0 | \u2014 | ||||
Net deferred income taxes | $ | 961.2 | $ | (996.9) | $ | 1,039.2 | $ | (1,073.1) |
A rollforward of the Company\u2019s valuation allowance for deferred tax assets is as follows:
Additions | Charged | |||||||||
Balance\u00a0at | Charged | (Credited) | ||||||||
Beginning\u00a0of | to | to Other | Balance at | |||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Period | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Expenses(1) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Accounts(2) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | End of\u00a0Period | ||
Calendar Year 2025 | ||||||||||
Valuation allowance-deferred income tax assets | $ | 1,711.5 | 126.1 | 29.0 | $ | 1,866.6 | ||||
Calendar Year 2024 | ||||||||||
Valuation allowance-deferred income tax assets | $ | 1,641.3 | 84.5 | (14.3) | $ | 1,711.5 | ||||
Calendar Year 2023 | ||||||||||
Valuation allowance-deferred income tax assets | $ | 1,513.0 | 122.1 | 6.2 | $ | 1,641.3 |
| (1) | Primarily relates to the Company\u2019s increase in the current year\u2019s federal, state, and international net operating losses. |
| (2) | Primarily relates to amounts resulting from the Company\u2019s changes in deferred tax assets and associated valuation allowance that are not related to income statement activity, as well as amounts charged to other comprehensive income. |
The Company has federal income tax net operating loss carryforwards of $1,780.1 million. Approximately $313.7 million will expire between 2026 and 2037 and will be limited annually due to certain change in ownership provisions of the Code. Approximately $1,466.4 million can be used indefinitely. The Company\u2019s foreign net operating losses of $1,068.4\u00a0million can be used indefinitely. The Company also has state income tax loss carryforwards of $3,042.6 million. Approximately $2,254.9 million may be used over various periods ranging from 1 to 20 years. Approximately $787.7 million can be used indefinitely.
A reconciliation of the change in the amount of unrecognized tax benefits was as follows:
Year\u00a0Ended | |||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2023 | |||
Balance at beginning of period | $ | 5.5 | $ | 5.5 | $ | 7.4 | |||
Gross decreases\u2014expiration of statute of limitations | \u2014 | \u2014 | (1.9) | ||||||
Balance at end of period | $ | 5.5 | $ | 5.5 | $ | 5.5 |
The Company, or one of its subsidiaries, files income tax returns in the U.S. federal jurisdiction, and various state and foreign jurisdictions. Generally, tax years beginning after December\u00a031, 2006 are still open to examination by various taxing authorities. Additionally, as discussed above, the Company has net operating loss (\u201cNOL\u201d) carryforwards for tax years ended December\u00a031, 2007 through December\u00a031, 2025, in the U.S. and various state jurisdictions which have carryforwards of varying lengths of time. These NOLs are subject to adjustment based on the statute of limitations applicable to the return in which they are utilized, not the year in which they are generated. Various state, local and foreign income tax returns are also under examination by taxing authorities. The Company does not believe that the outcome of any examination will have a material impact on its consolidated financial statements.
"}]},{"name":"rpt:f-1625","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Year\u00a0Ended | |||||||||
(In\u00a0millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2023 | |||
Current: | |||||||||
Federal | $ | \u2014 | $ | \u2014 | $ | \u2014 | |||
Foreign | \u00a0 | 1.4 | \u00a0 | 2.4 | \u00a0 | 1.9 | |||
State | \u00a0 | 1.3 | \u00a0 | (1.8) | \u00a0 | 0.8 | |||
Total current | \u00a0 | 2.7 | \u00a0 | 0.6 | \u00a0 | 2.7 | |||
Deferred: | |||||||||
Federal | \u00a0 | 0.4 | \u00a0 | 0.5 | \u00a0 | 0.4 | |||
Foreign | \u00a0 | 0.4 | \u00a0 | (0.3) | \u00a0 | (0.2) | |||
State | \u00a0 | 1.0 | \u00a0 | 1.3 | \u00a0 | 0.5 | |||
Total deferred | \u00a0 | 1.8 | \u00a0 | 1.5 | \u00a0 | 0.7 | |||
Total provision | $ | 4.5 | $ | 2.1 | $ | 3.4 |
"}]},{"name":"rpt:f-1626","factDimensions":{"xbrl:concept":"us-gaap:CurrentForeignTaxExpenseBenefit","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1400000","decimals":-5}]},{"name":"rpt:f-1627","factDimensions":{"xbrl:concept":"us-gaap:CurrentForeignTaxExpenseBenefit","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2400000","decimals":-5}]},{"name":"rpt:f-1628","factDimensions":{"xbrl:concept":"us-gaap:CurrentForeignTaxExpenseBenefit","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1900000","decimals":-5}]},{"name":"rpt:f-1629","factDimensions":{"xbrl:concept":"us-gaap:CurrentStateAndLocalTaxExpenseBenefit","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1300000","decimals":-5}]},{"name":"rpt:f-1630","factDimensions":{"xbrl:concept":"us-gaap:CurrentStateAndLocalTaxExpenseBenefit","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-1800000","decimals":-5}]},{"name":"rpt:f-1631","factDimensions":{"xbrl:concept":"us-gaap:CurrentStateAndLocalTaxExpenseBenefit","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"800000","decimals":-5}]},{"name":"rpt:f-1632","factDimensions":{"xbrl:concept":"us-gaap:CurrentIncomeTaxExpenseBenefit","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2700000","decimals":-5}]},{"name":"rpt:f-1633","factDimensions":{"xbrl:concept":"us-gaap:CurrentIncomeTaxExpenseBenefit","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"600000","decimals":-5}]},{"name":"rpt:f-1634","factDimensions":{"xbrl:concept":"us-gaap:CurrentIncomeTaxExpenseBenefit","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2700000","decimals":-5}]},{"name":"rpt:f-1635","factDimensions":{"xbrl:concept":"us-gaap:DeferredFederalIncomeTaxExpenseBenefit","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"400000","decimals":-5}]},{"name":"rpt:f-1636","factDimensions":{"xbrl:concept":"us-gaap:DeferredFederalIncomeTaxExpenseBenefit","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"500000","decimals":-5}]},{"name":"rpt:f-1637","factDimensions":{"xbrl:concept":"us-gaap:DeferredFederalIncomeTaxExpenseBenefit","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"400000","decimals":-5}]},{"name":"rpt:f-1638","factDimensions":{"xbrl:concept":"us-gaap:DeferredForeignIncomeTaxExpenseBenefit","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"400000","decimals":-5}]},{"name":"rpt:f-1639","factDimensions":{"xbrl:concept":"us-gaap:DeferredForeignIncomeTaxExpenseBenefit","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-300000","decimals":-5}]},{"name":"rpt:f-1640","factDimensions":{"xbrl:concept":"us-gaap:DeferredForeignIncomeTaxExpenseBenefit","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-200000","decimals":-5}]},{"name":"rpt:f-1641","factDimensions":{"xbrl:concept":"us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1000000","decimals":-5}]},{"name":"rpt:f-1642","factDimensions":{"xbrl:concept":"us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1300000","decimals":-5}]},{"name":"rpt:f-1643","factDimensions":{"xbrl:concept":"us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"500000","decimals":-5}]},{"name":"rpt:f-1644","factDimensions":{"xbrl:concept":"us-gaap:DeferredIncomeTaxExpenseBenefit","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1800000","decimals":-5}]},{"name":"rpt:f-1645","factDimensions":{"xbrl:concept":"us-gaap:DeferredIncomeTaxExpenseBenefit","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"1500000","decimals":-5}]},{"name":"rpt:f-1646","factDimensions":{"xbrl:concept":"us-gaap:DeferredIncomeTaxExpenseBenefit","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"700000","decimals":-5}]},{"name":"rpt:f-1647","factDimensions":{"xbrl:concept":"us-gaap:IncomeTaxExpenseBenefit","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"4500000","decimals":-5}]},{"name":"rpt:f-1648","factDimensions":{"xbrl:concept":"us-gaap:IncomeTaxExpenseBenefit","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"2100000","decimals":-5}]},{"name":"rpt:f-1649","factDimensions":{"xbrl:concept":"us-gaap:IncomeTaxExpenseBenefit","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"3400000","decimals":-5}]},{"name":"rpt:f-1650","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"
Year\u00a0Ended | |||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2023 | |||
Domestic | $ | (445.9) | $ | (192.4) | $ | (216.7) | |||
Foreign | \u00a0 | (182.0) | \u00a0 | (158.1) | \u00a0 | (176.5) | |||
Total | $ | (627.9) | $ | (350.5) | $ | (393.2) |
Year Ended | |||||||||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2023 | |||||||||
Income tax expense (benefit) at the federal statutory rate | $ | (131.9) | 21.0 | % | $ | (73.6) | 21.0 | % | $ | (82.5) | 21.0 | % | |||
State and Local Income Taxes (1) | (21.1) | 3.4 | % | (5.8) | 1.7 | % | (16.8) | 4.3 | % | ||||||
State Valuation allowance adjustments | 23.4 | (3.7) | % | 5.0 | (1.4) | % | 18.1 | (4.6) | % | ||||||
Foreign Tax Effects | |||||||||||||||
United Kingdom | |||||||||||||||
Statutory Tax Rate Difference between the UK and the United States | (5.4) | 0.9 | % | (5.0) | 1.4 | % | (3.7) | 0.9 | % | ||||||
Valuation allowance adjustments | 33.5 | (5.3) | % | 29.6 | (8.4) | % | 35.2 | (9.0) | % | ||||||
Other | 5.4 | (0.9) | % | 2.1 | (0.6) | % | \u2014 | \u2014 | % | ||||||
Italy | |||||||||||||||
Valuation allowance adjustments | 1.4 | (0.2) | % | 6.0 | (1.7) | % | 12.1 | (3.1) | % | ||||||
Return-to-provision | (0.2) | 0.0 | % | (3.9) | 1.1 | % | (7.0) | 1.8 | % | ||||||
Other | (0.3) | 0.0 | % | (2.4) | 0.7 | % | (3.1) | 0.8 | % | ||||||
Germany | |||||||||||||||
Nondeductible items | 3.3 | (0.5) | % | 0.9 | (0.3) | % | 0.9 | (0.2) | % | ||||||
Valuation allowance adjustments | (5.5) | 0.9 | % | 0.2 | (0.1) | % | (1.4) | 0.4 | % | ||||||
Other | 1.4 | (0.2) | % | 1.5 | (0.4) | % | (2.5) | 0.6 | % | ||||||
Other Foreign Jurisdictions | 6.4 | (1.0) | % | 6.4 | (1.8) | % | 8.2 | (2.1) | % | ||||||
Enactment of New Tax Laws | |||||||||||||||
Change in Tax Rate | \u2014 | \u2014 | % | \u2014 | \u2014 | % | \u2014 | \u2014 | % | ||||||
Enactment of Cross-Border Tax Laws | \u00a0 | \u00a0 | \u00a0 | ||||||||||||
Global Intangible low-taxed income (GILTI) | \u00a0 | \u2014 | \u2014 | % | \u00a0 | \u2014 | \u2014 | % | \u00a0 | \u2014 | \u2014 | % | |||
Tax Credits | \u00a0 | (1.4) | 0.2 | % | \u00a0 | (1.5) | 0.4 | % | \u00a0 | (1.3) | 0.3 | % | |||
Change in Valuation Allowances | 78.9 | (12.6) | % | 37.1 | (10.6) | % | 51.7 | (13.2) | % | ||||||
Nontaxable or nondeductible items | |||||||||||||||
Nondeductible compensation | \u00a0 | 4.3 | (0.7) | % | \u00a0 | 9.5 | (2.7) | % | 3.9 | (1.0) | % | ||||
Litigation | \u2014 | \u2014 | % | (8.4) | 2.4 | % | 20.8 | (5.3) | % | ||||||
Disqualified debt interest | 7.5 | (1.2) | % | 3.8 | (1.1) | % | (38.4) | 9.8 | % | ||||||
Other | 0.5 | (0.1) | % | 0.6 | (0.2) | % | \u00a0 | (2.7) | 0.7 | % | |||||
Changes in unrecognized tax benefits | \u00a0 | \u2014 | \u2014 | % | \u00a0 | \u2014 | \u2014 | % | \u00a0 | (0.2) | 0.1 | % | |||
Other Adjustments | 4.3 | (0.7) | % | \u2014 | \u2014 | % | 12.1 | (3.1) | % | ||||||
Income tax expense/Effective income tax rate | $ | 4.5 | (0.7) | % | $ | 2.1 | (0.6) | % | $ | 3.4 | (0.9) | % |
| (1) | California, Illinois and New York made up the majority in 2024 and 2023. |
December\u00a031, 2025 | December\u00a031, 2024 | |||||||||||
Deferred Income Tax | Deferred Income Tax | |||||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Assets | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Liabilities | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Assets | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Liabilities | ||||
Tangible assets | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | $ | \u2014 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | $ | (55.9) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | $ | \u2014 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | $ | (60.8) |
Right-of-use assets | \u2014 | (802.2) | \u2014 | (831.5) | ||||||||
Accrued liabilities | \u00a0 | 13.7 | \u00a0 | \u2014 | \u00a0 | 11.2 | \u00a0 | \u2014 | ||||
Intangible assets | \u00a0 | \u2014 | \u00a0 | (135.5) | \u00a0 | \u2014 | \u00a0 | (128.0) | ||||
Receivables | \u00a0 | \u2014 | \u00a0 | (2.2) | \u00a0 | 12.1 | \u00a0 | \u2014 | ||||
Investments | \u00a0 | 2.5 | \u00a0 | \u2014 | \u00a0 | 44.4 | \u00a0 | \u2014 | ||||
Capital loss carryforwards | \u00a0 | 2.1 | \u00a0 | \u2014 | \u00a0 | 4.6 | \u00a0 | \u2014 | ||||
Pension and deferred compensation | \u00a0 | 16.1 | \u00a0 | \u2014 | \u00a0 | 15.5 | \u00a0 | \u2014 | ||||
Corporate borrowings | \u00a0 | \u2014 | \u00a0 | (1.1) | \u00a0 | \u2014 | \u00a0 | (52.8) | ||||
Disallowed interest | 785.1 | \u2014 | 663.2 | \u2014 | ||||||||
Deferred revenue | \u00a0 | 164.9 | \u00a0 | \u2014 | \u00a0 | 163.2 | \u00a0 | \u2014 | ||||
Lease liabilities | \u00a0 | 1,041.5 | \u00a0 | \u2014 | \u00a0 | 1,077.5 | \u00a0 | \u2014 | ||||
Other credit carryovers | \u00a0 | 32.6 | \u00a0 | \u2014 | \u00a0 | 31.1 | \u00a0 | \u2014 | ||||
Net operating loss carryforwards | \u00a0 | 769.3 | \u00a0 | \u2014 | \u00a0 | 727.9 | \u00a0 | \u2014 | ||||
Total | $ | 2,827.8 | $ | (996.9) | $ | 2,750.7 | $ | (1,073.1) | ||||
Less: Valuation allowance | \u00a0 | (1,866.6) | \u00a0 | \u2014 | \u00a0 | (1,711.5) | \u00a0 | \u2014 | ||||
Net deferred income taxes | $ | 961.2 | $ | (996.9) | $ | 1,039.2 | $ | (1,073.1) |
Additions | Charged | |||||||||
Balance\u00a0at | Charged | (Credited) | ||||||||
Beginning\u00a0of | to | to Other | Balance at | |||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Period | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Expenses(1) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Accounts(2) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | End of\u00a0Period | ||
Calendar Year 2025 | ||||||||||
Valuation allowance-deferred income tax assets | $ | 1,711.5 | 126.1 | 29.0 | $ | 1,866.6 | ||||
Calendar Year 2024 | ||||||||||
Valuation allowance-deferred income tax assets | $ | 1,641.3 | 84.5 | (14.3) | $ | 1,711.5 | ||||
Calendar Year 2023 | ||||||||||
Valuation allowance-deferred income tax assets | $ | 1,513.0 | 122.1 | 6.2 | $ | 1,641.3 |
| (1) | Primarily relates to the Company\u2019s increase in the current year\u2019s federal, state, and international net operating losses. |
| (2) | Primarily relates to amounts resulting from the Company\u2019s changes in deferred tax assets and associated valuation allowance that are not related to income statement activity, as well as amounts charged to other comprehensive income. |
Year\u00a0Ended | |||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2023 | |||
Balance at beginning of period | $ | 5.5 | $ | 5.5 | $ | 7.4 | |||
Gross decreases\u2014expiration of statute of limitations | \u2014 | \u2014 | (1.9) | ||||||
Balance at end of period | $ | 5.5 | $ | 5.5 | $ | 5.5 |
NOTE 10\u2014FAIR VALUE MEASUREMENTS
Fair value refers to the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the market in which the entity transacts business. The inputs used to develop these fair value measurements are established in a hierarchy, which ranks the quality and reliability of the information used to determine the fair values. The fair value classification is based on levels of inputs. Assets and liabilities that are carried at fair value are classified and disclosed in one of the following categories:
Level\u00a01: | Quoted market prices in active markets for identical assets or liabilities. |
Level\u00a02: | Observable inputs that are corroborated by market data. |
Level\u00a03: | Unobservable inputs that are not corroborated by market data. |
Recurring Fair Value Measurements. The following tables summarize the fair value hierarchy of the Company\u2019s financial instruments carried at fair value on a recurring basis:
Fair Value Measurements at December\u00a031, 2025 Using | ||||||||||||
Significant | ||||||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Total\u00a0Carrying | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Quoted\u00a0prices\u00a0in | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant\u00a0other | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | unobservable | |||||
Value at | active\u00a0market | observable\u00a0inputs | inputs | |||||||||
(In millions) | December\u00a031, 2025 | (Level\u00a01) | (Level\u00a02) | (Level\u00a03) | ||||||||
Corporate Borrowings: | ||||||||||||
Bifurcated embedded derivative - 6.00%/8.00% Cash/PIK Toggle Senior Secured Exchangeable Notes due 2030 | $ | 12.6 | $ | \u2014 | $ | \u2014 | $ | 12.6 | ||||
Bifurcated embedded derivative - Senior Secured Exchangeable Notes due 2030 | 131.9 | \u2014 | \u2014 | 131.9 | ||||||||
Total liabilities at fair value | $ | 144.5 | $ | \u2014 | $ | \u2014 | $ | 144.5 |
Fair Value Measurements at December\u00a031, 2024 Using | ||||||||||||
Significant | ||||||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Total\u00a0Carrying | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Quoted\u00a0prices\u00a0in | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant\u00a0other | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | unobservable | |||||
Value at | active\u00a0market | observable\u00a0inputs | inputs | |||||||||
(In millions) | December\u00a031, 2024 | (Level\u00a01) | (Level\u00a02) | (Level\u00a03) | ||||||||
Corporate Borrowings: | ||||||||||||
Bifurcated embedded derivative - 6.00%/8.00% Cash/PIK Toggle Senior Secured Exchangeable Notes due 2030 | $ | 157.6 | $ | \u2014 | $ | \u2014 | $ | 157.6 | ||||
Total liabilities at fair value | $ | 157.6 | $ | \u2014 | $ | \u2014 | $ | 157.6 |
Senior Secured Notes due 2030 embedded derivative valuation. The Company\u2019s Senior Secured Exchangeable Notes due 2030 have conversion features that required bifurcation from the host instrument pursuant to ASC 815\u2014Derivatives and Hedging. These conversion features were combined into a single derivative that comprises all features requiring bifurcation. The derivative features have been valued using a combination of Monte Carlo simulations, binomial lattice models, and discounted cash flow models. Monte Carlo simulations use repeated random sampling to simulate a wide range of possible outcomes. The binomial lattice models consist of simulated Common Stock prices from the valuation date to the maturity of the notes. The significant inputs used to value the derivative include the share price of the Common Stock, the volatility of the share price, time to maturity, risk-free interest rate, credit spread, and discount yield. The Company measures the derivative at fair value at the end of each reporting period with any changes in fair value recorded to other expense (income) in the consolidated statements of operations.
6.00%/8.00% Cash/PIK Toggle Senior Secured Exchangeable Notes due 2030. The Company\u2019s Existing Exchangeable Notes have conversion features that required bifurcation from the host instrument pursuant to ASC 815\u2014Derivatives and Hedging. These conversion features were combined into a single derivative that comprises all features requiring bifurcation, see Note 7\u2014Corporate Borrowings and Finance Lease Liabilities for further information. The derivative features have been valued using binomial lattice models. The binomial lattice models consist of simulated Common Stock prices from the valuation date to the maturity of the notes. The significant inputs used to value the derivative include the share price of the Common Stock, the volatility of the share price, time to maturity, risk-free interest rate, credit spread, and the discount yield. The Company measures the derivative at fair value at the end of each reporting period with any changes in fair value recorded to other expense (income) in the consolidated statements of operations.
Nonrecurring Fair Value Measurements. The following tables summarize the Company\u2019s assets that were written down to their fair value on a nonrecurring basis as part of the Company\u2019s impairment evaluation:
Fair Value Measurements at December\u00a031, 2025 Using | |||||||||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant\u00a0other | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant | \u00a0 | ||||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Total\u00a0Carrying | Quoted\u00a0prices\u00a0in | observable | unobservable | Total | ||||||||||
Value at | active\u00a0market | inputs | inputs | Impairment | |||||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | (Level\u00a01) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | (Level\u00a02) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | (Level\u00a03) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Losses | |||||
Property, net: | |||||||||||||||
Property, net | $ | 22.5 | $ | \u2014 | $ | \u2014 | $ | 22.5 | $ | 19.2 | |||||
Operating lease right-of-use assets: | |||||||||||||||
Operating lease right-of-use assets | 42.0 | \u2014 | \u2014 | 42.0 | 24.3 | ||||||||||
Total | $ | 64.5 | $ | \u2014 | $ | \u2014 | $ | 64.5 | $ | 43.5 |
Fair Value Measurements at December\u00a031, 2024 Using | |||||||||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant\u00a0other | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant | \u00a0 | ||||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Total\u00a0Carrying | Quoted\u00a0prices\u00a0in | observable | unobservable | Total | ||||||||||
Value at | active\u00a0market | inputs | inputs | Impairment | |||||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | (Level\u00a01) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | (Level\u00a02) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | (Level\u00a03) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Losses | |||||
Property, net: | |||||||||||||||
Property, net | $ | 16.5 | $ | \u2014 | $ | \u2014 | $ | 16.5 | $ | 18.1 | |||||
Operating lease right-of-use assets: | |||||||||||||||
Operating lease right-of-use assets | 45.6 | \u2014 | \u2014 | 45.6 | 54.2 | ||||||||||
Total | $ | 62.1 | $ | \u2014 | $ | \u2014 | $ | 62.1 | $ | 72.3 |
Valuation Techniques. The Company primarily uses a discounted cash flow method in estimating the fair value of its long-lived assets. There is considerable management judgment with respect to cash flow estimates and appropriate discount rates to be used in determining fair value, and accordingly, actual results could vary significantly from such estimates. Such judgments and estimates include estimates of future attendance, revenues, cost expectations, capital expenditures, and the cost of capital, among others. At December 31, 2025, estimated cash flows were discounted at 9.5% for theatres in U.S. markets and 10.5% for theatres in the International markets. At December 31, 2024, estimated cash flows were discounted at 9.0% for theatres in U.S. markets and 10.5% for theatres in International markets.
The following table summarizes the fair value hierarchy of the debt component of the Company\u2019s Senior Secured Exchangeable Notes due 2030 as of July 1, 2025:
Fair Value Measurements at July 1, 2025 Using | ||||||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant\u00a0other | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant | ||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Total\u00a0Carrying | Quoted\u00a0prices\u00a0in | observable | unobservable | ||||||||
Value at | active\u00a0market | inputs | inputs | |||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | July 1, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | (Level\u00a01) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | (Level\u00a02) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | (Level\u00a03) | ||||
Corporate Borrowings: | ||||||||||||
Senior Secured Exchangeable Notes due 2030 | $ | 159.0 | $ | \u2014 | $ | 159.0 | $ | \u2014 |
Valuation Technique. The Company estimated the fair value utilizing a discounted cash flow analysis with a discount yield interpolated by reference to the Company\u2019s other outstanding debt instruments with consideration given to the nature of collateral available to the security relative to the Company\u2019s other debt instruments. See Note 7\u2014Corporate Borrowings and Finance Lease Liabilities for further information.
Other Fair Value Measurement Disclosures. The Company is required to disclose the fair value of financial instruments that are not recognized at fair value in the statement of financial position for which it is practicable to estimate that value:
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Fair Value Measurements at December\u00a031, 2025 Using | |||||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant\u00a0other | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant | ||||||||
Total\u00a0Carrying | Quoted\u00a0prices\u00a0in | observable | unobservable | |||||||||
Value at | active\u00a0market | inputs | inputs | |||||||||
(In millions) | December\u00a031, 2025 | (Level\u00a01) | (Level\u00a02) | (Level\u00a03) | ||||||||
Current maturities of corporate borrowings | $ | 19.9 | $ | \u2014 | $ | 19.9 | $ | \u2014 | ||||
Corporate borrowings (excluding derivatives) | \u00a0 | 3,874.1 | \u00a0 | \u2014 | \u00a0 | 3,864.0 | \u2014 |
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Fair Value Measurements at December\u00a031, 2024 Using | |||||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant\u00a0other | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant | ||||||||
Total\u00a0Carrying | Quoted\u00a0prices\u00a0in | observable | unobservable | |||||||||
Value at | active\u00a0market | inputs | inputs | |||||||||
(In millions) | December\u00a031, 2024 | (Level\u00a01) | (Level\u00a02) | (Level\u00a03) | ||||||||
Current maturities of corporate borrowings | $ | 64.2 | $ | \u2014 | $ | 65.0 | $ | \u2014 | ||||
Corporate borrowings (excluding derivatives) | \u00a0 | 3,853.3 | \u00a0 | \u2014 | \u00a0 | 3,866.3 | \u00a0 | \u2014 |
Valuation Technique. Quoted market prices and observable market-based inputs were used to estimate fair value for Level\u00a02 inputs. The Company valued these notes at principal value less an estimated discount reflecting a market yield to maturity. See Note\u00a07\u2014Corporate Borrowings and Finance Lease Liabilities for further information.
The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable, and accrued liabilities approximate fair value because of the short maturity of these instruments.
"}]},{"name":"rpt:f-1854","factDimensions":{"xbrl:concept":"us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Fair Value Measurements at December\u00a031, 2025 Using | ||||||||||||
Significant | ||||||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Total\u00a0Carrying | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Quoted\u00a0prices\u00a0in | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant\u00a0other | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | unobservable | |||||
Value at | active\u00a0market | observable\u00a0inputs | inputs | |||||||||
(In millions) | December\u00a031, 2025 | (Level\u00a01) | (Level\u00a02) | (Level\u00a03) | ||||||||
Corporate Borrowings: | ||||||||||||
Bifurcated embedded derivative - 6.00%/8.00% Cash/PIK Toggle Senior Secured Exchangeable Notes due 2030 | $ | 12.6 | $ | \u2014 | $ | \u2014 | $ | 12.6 | ||||
Bifurcated embedded derivative - Senior Secured Exchangeable Notes due 2030 | 131.9 | \u2014 | \u2014 | 131.9 | ||||||||
Total liabilities at fair value | $ | 144.5 | $ | \u2014 | $ | \u2014 | $ | 144.5 |
Fair Value Measurements at December\u00a031, 2024 Using | ||||||||||||
Significant | ||||||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Total\u00a0Carrying | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Quoted\u00a0prices\u00a0in | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant\u00a0other | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | unobservable | |||||
Value at | active\u00a0market | observable\u00a0inputs | inputs | |||||||||
(In millions) | December\u00a031, 2024 | (Level\u00a01) | (Level\u00a02) | (Level\u00a03) | ||||||||
Corporate Borrowings: | ||||||||||||
Bifurcated embedded derivative - 6.00%/8.00% Cash/PIK Toggle Senior Secured Exchangeable Notes due 2030 | $ | 157.6 | $ | \u2014 | $ | \u2014 | $ | 157.6 | ||||
Total liabilities at fair value | $ | 157.6 | $ | \u2014 | $ | \u2014 | $ | 157.6 |
"}]},{"name":"rpt:f-1855","factDimensions":{"xbrl:concept":"us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:DebtInstrumentAxis":"amch:ToggleSeniorSecuredExchangeableNotesDue2030Member","us-gaap:FairValueByMeasurementFrequencyAxis":"us-gaap:FairValueMeasurementsRecurringMember"},"factValues":[{"value":"12600000","decimals":-5}]},{"name":"rpt:f-1856","factDimensions":{"xbrl:concept":"us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:DebtInstrumentAxis":"amch:ToggleSeniorSecuredExchangeableNotesDue2030Member","us-gaap:FairValueByFairValueHierarchyLevelAxis":"us-gaap:FairValueInputsLevel3Member","us-gaap:FairValueByMeasurementFrequencyAxis":"us-gaap:FairValueMeasurementsRecurringMember"},"factValues":[{"value":"12600000","decimals":-5}]},{"name":"rpt:f-1857","factDimensions":{"xbrl:concept":"us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:DebtInstrumentAxis":"amch:NewExchangeableNotesMember","us-gaap:FairValueByMeasurementFrequencyAxis":"us-gaap:FairValueMeasurementsRecurringMember"},"factValues":[{"value":"131900000","decimals":-5}]},{"name":"rpt:f-1858","factDimensions":{"xbrl:concept":"us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:DebtInstrumentAxis":"amch:NewExchangeableNotesMember","us-gaap:FairValueByFairValueHierarchyLevelAxis":"us-gaap:FairValueInputsLevel3Member","us-gaap:FairValueByMeasurementFrequencyAxis":"us-gaap:FairValueMeasurementsRecurringMember"},"factValues":[{"value":"131900000","decimals":-5}]},{"name":"rpt:f-1859","factDimensions":{"xbrl:concept":"us-gaap:FinancialLiabilitiesFairValueDisclosure","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:FairValueByMeasurementFrequencyAxis":"us-gaap:FairValueMeasurementsRecurringMember"},"factValues":[{"value":"144500000","decimals":-5}]},{"name":"rpt:f-1860","factDimensions":{"xbrl:concept":"us-gaap:FinancialLiabilitiesFairValueDisclosure","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:FairValueByFairValueHierarchyLevelAxis":"us-gaap:FairValueInputsLevel3Member","us-gaap:FairValueByMeasurementFrequencyAxis":"us-gaap:FairValueMeasurementsRecurringMember"},"factValues":[{"value":"144500000","decimals":-5}]},{"name":"rpt:f-1861","factDimensions":{"xbrl:concept":"us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:DebtInstrumentAxis":"amch:ToggleSeniorSecuredExchangeableNotesDue2030Member","us-gaap:FairValueByMeasurementFrequencyAxis":"us-gaap:FairValueMeasurementsRecurringMember"},"factValues":[{"value":"157600000","decimals":-5}]},{"name":"rpt:f-1862","factDimensions":{"xbrl:concept":"us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:DebtInstrumentAxis":"amch:ToggleSeniorSecuredExchangeableNotesDue2030Member","us-gaap:FairValueByFairValueHierarchyLevelAxis":"us-gaap:FairValueInputsLevel3Member","us-gaap:FairValueByMeasurementFrequencyAxis":"us-gaap:FairValueMeasurementsRecurringMember"},"factValues":[{"value":"157600000","decimals":-5}]},{"name":"rpt:f-1863","factDimensions":{"xbrl:concept":"us-gaap:FinancialLiabilitiesFairValueDisclosure","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:FairValueByMeasurementFrequencyAxis":"us-gaap:FairValueMeasurementsRecurringMember"},"factValues":[{"value":"157600000","decimals":-5}]},{"name":"rpt:f-1864","factDimensions":{"xbrl:concept":"us-gaap:FinancialLiabilitiesFairValueDisclosure","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:FairValueByFairValueHierarchyLevelAxis":"us-gaap:FairValueInputsLevel3Member","us-gaap:FairValueByMeasurementFrequencyAxis":"us-gaap:FairValueMeasurementsRecurringMember"},"factValues":[{"value":"157600000","decimals":-5}]},{"name":"rpt:f-1865","factDimensions":{"xbrl:concept":"us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"
Fair Value Measurements at December\u00a031, 2025 Using | |||||||||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant\u00a0other | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant | \u00a0 | ||||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Total\u00a0Carrying | Quoted\u00a0prices\u00a0in | observable | unobservable | Total | ||||||||||
Value at | active\u00a0market | inputs | inputs | Impairment | |||||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | (Level\u00a01) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | (Level\u00a02) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | (Level\u00a03) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Losses | |||||
Property, net: | |||||||||||||||
Property, net | $ | 22.5 | $ | \u2014 | $ | \u2014 | $ | 22.5 | $ | 19.2 | |||||
Operating lease right-of-use assets: | |||||||||||||||
Operating lease right-of-use assets | 42.0 | \u2014 | \u2014 | 42.0 | 24.3 | ||||||||||
Total | $ | 64.5 | $ | \u2014 | $ | \u2014 | $ | 64.5 | $ | 43.5 |
Fair Value Measurements at December\u00a031, 2024 Using | |||||||||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant\u00a0other | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant | \u00a0 | ||||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Total\u00a0Carrying | Quoted\u00a0prices\u00a0in | observable | unobservable | Total | ||||||||||
Value at | active\u00a0market | inputs | inputs | Impairment | |||||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | (Level\u00a01) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | (Level\u00a02) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | (Level\u00a03) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Losses | |||||
Property, net: | |||||||||||||||
Property, net | $ | 16.5 | $ | \u2014 | $ | \u2014 | $ | 16.5 | $ | 18.1 | |||||
Operating lease right-of-use assets: | |||||||||||||||
Operating lease right-of-use assets | 45.6 | \u2014 | \u2014 | 45.6 | 54.2 | ||||||||||
Total | $ | 62.1 | $ | \u2014 | $ | \u2014 | $ | 62.1 | $ | 72.3 |
Fair Value Measurements at July 1, 2025 Using | ||||||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant\u00a0other | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant | ||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Total\u00a0Carrying | Quoted\u00a0prices\u00a0in | observable | unobservable | ||||||||
Value at | active\u00a0market | inputs | inputs | |||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | July 1, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | (Level\u00a01) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | (Level\u00a02) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | (Level\u00a03) | ||||
Corporate Borrowings: | ||||||||||||
Senior Secured Exchangeable Notes due 2030 | $ | 159.0 | $ | \u2014 | $ | 159.0 | $ | \u2014 |
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Fair Value Measurements at December\u00a031, 2025 Using | |||||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant\u00a0other | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant | ||||||||
Total\u00a0Carrying | Quoted\u00a0prices\u00a0in | observable | unobservable | |||||||||
Value at | active\u00a0market | inputs | inputs | |||||||||
(In millions) | December\u00a031, 2025 | (Level\u00a01) | (Level\u00a02) | (Level\u00a03) | ||||||||
Current maturities of corporate borrowings | $ | 19.9 | $ | \u2014 | $ | 19.9 | $ | \u2014 | ||||
Corporate borrowings (excluding derivatives) | \u00a0 | 3,874.1 | \u00a0 | \u2014 | \u00a0 | 3,864.0 | \u2014 |
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Fair Value Measurements at December\u00a031, 2024 Using | |||||||||||
\u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant\u00a0other | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Significant | ||||||||
Total\u00a0Carrying | Quoted\u00a0prices\u00a0in | observable | unobservable | |||||||||
Value at | active\u00a0market | inputs | inputs | |||||||||
(In millions) | December\u00a031, 2024 | (Level\u00a01) | (Level\u00a02) | (Level\u00a03) | ||||||||
Current maturities of corporate borrowings | $ | 64.2 | $ | \u2014 | $ | 65.0 | $ | \u2014 | ||||
Corporate borrowings (excluding derivatives) | \u00a0 | 3,853.3 | \u00a0 | \u2014 | \u00a0 | 3,866.3 | \u00a0 | \u2014 |
"}]},{"name":"rpt:f-1891","factDimensions":{"xbrl:concept":"us-gaap:LongTermDebtCurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:FairValueByMeasurementBasisAxis":"us-gaap:CarryingReportedAmountFairValueDisclosureMember"},"factValues":[{"value":"19900000","decimals":-5}]},{"name":"rpt:f-1892","factDimensions":{"xbrl:concept":"amch:LongTermDebtCurrentFairValueDisclosure","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:FairValueByFairValueHierarchyLevelAxis":"us-gaap:FairValueInputsLevel2Member"},"factValues":[{"value":"19900000","decimals":-5}]},{"name":"rpt:f-1893","factDimensions":{"xbrl:concept":"us-gaap:LongTermDebtNoncurrent","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:FairValueByMeasurementBasisAxis":"us-gaap:CarryingReportedAmountFairValueDisclosureMember"},"factValues":[{"value":"3874100000","decimals":-5}]},{"name":"rpt:f-1894","factDimensions":{"xbrl:concept":"us-gaap:LongTermDebtFairValue","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:FairValueByFairValueHierarchyLevelAxis":"us-gaap:FairValueInputsLevel2Member"},"factValues":[{"value":"3864000000","decimals":-5}]},{"name":"rpt:f-1895","factDimensions":{"xbrl:concept":"us-gaap:LongTermDebtCurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:FairValueByMeasurementBasisAxis":"us-gaap:CarryingReportedAmountFairValueDisclosureMember"},"factValues":[{"value":"64200000","decimals":-5}]},{"name":"rpt:f-1896","factDimensions":{"xbrl:concept":"amch:LongTermDebtCurrentFairValueDisclosure","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:FairValueByFairValueHierarchyLevelAxis":"us-gaap:FairValueInputsLevel2Member"},"factValues":[{"value":"65000000","decimals":-5}]},{"name":"rpt:f-1897","factDimensions":{"xbrl:concept":"us-gaap:LongTermDebtNoncurrent","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:FairValueByMeasurementBasisAxis":"us-gaap:CarryingReportedAmountFairValueDisclosureMember"},"factValues":[{"value":"3853300000","decimals":-5}]},{"name":"rpt:f-1898","factDimensions":{"xbrl:concept":"us-gaap:LongTermDebtFairValue","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:FairValueByFairValueHierarchyLevelAxis":"us-gaap:FairValueInputsLevel2Member"},"factValues":[{"value":"3866300000","decimals":-5}]},{"name":"rpt:f-1899","factDimensions":{"xbrl:concept":"us-gaap:SegmentReportingDisclosureTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"
NOTE 11\u2014SEGMENT REPORTING
The Company reports information about operating segments in accordance with ASC 280-10, Segment Reporting, which requires financial information to be reported based on the way management organizes segments within a company for making operating decisions and evaluating performance. Management has organized the Company around differences in geographic areas. The Company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. The International markets reportable segment has operations in or partial interest in theatres in the United Kingdom, Germany, Spain, Italy, Ireland, Portugal, Sweden, Finland, Norway, and Denmark.
Each segment\u2019s revenue is derived from admissions, food and beverage sales and other ancillary revenues, primarily screen advertising, loyalty membership fees, ticket sales, gift card income and exchange ticket income. The
measure of segment profit and loss the Company\u2019s chief operating decision maker (\u201cCODM\u201d) uses to evaluate performance and allocate its resources is Adjusted EBITDA, as defined in the reconciliation table below. During the year ended December 31, 2024, the Company changed the definition of Adjusted EBITDA to no longer further adjust for \u201ccash distributions from non-consolidated entities\u201d and \u201cother non-cash rent benefit.\u201d All comparative period information for Adjusted EBITDA has been re-cast to conform with the current definition.
The Company\u2019s CODM is the chief executive officer. The Company does not report asset information by segment because that information is not used to evaluate the performance of or allocate resources between segments. The CODM assess segment performance quarterly by comparing segment annual Adjusted EBITDA against budgeted and/or forecasted Adjusted EBITDA.
The CODM uses Adjusted EBITDA for each segment to determine how to allocate resources for future capital expenditures and for general corporate purposes. The Company defines Adjusted EBITDA as net earnings (loss) plus (i) income tax provision (benefit), (ii) interest expense and (iii) depreciation and amortization, as further adjusted to eliminate the impact of certain items that the Company does not consider indicative of the Company\u2019s ongoing operating performance and to include attributable EBITDA from equity investments in theatre operations in International markets.
The following tables below provide reconciliation of segment revenues to Adjusted EBITDA:
Year Ended | |||||||||
December\u00a031, 2025 | |||||||||
(In\u00a0millions) | U.S. Markets | International Markets | Consolidated | ||||||
Revenues (1) | $ | 3,706.1 | $ | 1,142.8 | $ | 4,848.9 | |||
Less: | |||||||||
Film exhibition costs | 1,020.5 | 254.7 | 1,275.2 | ||||||
Food and beverage costs | \u00a0 | 241.2 | \u00a0 | 85.8 | \u00a0 | 327.0 | |||
Operating expense, excluding depreciation and amortization (2) | \u00a0 | 1,318.9 | \u00a0 | 452.5 | \u00a0 | 1,771.4 | |||
Rent | \u00a0 | 650.1 | \u00a0 | 237.2 | \u00a0 | 887.3 | |||
General and administrative expense - other, excluding depreciation and amortization (3) | 128.3 | \u00a0 | 85.1 | 213.4 | |||||
Other segment items (4) | \u00a0 | 1.1 | (14.0) | (12.9) | |||||
Adjusted EBITDA | $ | 346.0 | $ | 41.5 | $ | 387.5 |
Year Ended | |||||||||
December\u00a031, 2024 | |||||||||
(In\u00a0millions) | U.S. Markets | International Markets | Consolidated | ||||||
Revenues (1) | $ | 3,544.2 | $ | 1,093.0 | $ | 4,637.2 | |||
Less: | |||||||||
Film exhibition costs | 988.8 | 250.4 | 1,239.2 | ||||||
Food and beverage costs | \u00a0 | 225.7 | \u00a0 | 79.9 | \u00a0 | 305.6 | |||
Operating expense, excluding depreciation and amortization (2) | \u00a0 | 1,249.0 | \u00a0 | 425.0 | \u00a0 | 1,674.0 | |||
Rent | \u00a0 | 649.9 | 223.7 | 873.6 | |||||
General and administrative expense - other, excluding depreciation and amortization (3) | 130.6 | \u00a0 | 74.2 | 204.8 | |||||
Other segment items (4) | \u00a0 | (1.3) | \u00a0 | (2.6) | \u00a0 | (3.9) | |||
Adjusted EBITDA | $ | 301.5 | $ | 42.4 | $ | 343.9 |
Year Ended | |||||||||
December\u00a031, 2023 | |||||||||
(In\u00a0millions) | U.S. Markets | International Markets | Consolidated | ||||||
Revenues | $ | 3,688.7 | $ | 1,123.9 | $ | 4,812.6 | |||
Less: | |||||||||
Film exhibition costs | 1,023.3 | 267.8 | 1,291.1 | ||||||
Food and beverage costs | \u00a0 | 233.9 | \u00a0 | 81.4 | \u00a0 | 315.3 | |||
Operating expense, excluding depreciation and amortization (2) | \u00a0 | 1,261.8 | \u00a0 | 427.2 | \u00a0 | 1,689.0 | |||
Rent | \u00a0 | 651.5 | 222.0 | 873.5 | |||||
General and administrative expense - other, excluding depreciation and amortization (3) | 130.9 | \u00a0 | 68.5 | 199.4 | |||||
Other segment items (4) | \u00a0 | (3.8) | \u00a0 | (6.2) | \u00a0 | (10.0) | |||
Adjusted EBITDA | $ | 391.1 | $ | 63.2 | $ | 454.3 |
| (1) | All segment revenues are comprised of revenues from external customers. |
| (2) | Operating expense, excluding depreciation and amortization excludes certain operating expenses as further defined in the reconciliation of net loss to Adjusted EBITDA below. |
| (3) | General and administrative expense \u2013 other, excluding depreciation and amortization excludes stock compensation expense. |
| (4) | Other segment items include government assistance, business interruption insurance recoveries, net periodic pension cost (benefit), and attributable EBITDA from international theatre joint ventures. |
Other segment disclosures:
Year Ended | |||||||||
December\u00a031, 2025 | |||||||||
(In\u00a0millions) | U.S. Markets | International Markets | Consolidated | ||||||
Depreciation and amortization | $ | 239.1 | $ | 74.3 | $ | 313.4 | |||
Income tax provision | 2.7 | 1.8 | 4.5 | ||||||
Other expense (income) | 159.2 | (40.0) | 119.2 | ||||||
Other significant noncash items: | |||||||||
Stock-based compensation expense | 15.8 | 1.1 | 16.9 | ||||||
Impairment of long-lived assets | 28.0 | 15.5 | 43.5 | ||||||
Equity in earnings of non-consolidated entities | (5.7) | (1.1) | (6.8) | ||||||
Capital expenditures | 174.2 | 71.9 | 246.1 |
Year Ended | |||||||||
December\u00a031, 2024 | |||||||||
(In\u00a0millions) | U.S. Markets | International Markets | Consolidated | ||||||
Depreciation and amortization | $ | 247.5 | $ | 72.0 | $ | 319.5 | |||
Income tax provision | \u2014 | 2.1 | 2.1 | ||||||
Other income | (113.7) | (30.1) | (143.8) | ||||||
Other significant noncash items: | |||||||||
Stock-based compensation expense | 20.0 | 2.0 | 22.0 | ||||||
Impairment of long-lived assets | 51.9 | 20.4 | 72.3 | ||||||
Equity in earnings of non-consolidated entities | (10.7) | (1.7) | (12.4) | ||||||
Capital expenditures | 171.4 | 74.1 | 245.5 |
Year Ended | |||||||||
December\u00a031, 2023 | |||||||||
(In\u00a0millions) | U.S. Markets | International Markets | Consolidated | ||||||
Depreciation and amortization | $ | 286.5 | $ | 78.5 | $ | 365.0 | |||
Income tax provision | 1.8 | 1.6 | 3.4 | ||||||
Other income | (47.3) | (21.8) | (69.1) | ||||||
Other significant noncash items: | |||||||||
Stock-based compensation expense | 38.3 | 4.2 | 42.5 | ||||||
Impairment of long-lived assets | 49.2 | 57.7 | 106.9 | ||||||
Equity in earnings of non-consolidated entities | (5.5) | (2.2) | (7.7) | ||||||
Capital expenditures | 167.0 | 58.6 | 225.6 |
The following table sets forth a reconciliation of net loss to Adjusted EBITDA:
Year Ended | |||||||||
(In\u00a0millions) | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | December\u00a031, 2023 | |||||
Net loss | $ | (632.4) | $ | (352.6) | $ | (396.6) | |||
Plus: | |||||||||
Income tax provision (1) | \u00a0 | 4.5 | \u00a0 | 2.1 | 3.4 | ||||
Interest expense | \u00a0 | 530.2 | \u00a0 | 443.7 | 411.2 | ||||
Depreciation and amortization | \u00a0 | 313.4 | \u00a0 | 319.5 | 365.0 | ||||
Impairment of long-lived assets (2) | \u00a0 | 43.5 | \u00a0 | 72.3 | 106.9 | ||||
Certain operating expense (3) | \u00a0 | 14.6 | \u00a0 | 5.4 | 2.5 | ||||
Equity in earnings of non-consolidated entities (4) | \u00a0 | (6.8) | \u00a0 | (12.4) | (7.7) | ||||
Attributable EBITDA (5) | 2.3 | 1.9 | 2.2 | ||||||
Investment income (6) | \u00a0 | (32.1) | \u00a0 | (16.3) | (15.5) | ||||
Other expense (income) (7) | \u00a0 | 129.8 | \u00a0 | (141.8) | (61.3) | ||||
Merger, acquisition and other costs (8) | \u00a0 | 3.6 | \u00a0 | 0.1 | 1.7 | ||||
Stock-based compensation expense (9) | \u00a0 | 16.9 | \u00a0 | 22.0 | 42.5 | ||||
Adjusted EBITDA | $ | 387.5 | $ | 343.9 | $ | 454.3 |
| (1) | For information regarding the income tax provision (benefit), see Note 9\u2014Income Taxes. |
| (2) | During the year ended December 31, 2025, the Company recorded non-cash impairment charges related to its long-lived assets of $28.0 million on 47 theatres in the U.S. markets with 560 screens which were related to property, net and operating lease right-of-use assets, net and $15.5 million on 20 theatres in the International markets with 159 screens which were related to property, net and operating lease right-of-use assets, net. |
During the year ended December 31, 2024, the Company recorded non-cash impairment charges related to its long-lived assets of $51.9 million on 39 theatres in the U.S. markets with 469 screens which were related to property, net and operating lease right-of-use assets, net and $20.4 million on 23 theatres in the International markets with 188 screens which were related to property, net and operating lease right-of-use assets, net.
During the year ended December 31, 2023, the Company recorded non-cash impairment charges related to its long-lived assets of $49.2 million on 68 theatres in the U.S. markets with 738 screens which were related to property, net and operating lease right-of-use assets, net and $57.7 million on 57 theatres in the International markets with 488 screens which were related to property, net and operating lease right-of-use assets, net.
| (3) | Amounts represent preopening expense related to temporarily closed screens under renovation, theatre and other closure expense for the permanent closure of screens, disposition of assets, and other non-operating gains or losses included in operating expenses. The Company has excluded these items as they are non-cash in nature or are non-operating in nature. |
| (4) | Equity in earnings of non-consolidated entities during the year ended December 31, 2025, primarily consisted of equity in earnings from AC JV of $(4.8) million. Equity in earnings of non-consolidated entities during the year ended December 31, 2024, primarily consisted of equity in earnings from AC JV of $(10.0) million. Equity in earnings of non-consolidated entities during the year ended December 31, 2023, primarily consisted of equity in earnings from AC JV of $(4.9) million. |
| (5) | Attributable EBITDA includes the EBITDA from equity investments in theatre operators in certain International markets. See below for a reconciliation of the Company\u2019s equity in (earnings) of non-consolidated entities to attributable EBITDA. Because these equity investments are in theatre operators in regions where the Company holds a significant market share, the Company believes attributable EBITDA is more indicative of the performance of these equity investments and management uses this measure to monitor and evaluate these equity investments. |
Year Ended | |||||||||
(In\u00a0millions) | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | December\u00a031, 2023 | |||||
Equity in (earnings) of non-consolidated entities | $ | (6.8) | $ | (12.4) | $ | (7.7) | |||
Less: | |||||||||
Equity in (earnings) of non-consolidated entities excluding International theatre joint ventures | (5.7) | (11.5) | (6.6) | ||||||
Equity in earnings of International theatre joint ventures | 1.1 | 0.9 | 1.1 | ||||||
Income tax provision | 0.1 | \u2014 | 0.1 | ||||||
Investment income | (0.5) | (0.4) | (0.6) | ||||||
Interest expense | 0.2 | 0.1 | 0.2 | ||||||
Depreciation and amortization | 1.4 | 1.3 | 1.4 | ||||||
Attributable EBITDA | $ | 2.3 | $ | 1.9 | $ | 2.2 |
| (6) | Investment income during the year ended December 31, 2025 includes interest income of $(8.0) million and realized and unrealized gains on the Company\u2019s investments in Hycroft of $(34.4) million, partially offset by an impairment of an equity security without a readily determinable fair value of $10.3 million. |
Investment income during the year ended December 31, 2024 includes interest income of $(19.2) million, partially offset by unrealized losses on the Company\u2019s investments in Hycroft of $2.9 million.
Investment income during the year ended December 31, 2023 included a $(15.5) million gain on sale of the Company\u2019s investment in Saudi Cinema Company LLC and interest income of $(15.4) million, partially offset by unrealized losses on the Company\u2019s investments in Hycroft of $12.6 million, $1.8 million of expense for NCM common units, and a $1.0 million impairment of an equity security without a readily determinable fair value.
| (7) | Other expense during the year ended December 31, 2025 includes net losses on debt extinguishment of $196.0 million, an increase in the fair value of the bifurcated embedded derivative in the New Exchangeable Notes of $19.3 million, and term loan modification third party fees of $3.1 million, partially offset by a decrease in the fair value of the bifurcated embedded derivative in the Existing Exchangeable Notes of $(56.7) million, foreign currency transaction gains of $(28.1) million, and shareholder litigation recoveries of $(3.8) million. |
Other income for the year ended December 31, 2024 includes a decrease in the fair value of the bifurcated embedded derivative in the Existing Exchangeable Notes of $(75.8) million, shareholder litigation recoveries of $(40.2) million, net gains on debt extinguishment of $(38.9) million, and a vendor dispute of $(36.2) million, partially offset by term loan modification third party fees of $42.3 million and foreign currency transaction losses of $7.0 million.
Other income for the year ended December 31, 2023 includes gains on debt extinguishment of $(142.8) million and foreign currency transaction gains of $(17.8) million, partially offset by a non-cash litigation charge of $99.3 million.
| (8) | Merger, acquisition and other costs are excluded as they are non-operating in nature. |
| (9) | Non-cash expense included in general and administrative: other. |
Financial information about geographic area is as follows:
Year Ended | |||||||||
Revenues (In millions) | December\u00a031, 2025 | December\u00a031, 2024 | December\u00a031, 2023 | ||||||
United States | $ | 3,706.1 | $ | 3,544.2 | $ | 3,688.7 | |||
United Kingdom | 428.5 | 408.8 | 400.9 | ||||||
Spain | 153.4 | 143.3 | 148.2 | ||||||
Sweden | 122.5 | 116.4 | 124.9 | ||||||
Italy | 147.3 | 147.6 | 151.9 | ||||||
Germany | 124.3 | 111.6 | 125.8 | ||||||
Finland | 84.7 | 90.1 | 97.9 | ||||||
Ireland | 33.1 | 32.5 | 32.2 | ||||||
Other foreign countries | 49.0 | 42.7 | 42.1 | ||||||
Total revenues | $ | 4,848.9 | $ | 4,637.2 | $ | 4,812.6 |
As of | As of | |||||
Long-term assets, net (In millions) | December\u00a031, 2025 | December\u00a031, 2024 | ||||
United States | $ | 5,267.4 | $ | 5,474.2 | ||
International | 2,019.9 | 1,826.1 | ||||
Total long-term assets (1) | $ | 7,287.3 | $ | 7,300.3 |
| (1) | Long-term assets are comprised of property, operating lease right-of-use assets, intangible assets, goodwill, deferred tax assets, net and other long-term assets. |
Year Ended | |||||||||
December\u00a031, 2025 | |||||||||
(In\u00a0millions) | U.S. Markets | International Markets | Consolidated | ||||||
Revenues (1) | $ | 3,706.1 | $ | 1,142.8 | $ | 4,848.9 | |||
Less: | |||||||||
Film exhibition costs | 1,020.5 | 254.7 | 1,275.2 | ||||||
Food and beverage costs | \u00a0 | 241.2 | \u00a0 | 85.8 | \u00a0 | 327.0 | |||
Operating expense, excluding depreciation and amortization (2) | \u00a0 | 1,318.9 | \u00a0 | 452.5 | \u00a0 | 1,771.4 | |||
Rent | \u00a0 | 650.1 | \u00a0 | 237.2 | \u00a0 | 887.3 | |||
General and administrative expense - other, excluding depreciation and amortization (3) | 128.3 | \u00a0 | 85.1 | 213.4 | |||||
Other segment items (4) | \u00a0 | 1.1 | (14.0) | (12.9) | |||||
Adjusted EBITDA | $ | 346.0 | $ | 41.5 | $ | 387.5 |
Year Ended | |||||||||
December\u00a031, 2024 | |||||||||
(In\u00a0millions) | U.S. Markets | International Markets | Consolidated | ||||||
Revenues (1) | $ | 3,544.2 | $ | 1,093.0 | $ | 4,637.2 | |||
Less: | |||||||||
Film exhibition costs | 988.8 | 250.4 | 1,239.2 | ||||||
Food and beverage costs | \u00a0 | 225.7 | \u00a0 | 79.9 | \u00a0 | 305.6 | |||
Operating expense, excluding depreciation and amortization (2) | \u00a0 | 1,249.0 | \u00a0 | 425.0 | \u00a0 | 1,674.0 | |||
Rent | \u00a0 | 649.9 | 223.7 | 873.6 | |||||
General and administrative expense - other, excluding depreciation and amortization (3) | 130.6 | \u00a0 | 74.2 | 204.8 | |||||
Other segment items (4) | \u00a0 | (1.3) | \u00a0 | (2.6) | \u00a0 | (3.9) | |||
Adjusted EBITDA | $ | 301.5 | $ | 42.4 | $ | 343.9 |
Year Ended | |||||||||
December\u00a031, 2023 | |||||||||
(In\u00a0millions) | U.S. Markets | International Markets | Consolidated | ||||||
Revenues | $ | 3,688.7 | $ | 1,123.9 | $ | 4,812.6 | |||
Less: | |||||||||
Film exhibition costs | 1,023.3 | 267.8 | 1,291.1 | ||||||
Food and beverage costs | \u00a0 | 233.9 | \u00a0 | 81.4 | \u00a0 | 315.3 | |||
Operating expense, excluding depreciation and amortization (2) | \u00a0 | 1,261.8 | \u00a0 | 427.2 | \u00a0 | 1,689.0 | |||
Rent | \u00a0 | 651.5 | 222.0 | 873.5 | |||||
General and administrative expense - other, excluding depreciation and amortization (3) | 130.9 | \u00a0 | 68.5 | 199.4 | |||||
Other segment items (4) | \u00a0 | (3.8) | \u00a0 | (6.2) | \u00a0 | (10.0) | |||
Adjusted EBITDA | $ | 391.1 | $ | 63.2 | $ | 454.3 |
| (1) | All segment revenues are comprised of revenues from external customers. |
| (2) | Operating expense, excluding depreciation and amortization excludes certain operating expenses as further defined in the reconciliation of net loss to Adjusted EBITDA below. |
| (3) | General and administrative expense \u2013 other, excluding depreciation and amortization excludes stock compensation expense. |
| (4) | Other segment items include government assistance, business interruption insurance recoveries, net periodic pension cost (benefit), and attributable EBITDA from international theatre joint ventures. |
Year Ended | |||||||||
December\u00a031, 2025 | |||||||||
(In\u00a0millions) | U.S. Markets | International Markets | Consolidated | ||||||
Depreciation and amortization | $ | 239.1 | $ | 74.3 | $ | 313.4 | |||
Income tax provision | 2.7 | 1.8 | 4.5 | ||||||
Other expense (income) | 159.2 | (40.0) | 119.2 | ||||||
Other significant noncash items: | |||||||||
Stock-based compensation expense | 15.8 | 1.1 | 16.9 | ||||||
Impairment of long-lived assets | 28.0 | 15.5 | 43.5 | ||||||
Equity in earnings of non-consolidated entities | (5.7) | (1.1) | (6.8) | ||||||
Capital expenditures | 174.2 | 71.9 | 246.1 |
Year Ended | |||||||||
December\u00a031, 2024 | |||||||||
(In\u00a0millions) | U.S. Markets | International Markets | Consolidated | ||||||
Depreciation and amortization | $ | 247.5 | $ | 72.0 | $ | 319.5 | |||
Income tax provision | \u2014 | 2.1 | 2.1 | ||||||
Other income | (113.7) | (30.1) | (143.8) | ||||||
Other significant noncash items: | |||||||||
Stock-based compensation expense | 20.0 | 2.0 | 22.0 | ||||||
Impairment of long-lived assets | 51.9 | 20.4 | 72.3 | ||||||
Equity in earnings of non-consolidated entities | (10.7) | (1.7) | (12.4) | ||||||
Capital expenditures | 171.4 | 74.1 | 245.5 |
Year Ended | |||||||||
December\u00a031, 2023 | |||||||||
(In\u00a0millions) | U.S. Markets | International Markets | Consolidated | ||||||
Depreciation and amortization | $ | 286.5 | $ | 78.5 | $ | 365.0 | |||
Income tax provision | 1.8 | 1.6 | 3.4 | ||||||
Other income | (47.3) | (21.8) | (69.1) | ||||||
Other significant noncash items: | |||||||||
Stock-based compensation expense | 38.3 | 4.2 | 42.5 | ||||||
Impairment of long-lived assets | 49.2 | 57.7 | 106.9 | ||||||
Equity in earnings of non-consolidated entities | (5.5) | (2.2) | (7.7) | ||||||
Capital expenditures | 167.0 | 58.6 | 225.6 |
The following table sets forth a reconciliation of net loss to Adjusted EBITDA:
Year Ended | |||||||||
(In\u00a0millions) | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | December\u00a031, 2023 | |||||
Net loss | $ | (632.4) | $ | (352.6) | $ | (396.6) | |||
Plus: | |||||||||
Income tax provision (1) | \u00a0 | 4.5 | \u00a0 | 2.1 | 3.4 | ||||
Interest expense | \u00a0 | 530.2 | \u00a0 | 443.7 | 411.2 | ||||
Depreciation and amortization | \u00a0 | 313.4 | \u00a0 | 319.5 | 365.0 | ||||
Impairment of long-lived assets (2) | \u00a0 | 43.5 | \u00a0 | 72.3 | 106.9 | ||||
Certain operating expense (3) | \u00a0 | 14.6 | \u00a0 | 5.4 | 2.5 | ||||
Equity in earnings of non-consolidated entities (4) | \u00a0 | (6.8) | \u00a0 | (12.4) | (7.7) | ||||
Attributable EBITDA (5) | 2.3 | 1.9 | 2.2 | ||||||
Investment income (6) | \u00a0 | (32.1) | \u00a0 | (16.3) | (15.5) | ||||
Other expense (income) (7) | \u00a0 | 129.8 | \u00a0 | (141.8) | (61.3) | ||||
Merger, acquisition and other costs (8) | \u00a0 | 3.6 | \u00a0 | 0.1 | 1.7 | ||||
Stock-based compensation expense (9) | \u00a0 | 16.9 | \u00a0 | 22.0 | 42.5 | ||||
Adjusted EBITDA | $ | 387.5 | $ | 343.9 | $ | 454.3 |
| (1) | For information regarding the income tax provision (benefit), see Note 9\u2014Income Taxes. |
| (2) | During the year ended December 31, 2025, the Company recorded non-cash impairment charges related to its long-lived assets of $28.0 million on 47 theatres in the U.S. markets with 560 screens which were related to property, net and operating lease right-of-use assets, net and $15.5 million on 20 theatres in the International markets with 159 screens which were related to property, net and operating lease right-of-use assets, net. |
During the year ended December 31, 2024, the Company recorded non-cash impairment charges related to its long-lived assets of $51.9 million on 39 theatres in the U.S. markets with 469 screens which were related to property, net and operating lease right-of-use assets, net and $20.4 million on 23 theatres in the International markets with 188 screens which were related to property, net and operating lease right-of-use assets, net.
During the year ended December 31, 2023, the Company recorded non-cash impairment charges related to its long-lived assets of $49.2 million on 68 theatres in the U.S. markets with 738 screens which were related to property, net and operating lease right-of-use assets, net and $57.7 million on 57 theatres in the International markets with 488 screens which were related to property, net and operating lease right-of-use assets, net.
| (3) | Amounts represent preopening expense related to temporarily closed screens under renovation, theatre and other closure expense for the permanent closure of screens, disposition of assets, and other non-operating gains or losses included in operating expenses. The Company has excluded these items as they are non-cash in nature or are non-operating in nature. |
| (4) | Equity in earnings of non-consolidated entities during the year ended December 31, 2025, primarily consisted of equity in earnings from AC JV of $(4.8) million. Equity in earnings of non-consolidated entities during the year ended December 31, 2024, primarily consisted of equity in earnings from AC JV of $(10.0) million. Equity in earnings of non-consolidated entities during the year ended December 31, 2023, primarily consisted of equity in earnings from AC JV of $(4.9) million. |
| (5) | Attributable EBITDA includes the EBITDA from equity investments in theatre operators in certain International markets. See below for a reconciliation of the Company\u2019s equity in (earnings) of non-consolidated entities to attributable EBITDA. Because these equity investments are in theatre operators in regions where the Company holds a significant market share, the Company believes attributable EBITDA is more indicative of the performance of these equity investments and management uses this measure to monitor and evaluate these equity investments. |
Year Ended | |||||||||
(In\u00a0millions) | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | December\u00a031, 2023 | |||||
Equity in (earnings) of non-consolidated entities | $ | (6.8) | $ | (12.4) | $ | (7.7) | |||
Less: | |||||||||
Equity in (earnings) of non-consolidated entities excluding International theatre joint ventures | (5.7) | (11.5) | (6.6) | ||||||
Equity in earnings of International theatre joint ventures | 1.1 | 0.9 | 1.1 | ||||||
Income tax provision | 0.1 | \u2014 | 0.1 | ||||||
Investment income | (0.5) | (0.4) | (0.6) | ||||||
Interest expense | 0.2 | 0.1 | 0.2 | ||||||
Depreciation and amortization | 1.4 | 1.3 | 1.4 | ||||||
Attributable EBITDA | $ | 2.3 | $ | 1.9 | $ | 2.2 |
| (6) | Investment income during the year ended December 31, 2025 includes interest income of $(8.0) million and realized and unrealized gains on the Company\u2019s investments in Hycroft of $(34.4) million, partially offset by an impairment of an equity security without a readily determinable fair value of $10.3 million. |
Investment income during the year ended December 31, 2024 includes interest income of $(19.2) million, partially offset by unrealized losses on the Company\u2019s investments in Hycroft of $2.9 million.
Investment income during the year ended December 31, 2023 included a $(15.5) million gain on sale of the Company\u2019s investment in Saudi Cinema Company LLC and interest income of $(15.4) million, partially offset by unrealized losses on the Company\u2019s investments in Hycroft of $12.6 million, $1.8 million of expense for NCM common units, and a $1.0 million impairment of an equity security without a readily determinable fair value.
| (7) | Other expense during the year ended December 31, 2025 includes net losses on debt extinguishment of $196.0 million, an increase in the fair value of the bifurcated embedded derivative in the New Exchangeable Notes of $19.3 million, and term loan modification third party fees of $3.1 million, partially offset by a decrease in the fair value of the bifurcated embedded derivative in the Existing Exchangeable Notes of $(56.7) million, foreign currency transaction gains of $(28.1) million, and shareholder litigation recoveries of $(3.8) million. |
Other income for the year ended December 31, 2024 includes a decrease in the fair value of the bifurcated embedded derivative in the Existing Exchangeable Notes of $(75.8) million, shareholder litigation recoveries of $(40.2) million, net gains on debt extinguishment of $(38.9) million, and a vendor dispute of $(36.2) million, partially offset by term loan modification third party fees of $42.3 million and foreign currency transaction losses of $7.0 million.
Other income for the year ended December 31, 2023 includes gains on debt extinguishment of $(142.8) million and foreign currency transaction gains of $(17.8) million, partially offset by a non-cash litigation charge of $99.3 million.
| (8) | Merger, acquisition and other costs are excluded as they are non-operating in nature. |
| (9) | Non-cash expense included in general and administrative: other. |
Year Ended | |||||||||
Revenues (In millions) | December\u00a031, 2025 | December\u00a031, 2024 | December\u00a031, 2023 | ||||||
United States | $ | 3,706.1 | $ | 3,544.2 | $ | 3,688.7 | |||
United Kingdom | 428.5 | 408.8 | 400.9 | ||||||
Spain | 153.4 | 143.3 | 148.2 | ||||||
Sweden | 122.5 | 116.4 | 124.9 | ||||||
Italy | 147.3 | 147.6 | 151.9 | ||||||
Germany | 124.3 | 111.6 | 125.8 | ||||||
Finland | 84.7 | 90.1 | 97.9 | ||||||
Ireland | 33.1 | 32.5 | 32.2 | ||||||
Other foreign countries | 49.0 | 42.7 | 42.1 | ||||||
Total revenues | $ | 4,848.9 | $ | 4,637.2 | $ | 4,812.6 |
As of | As of | |||||
Long-term assets, net (In millions) | December\u00a031, 2025 | December\u00a031, 2024 | ||||
United States | $ | 5,267.4 | $ | 5,474.2 | ||
International | 2,019.9 | 1,826.1 | ||||
Total long-term assets (1) | $ | 7,287.3 | $ | 7,300.3 |
| (1) | Long-term assets are comprised of property, operating lease right-of-use assets, intangible assets, goodwill, deferred tax assets, net and other long-term assets. |
NOTE 12\u2014ACCUMULATED OTHER COMPREHENSIVE LOSS
The following table presents the change in accumulated other comprehensive loss by component:
Foreign | |||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Currency | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Pension Benefits | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Total | |||
Balance December\u00a031, 2023 | $ | (77.7) | $ | (0.5) | $ | (78.2) | |||
Other comprehensive income (loss) | (55.6) | 1.8 | (53.8) | ||||||
Balance December\u00a031, 2024 | $ | (133.3) | $ | 1.3 | $ | (132.0) | |||
Other comprehensive income (loss) | 95.0 | (5.2) | 89.8 | ||||||
Balance December\u00a031, 2025 | $ | (38.3) | $ | (3.9) | $ | (42.2) |
The tax effects allocated to each component of other comprehensive income (loss) is as follows:
Year Ended | |||||||||||||||||||||||||||
December\u00a031, 2025 | December\u00a031, 2024 | December\u00a031, 2023 | |||||||||||||||||||||||||
\u00a0\u00a0\u200b\u00a0\u200b | \u00a0\u00a0\u200b\u00a0\u200b | Tax | \u00a0\u00a0\u200b\u00a0\u200b | \u00a0\u00a0\u200b\u00a0\u200b | \u00a0\u00a0\u200b\u00a0\u200b | Tax | \u00a0\u00a0\u200b\u00a0\u200b | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Tax | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | ||||||||||||||||
Pre-Tax | (Expense) | Net-of-Tax | Pre-Tax | (Expense) | Net-of-Tax | Pre-Tax | (Expense) | Net-of-Tax | |||||||||||||||||||
(In\u00a0millions) | Amount | Benefit | Amount | Amount | Benefit | Amount | Amount | Benefit | Amount | ||||||||||||||||||
Unrealized foreign currency translation adjustment | $ | 94.8 | $ | 0.2 | $ | 95.0 | $ | (55.5) | $ | (0.1) | $ | (55.6) | $ | 0.5 | $ | 0.6 | $ | 1.1 | |||||||||
Pension and other benefit adjustments: | |||||||||||||||||||||||||||
Net gain (loss) arising during the period, net of tax | (5.2) | \u2014 | (5.2) | 1.8 | \u2014 | 1.8 | (2.0) | \u2014 | (2.0) | ||||||||||||||||||
Other comprehensive income (loss) | $ | 89.6 | $ | 0.2 | $ | 89.8 | $ | (53.7) | $ | (0.1) | $ | (53.8) | $ | (1.5) | $ | 0.6 | $ | (0.9) |
"}]},{"name":"rpt:f-2187","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"
Foreign | |||||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Currency | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Pension Benefits | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Total | |||
Balance December\u00a031, 2023 | $ | (77.7) | $ | (0.5) | $ | (78.2) | |||
Other comprehensive income (loss) | (55.6) | 1.8 | (53.8) | ||||||
Balance December\u00a031, 2024 | $ | (133.3) | $ | 1.3 | $ | (132.0) | |||
Other comprehensive income (loss) | 95.0 | (5.2) | 89.8 | ||||||
Balance December\u00a031, 2025 | $ | (38.3) | $ | (3.9) | $ | (42.2) |
"}]},{"name":"rpt:f-2188","factDimensions":{"xbrl:concept":"us-gaap:StockholdersEquity","xbrl:period":"2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedTranslationAdjustmentMember"},"factValues":[{"value":"-77700000","decimals":-5}]},{"name":"rpt:f-2189","factDimensions":{"xbrl:concept":"us-gaap:StockholdersEquity","xbrl:period":"2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember"},"factValues":[{"value":"-500000","decimals":-5}]},{"name":"rpt:f-2190","factDimensions":{"xbrl:concept":"us-gaap:StockholdersEquity","xbrl:period":"2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedOtherComprehensiveIncomeMember"},"factValues":[{"value":"-78200000","decimals":-5}]},{"name":"rpt:f-2191","factDimensions":{"xbrl:concept":"us-gaap:OtherComprehensiveIncomeLossNetOfTax","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedTranslationAdjustmentMember"},"factValues":[{"value":"-55600000","decimals":-5}]},{"name":"rpt:f-2192","factDimensions":{"xbrl:concept":"us-gaap:OtherComprehensiveIncomeLossNetOfTax","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember"},"factValues":[{"value":"1800000","decimals":-5}]},{"name":"rpt:f-2193","factDimensions":{"xbrl:concept":"us-gaap:OtherComprehensiveIncomeLossNetOfTax","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedOtherComprehensiveIncomeMember"},"factValues":[{"value":"-53800000","decimals":-5}]},{"name":"rpt:f-2194","factDimensions":{"xbrl:concept":"us-gaap:StockholdersEquity","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedTranslationAdjustmentMember"},"factValues":[{"value":"-133300000","decimals":-5}]},{"name":"rpt:f-2195","factDimensions":{"xbrl:concept":"us-gaap:StockholdersEquity","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember"},"factValues":[{"value":"1300000","decimals":-5}]},{"name":"rpt:f-2196","factDimensions":{"xbrl:concept":"us-gaap:StockholdersEquity","xbrl:period":"2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedOtherComprehensiveIncomeMember"},"factValues":[{"value":"-132000000","decimals":-5}]},{"name":"rpt:f-2197","factDimensions":{"xbrl:concept":"us-gaap:OtherComprehensiveIncomeLossNetOfTax","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedTranslationAdjustmentMember"},"factValues":[{"value":"95000000","decimals":-5}]},{"name":"rpt:f-2198","factDimensions":{"xbrl:concept":"us-gaap:OtherComprehensiveIncomeLossNetOfTax","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember"},"factValues":[{"value":"-5200000","decimals":-5}]},{"name":"rpt:f-2199","factDimensions":{"xbrl:concept":"us-gaap:OtherComprehensiveIncomeLossNetOfTax","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedOtherComprehensiveIncomeMember"},"factValues":[{"value":"89800000","decimals":-5}]},{"name":"rpt:f-2200","factDimensions":{"xbrl:concept":"us-gaap:StockholdersEquity","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedTranslationAdjustmentMember"},"factValues":[{"value":"-38300000","decimals":-5}]},{"name":"rpt:f-2201","factDimensions":{"xbrl:concept":"us-gaap:StockholdersEquity","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember"},"factValues":[{"value":"-3900000","decimals":-5}]},{"name":"rpt:f-2202","factDimensions":{"xbrl:concept":"us-gaap:StockholdersEquity","xbrl:period":"2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedOtherComprehensiveIncomeMember"},"factValues":[{"value":"-42200000","decimals":-5}]},{"name":"rpt:f-2203","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"
Year Ended | |||||||||||||||||||||||||||
December\u00a031, 2025 | December\u00a031, 2024 | December\u00a031, 2023 | |||||||||||||||||||||||||
\u00a0\u00a0\u200b\u00a0\u200b | \u00a0\u00a0\u200b\u00a0\u200b | Tax | \u00a0\u00a0\u200b\u00a0\u200b | \u00a0\u00a0\u200b\u00a0\u200b | \u00a0\u00a0\u200b\u00a0\u200b | Tax | \u00a0\u00a0\u200b\u00a0\u200b | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | Tax | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | ||||||||||||||||
Pre-Tax | (Expense) | Net-of-Tax | Pre-Tax | (Expense) | Net-of-Tax | Pre-Tax | (Expense) | Net-of-Tax | |||||||||||||||||||
(In\u00a0millions) | Amount | Benefit | Amount | Amount | Benefit | Amount | Amount | Benefit | Amount | ||||||||||||||||||
Unrealized foreign currency translation adjustment | $ | 94.8 | $ | 0.2 | $ | 95.0 | $ | (55.5) | $ | (0.1) | $ | (55.6) | $ | 0.5 | $ | 0.6 | $ | 1.1 | |||||||||
Pension and other benefit adjustments: | |||||||||||||||||||||||||||
Net gain (loss) arising during the period, net of tax | (5.2) | \u2014 | (5.2) | 1.8 | \u2014 | 1.8 | (2.0) | \u2014 | (2.0) | ||||||||||||||||||
Other comprehensive income (loss) | $ | 89.6 | $ | 0.2 | $ | 89.8 | $ | (53.7) | $ | (0.1) | $ | (53.8) | $ | (1.5) | $ | 0.6 | $ | (0.9) |
"}]},{"name":"rpt:f-2204","factDimensions":{"xbrl:concept":"us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedTranslationAdjustmentMember"},"factValues":[{"value":"94800000","decimals":-5}]},{"name":"rpt:f-2205","factDimensions":{"xbrl:concept":"us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedTranslationAdjustmentMember"},"factValues":[{"value":"-200000","decimals":-5}]},{"name":"rpt:f-2206","factDimensions":{"xbrl:concept":"us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedTranslationAdjustmentMember"},"factValues":[{"value":"95000000","decimals":-5}]},{"name":"rpt:f-2207","factDimensions":{"xbrl:concept":"us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedTranslationAdjustmentMember"},"factValues":[{"value":"-55500000","decimals":-5}]},{"name":"rpt:f-2208","factDimensions":{"xbrl:concept":"us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedTranslationAdjustmentMember"},"factValues":[{"value":"100000","decimals":-5}]},{"name":"rpt:f-2209","factDimensions":{"xbrl:concept":"us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedTranslationAdjustmentMember"},"factValues":[{"value":"-55600000","decimals":-5}]},{"name":"rpt:f-2210","factDimensions":{"xbrl:concept":"us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedTranslationAdjustmentMember"},"factValues":[{"value":"500000","decimals":-5}]},{"name":"rpt:f-2211","factDimensions":{"xbrl:concept":"us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedTranslationAdjustmentMember"},"factValues":[{"value":"-600000","decimals":-5}]},{"name":"rpt:f-2212","factDimensions":{"xbrl:concept":"us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedTranslationAdjustmentMember"},"factValues":[{"value":"1100000","decimals":-5}]},{"name":"rpt:f-2213","factDimensions":{"xbrl:concept":"us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"},"factValues":[{"value":"-5200000","decimals":-5}]},{"name":"rpt:f-2214","factDimensions":{"xbrl:concept":"us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"},"factValues":[{"value":"-5200000","decimals":-5}]},{"name":"rpt:f-2215","factDimensions":{"xbrl:concept":"us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"},"factValues":[{"value":"1800000","decimals":-5}]},{"name":"rpt:f-2216","factDimensions":{"xbrl:concept":"us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"},"factValues":[{"value":"1800000","decimals":-5}]},{"name":"rpt:f-2217","factDimensions":{"xbrl:concept":"us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"},"factValues":[{"value":"-2000000","decimals":-5}]},{"name":"rpt:f-2218","factDimensions":{"xbrl:concept":"us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:StatementEquityComponentsAxis":"us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"},"factValues":[{"value":"-2000000","decimals":-5}]},{"name":"rpt:f-2219","factDimensions":{"xbrl:concept":"us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"89600000","decimals":-5}]},{"name":"rpt:f-2220","factDimensions":{"xbrl:concept":"us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-200000","decimals":-5}]},{"name":"rpt:f-2221","factDimensions":{"xbrl:concept":"us-gaap:OtherComprehensiveIncomeLossNetOfTax","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"89800000","decimals":-5}]},{"name":"rpt:f-2222","factDimensions":{"xbrl:concept":"us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-53700000","decimals":-5}]},{"name":"rpt:f-2223","factDimensions":{"xbrl:concept":"us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"100000","decimals":-5}]},{"name":"rpt:f-2224","factDimensions":{"xbrl:concept":"us-gaap:OtherComprehensiveIncomeLossNetOfTax","xbrl:period":"2024-01-01T00:00:00/2025-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-53800000","decimals":-5}]},{"name":"rpt:f-2225","factDimensions":{"xbrl:concept":"us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-1500000","decimals":-5}]},{"name":"rpt:f-2226","factDimensions":{"xbrl:concept":"us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-600000","decimals":-5}]},{"name":"rpt:f-2227","factDimensions":{"xbrl:concept":"us-gaap:OtherComprehensiveIncomeLossNetOfTax","xbrl:period":"2023-01-01T00:00:00/2024-01-01T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD"},"factValues":[{"value":"-900000","decimals":-5}]},{"name":"rpt:f-2228","factDimensions":{"xbrl:concept":"us-gaap:EarningsPerShareTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"
NOTE 13\u2014LOSS PER SHARE
Basic loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding. Diluted loss per share includes the effects of unvested RSUs with a service condition only, unvested contingently issuable PSUs that have service and performance conditions, and shares issuable upon conversion of the Existing Exchangeable Notes and New Exchangeable Notes, if dilutive. Diluted earnings per share is computed using the treasury stock method for the RSUs and PSUs and the if-converted method for the Existing Exchangeable Notes and New Exchangeable Notes.
The following table sets forth the computation of basic and diluted loss per common share:
Year Ended | Year Ended | Year Ended | |||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2023 | |||
Numerator: | |||||||||
Net loss for basic and diluted loss per share | $ | (632.4) | $ | (352.6) | $ | (396.6) | |||
Denominator (shares in thousands): | |||||||||
Weighted average shares for basic and diluted loss per common share | \u00a0 | 472,899 | \u00a0 | 332,920 | \u00a0 | 167,644 | |||
Basic and diluted loss per common share | $ | (1.34) | $ | (1.06) | $ | (2.37) |
Vested RSUs and PSUs have dividend rights identical to the Company\u2019s Common Stock and are treated as outstanding shares for purposes of computing basic and diluted loss per share.
Included in the computation of basic loss per share are 1,869,173 contingently issuable RSUs whose issuance conditions were satisfied when the grantee attained retirement eligibility or when the normal service conditions had been met. These contingently issuable RSUs will not be issued until their vesting dates. For the year ended December 31, 2025, December 31, 2024, and December 31, 2023, unvested RSUs of 2,703,905; 1,662,429; and 272,469, respectively, were not included in the computation of diluted loss per share because they would be anti-dilutive.
All Tranche Year PSUs which had been attained at December 31, 2025, December 31, 2024, and December 31, 2023 were included in basic loss per share for each respective period because the issuance of the related shares were contingent only upon the passage of time. Therefore, no granted Tranche Year PSUs at December 31, 2025, December 31, 2024, and December 31, 2023 could further dilute basic loss per share.
The Company has excluded approximately 22.3 million shares issuable upon conversion of the Existing Exchangeable Notes from the computation of diluted loss per share for the year ended December 31, 2025, because they would be anti-dilutive. The Company had excluded approximately 85.2 million shares issuable upon conversion of the Existing Exchangeable Notes from the computation of diluted loss per share for the year ended December 31, 2024, because they would have been anti-dilutive.
The New Exchangeable Notes are convertible into between 77.1 million and 141.4 million shares of Common Stock which could potentially dilute future basic earnings per share. Additionally, the Company has agreed to pay $21.3 million of fees payable in shares of Common Stock to holders of the New Exchangeable Notes. These additional shares could also potentially dilute future basic earnings per share. See Note 7\u2014Corporate Borrowings and Finance Lease Liabilities for more information.
"}]},{"name":"rpt:f-2229","factDimensions":{"xbrl:concept":"us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"Year Ended | Year Ended | Year Ended | |||||||
(In millions) | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2025 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2024 | \u00a0\u00a0\u200b\u00a0\u200b\u00a0\u200b | December\u00a031, 2023 | |||
Numerator: | |||||||||
Net loss for basic and diluted loss per share | $ | (632.4) | $ | (352.6) | $ | (396.6) | |||
Denominator (shares in thousands): | |||||||||
Weighted average shares for basic and diluted loss per common share | \u00a0 | 472,899 | \u00a0 | 332,920 | \u00a0 | 167,644 | |||
Basic and diluted loss per common share | $ | (1.34) | $ | (1.06) | $ | (2.37) |
NOTE 14\u2014SUBSEQUENT EVENTS
Share Issuances. In February 2026, the Company entered into a sales and registration agreement (the \u201c2026 Sales and Registration Agreement\u201d) with (1) Goldman Sachs & Co. LLC, B. Riley Securities, Inc. and Yorkville Securities, LLC, from time to time acting as sales agents (in such capacity, the \u201cSales Agents\u201d) and (2) Goldman Sachs & Co. LLC, as the Forward Seller of any and all Hedging Shares offered by the Forward Counterparty (in each case, as
defined below), and Goldman Sachs International, acting in its capacity as Forward Counterparty, relating to shares of Common Stock of the Company having an aggregate offering price of up to $150,000,000.
In accordance with the terms of the 2026 Sales and Registration Agreement, the Company may issue and sell shares of Common Stock covered by the prospectus supplement at any time and from time to time through the Sales Agents. The Sales Agents may act as agent on the Company\u2019s behalf or purchase shares of Common Stock from the Company as principal for its own account.
The Company also entered into a master confirmation (the \u201cMaster Confirmation\u201d) with Goldman Sachs International (in its capacity as buyer under any Forward (as defined herein), the \u201cForward Counterparty\u201d) pursuant to which the Company expects to enter into one or more collared forward transactions (each a \u201cForward\u201d), under which the Company agreed to sell up to the number of shares of Common Stock specified in such Forward (subject to adjustment as set forth therein) to the Forward Counterparty. If the Company enters into a Forward with the Forward Counterparty, to establish a hedge position under such Forward, the Forward Counterparty will have a pledge of up to the maximum number of shares of Common Stock deliverable under such Forward (the \u201cHedging Shares\u201d) from the Company, with a right to rehypothecate the pledged shares, and will rehypothecate and sell up to such maximum number of shares through Goldman Sachs & Co. LLC acting as the statutory underwriter (in such capacity, the \u201cForward Seller\u201d) in an offering under a prospectus supplement and accompanying prospectus over a period of time to be agreed between the Company and the Forward Counterparty for such Forward (an \u201cInitial Hedging Period\u201d), all subject to the terms of the 2026 Sales and Registration Agreement. The Initial Hedging Period for any Forward that the Company may enter into during a reporting quarter is expected to terminate during such reporting quarter or shortly thereafter. The establishment of such hedge positions could have the effect of decreasing, or limiting an increase in, the market price of Common Stock.
The Company has been advised by the Forward Counterparty that it expects that, on the same days during the Initial Hedging Period when it is selling a number of Hedging Shares underlying the Forward, the Forward Counterparty or its affiliate(s) will be contemporaneously purchasing a substantial portion of such number of shares in the open market for its own account, as the Forward Counterparty expects its initial hedge position in respect of any Forward to be substantially less than the number of shares underlying such Forward. Such purchases in the open market may have the effect of increasing, or limiting a decrease in the market price of Common Stock. The number of shares underlying any Forward will be reduced in the event that the Forward Counterparty is unable to introduce the maximum number of shares deliverable under the Forward into the public market during the Initial Hedging Period (including as a result of the prospectus being unavailable at any time during such Initial Hedging Period).
In addition, the Company has been advised by the Forward Counterparty that the Forward Counterparty expects to dynamically modify its hedge positions for its own account by it or its affiliate(s) buying or selling shares of Common Stock or engaging in derivatives or other transactions with respect to Common Stock from time to time during the term of a particular Forward, including during the valuation period for such Forward. The purchases and sales of shares of Common Stock or other hedging transactions by the Forward Counterparty to modify the Forward Counterparty\u2019s hedge positions from time to time during the term of the Forward may variously have a positive, negative or neutral impact on the market price of Common Stock, depending on market conditions at such times.
The settlement price per share under a Forward at maturity (whether on the scheduled maturity date or an accelerated maturity date, as applicable, for the Forward or a portion thereof) will be based on the arithmetic average of volume weighted prices of Common Stock during the valuation period for such Forward that will run between the completion of the Initial Hedging Period for such Forward or shortly thereafter and applicable maturity (the \u201cReference Price\u201d), subject to the agreed forward floor and cap prices. The Forward will specify the floor percentage (which will be less than 100%) and the cap percentage (which will be more than 100%). Upon completion of the Initial Hedging Period with respect to such Forward, the forward floor price and the forward cap price will be determined by multiplying the weighted average prices at which the Forward Counterparty will have sold the shares of Common Stock during the Initial Hedging Period to establish its hedge position for such Forward by the floor percentage and the cap percentage, respectively. The floor price is intended to mitigate the downside risk of any potential decline in the Reference Price below the floor price during the valuation period, but the cap price would also limit the potential upside benefit to the extent the Reference Price were to exceed the cap price during the valuation period. The Company will determine the scheduled maturity of a Forward at the time we enter into such Forward based, among other factors, upon the market conditions at the time, and the Company currently expects that such scheduled maturity will be approximately six months after completion of the Initial Hedging Period for such Forward.
If the Company enters into any Forward with the Forward Counterparty, the Company expects to receive under such Forward, (x) an initial cash payment after completion of the respective Initial Hedging Period for such Forward or shortly thereafter, based on, among other factors, the floor price and prepayment percentage agreed for such Forward, if any and (y) at maturity of such Forward (or a portion thereof), an additional payment, if any, to the extent that the total amount due under such Forward exceeds the initial cash payment. If the number of the shares of Common Stock underlying any Forward is reduced upon completion of the Initial Hedging Period therefor as described above, the Company would not be entitled to receive the full amounts upon prepayment and/or at maturity of such Forward that it may initially anticipate at the time of entry into such Forward.
Through February 20, 2026, the Company was paid $26.2 million as initial gross cash proceeds for 20.4 million shares of Common Stock sold in at-the-market offerings. Fees paid to sales agents were approximately $0.5 million.
Indenture Amendments. On January 29, 2026, Holdings and Muvico, entered into a letter agreement (the \u201cLetter Agreement\u201d) with certain holders of Muvico\u2019s New 2029 Notes, (such holders, the \u201cNew 2029 Noteholders\u201d) pursuant to which Holdings, Muvico, and the 2029 Noteholders agreed to amend the New 2029 Notes Indenture. The amendments (the \u201cIndenture Amendments\u201d) will, among other things, provide the Company with the flexibility to:
| \u25cf | refinance its Credit Agreement and the Odeon Notes issued by Odeon Finco PLC, a wholly-owned direct subsidiary of OCGL and an indirect subsidiary of Holdings, with new debt that may be secured and guaranteed by Holdings, OCGL, and Muvico, and |
| \u25cf | incur up to an additional $50 million of secured debt under the New 2029 Notes Indenture. |
Pursuant to the Letter Agreement, the parties agreed to cooperate (including cooperating with the trustee and the notes collateral agent) in good faith to memorialize and effectuate the Indenture Amendments as soon as reasonably practicable, and in any event, no later than February 23, 2026. In consideration for the 2029 Noteholders\u2019 agreement to the Indenture Amendments, the Company will pay the 2029 Noteholders a maximum fee of up to 17,806,866 shares of Common Stock (the \u201cConsent Fee\u201d), subject to a reduction depending on the trading price of the Common Stock for a period following the date of the Letter Agreement.
"}]},{"name":"rpt:f-2255","factDimensions":{"xbrl:concept":"amch:MaximumAggregateOfferingPrice","xbrl:period":"2026-02-21T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember","us-gaap:SubsidiarySaleOfStockAxis":"amch:SalesAndRegistrationAgreementMember"},"factValues":[{"value":"150000000","decimals":0}]},{"name":"rpt:f-2256","factDimensions":{"xbrl:concept":"us-gaap:ProceedsFromIssuanceOfCommonStock","xbrl:period":"2026-02-01T00:00:00/2026-02-21T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember","us-gaap:SubsidiarySaleOfStockAxis":"amch:AtMarketOfferingsMember"},"factValues":[{"value":"26200000","decimals":-5}]},{"name":"rpt:f-2257","factDimensions":{"xbrl:concept":"us-gaap:StockIssuedDuringPeriodSharesNewIssues","xbrl:period":"2026-02-01T00:00:00/2026-02-21T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"xbrla:shares","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember","us-gaap:SubsidiarySaleOfStockAxis":"amch:AtMarketOfferingsMember"},"factValues":[{"value":"20400000","decimals":-5}]},{"name":"rpt:f-2258","factDimensions":{"xbrl:concept":"us-gaap:PaymentsOfStockIssuanceCosts","xbrl:period":"2026-02-01T00:00:00/2026-02-21T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember","us-gaap:SubsidiarySaleOfStockAxis":"amch:AtMarketOfferingsMember"},"factValues":[{"value":"500000","decimals":-5}]},{"name":"rpt:f-2259","factDimensions":{"xbrl:concept":"amch:DebtInstrumentMaximumAdditionalBorrowingCapacity","xbrl:period":"2026-01-30T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"iso4217:USD","us-gaap:DebtInstrumentAxis":"amch:NewSeniorSecuredNotesDue2029Member","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember"},"factValues":[{"value":"50000000","decimals":-6}]},{"name":"rpt:f-2260","factDimensions":{"xbrl:concept":"amch:DebtInstrumentMaximumConsentFeesPayableInSharesOfEntity","xbrl:period":"2026-01-30T00:00:00","xbrl:entity":"cik:0001411579","xbrl:unit":"xbrla:shares","us-gaap:DebtInstrumentAxis":"amch:NewSeniorSecuredNotesDue2029Member","us-gaap:SubsequentEventTypeAxis":"us-gaap:SubsequentEventMember"},"factValues":[{"value":"17806866"}]},{"name":"rpt:f-2261","factDimensions":{"xbrl:concept":"ecd:NonRule10b51ArrAdoptedFlag","xbrl:period":"2025-10-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"false"}]},{"name":"rpt:f-2262","factDimensions":{"xbrl:concept":"ecd:Rule10b51ArrAdoptedFlag","xbrl:period":"2025-10-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"false"}]},{"name":"rpt:f-2263","factDimensions":{"xbrl:concept":"ecd:NonRule10b51ArrTrmntdFlag","xbrl:period":"2025-10-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"false"}]},{"name":"rpt:f-2264","factDimensions":{"xbrl:concept":"ecd:Rule10b51ArrTrmntdFlag","xbrl:period":"2025-10-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"false"}]},{"name":"rpt:f-2265","factDimensions":{"xbrl:concept":"ecd:InsiderTrdPoliciesProcAdoptedFlag","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"true"}]},{"name":"rpt:f-2266","factDimensions":{"xbrl:concept":"dei:AuditorFirmId","xbrl:period":"2025-01-01T00:00:00/2026-01-01T00:00:00","xbrl:entity":"cik:0001411579"},"factValues":[{"value":"42"}]}]}}